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INFLUENCE AND REGULATION OF PCBP2 AND YTHDF2 RNA-BINDING PROTEINS 





Embryonic stem cells (ESCs) are able to self-renew or differentiate into any cell type in the 
body, a property known as pluripotency that enables them to initiate early growth and 
development. However, the ethical implications of harvesting and manipulating ESCs hinders 
their use in basic research and the clinical applications. Thus, the discovery that somatic cells 
can be exogenously reprogrammed into induced pluripotent stem cells (iPSCs) offers new and 
exciting possibilities for gene therapy, personalized medicine and basic research. However, 
more research is needed into the mechanisms involved in regulating pluripotency in order for 
iPSCs to reach their full potential in the research lab and clinic.  
To maintain a state of self-renewal, yet also be able to rapidly differentiate in response to 
external signals, pluripotent stem cells need to exert tight control over gene expression through 
transcriptional and post-transcriptional mechanisms. There are several notable transcriptional 
networks that regulate pluripotency, but the post-transcriptional mechanisms remain poorly 
characterized. mRNA decay is one form of post-transcriptional regulation that can help to both 
maintain the steady-state of a transcriptome or facilitate its rapid remodeling. To this end, 
degradation rates are influenced by the elements contained in an mRNA and the RNA-binding 
proteins (RBPs) they associate with. Previous reports have indicated the RNA modification N6-
methyladenosine (m6A) and C-rich sequence elements (CREs) can affect mRNA decay in 
pluripotent stem cells. Therefore, we sought to further understand the roles of m6A and CREs in 
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mRNA decay in stem cells by characterizing the expression and mRNA targets of two RBPs that 
recognize these elements, YTHDF2 and PCBP2, respectively. 
In this thesis, I report YTHDF2 is differentially regulated in pluripotent and differentiated cells 
and that YTHDF2 contributes to pluripotency by targeting a group of mRNAs encoding factors 
important for neural development. The down-regulation of YTHDF2 during neural differentiation 
is consistent with increased expression of neural factors during this time. Moreover, YTHDF2 
expression is regulated at the level of translation via elements located in the first 300 
nucleotides of the 3’ untranslated region of YTHDF2 mRNA. Based on these results, I propose 
that stem cells are primed for rapid differentiation by transcribing low levels of mRNAs encoding 
neural factors that are subsequently targeted for degradation, in part by YTHDF2, until 
differentiation is induced. 
On the other hand, PCBP2 is up-regulated upon differentiation of pluripotent stem cells and 
regulates several mRNAs associated with pluripotency and development, including LIN28B. 
Notably, expression of long non-coding RNAs (lncRNAs) that contain human endogenous 
retrovirus element H (HERV-H) is influenced by PCBP2. HERV-H lncRNAs are almost 
exclusively expressed in stem cells and play a role in maintaining a pluripotent state, although 
their functions are not fully understood. Intriguingly, some HERV-lncRNAs can also regulate 
PCBP2 expression, as altering the expression of LINC01356 or LINC00458 effects PCBP2 
protein levels. Based on these results, I propose the reciprocal regulation of PCBP2 and HERV-
H lncRNAs influences whether stem cells maintain a state of self-renewal or differentiate. 
Taken together, these findings demonstrate that YTHDF2 and PCBP2 post-transcriptionally 
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Chapter 1: Introduction 
 
 
This project addresses two important aspects of the contribution of RNA-binding proteins 
that contribute to post-transcriptional control mechanisms to human stem cell biology. First, we 
explored the role of the N6-methyladenosine (m6A) reader protein YTHDF2 on the targeted 
regulation of gene expression during pluripotency and beyond. Next, we investigated the role of 
poly(C)-binding protein 2 (PCBP2), a C-rich element (CRE) RNA-binding protein, on stem cell 
biology due to the fact that messenger RNAs (mRNAs) containing CREs are dramatically 
regulated during development. Collectively, this project provides a variety of insights into the 
post-transcriptional control of early development. This introduction will begin with an overview of 
stem cell biology followed by a discussion of mechanisms of mRNA decay since this post-
transcriptional process is the major cytoplasmic contributor to changes in gene expression 
patterns. Finally, I will provide the detailed scientific premise for studying both m6A RNA 
methylation as well as PCBP proteins in the context of stem cell biology. 
 
1.1 Stem cells 
1.1.1 Embryonic stem cells 
Embryonic stem cells (ESCs) possess the unique characteristics of self-renewal and 
pluripotency, granting them the ability to replicate indefinitely or differentiate into other cell 
types. These exclusive traits allow them to play a critical role during development of an 
organism (Odorico et al. 2001). During embryogenesis, ESCs differentiate in order to form the 
three primary germ layers: endoderm, mesoderm and ectoderm (Itskovitz-Eldor et al. 2000). In 
adult tissue, multipotent stem cells can act as reservoirs, replenishing cells which are rapidly 
turned over or damaged. For example, the hematopoietic stem cells (HSCs) in bone marrow 
function to continually replace red and white blood cells (Crane et al. 2017). 
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1.1.2 Induced pluripotent stem cells 
The field of stem cell biology was revolutionized in the mid-2000s when Yamanaka and 
colleagues demonstrated that both mouse and human adult fibroblasts, aka somatic cells, can 
be reprogrammed into induced pluripotent stem cells (iPSCs) simply by transfecting in a group 
of transcription factors (Takahashi and Yamanaka 2006; Takahashi et al. 2007). These genes 
OCT4, SOX2, KLF4 and MYC, along with NANOG (Boyer et al. 2005; Pan and Thomson 2007), 
became known as the major pluripotency factors. Since then, various combinations of 
transcription factors, RNA-binding proteins (RBPs) and microRNAs (miRNAs) have been shown 
to yield iPSCs from somatic cells (Takahashi and Yamanaka 2016; Zviran et al. 2018).  
 
1.1.3 Naïve and primed pluripotent states 
Pluripotency is dynamic over the course of development. Typically, pluripotent stem cells 
can be classified as either naïve or primed based on their ability to maintain self-renewal 
following inhibition of mitogen-activated protein kinase kinase (MEK) signaling (Nichols and 
Smith 2009; Weinberger et al. 2016). MEK is a member of the MAPK/ERK signaling pathway 
and thus contributes to the regulation of various cellular processes including cell cycle entry and 
proliferation, differentiation, survival and apoptosis (Sun et al. 2015). Naïve stem cells exhibit 
higher expression of pluripotency factors, coupled with lower expression of lineage-specific 
factors, which enables them to maintain a state of self-renewal following abrogation of MEK 
signaling and/or other epigenetic regulators (Nichols and Smith 2009; Weinberger et al. 2016). 
Conversely, the reciprocal expression profile is observed in primed stem cells, lower 
pluripotency and higher lineage-specific expression, which results in differentiation and/or 
apoptosis following MEK inhibition. The current model in the field suggests naïve stem cells 
transition into primed stem cells over the course of development to enable a more rapid 
response when differentiation is induced (Weinberger et al. 2016; Collier et al. 2017; Kalkan et 
al. 2017; Ware et al. 2014). iPSCs, particularly human iPSCs, are typically reprogrammed into a 
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primed state. However, there are ways to coax iPSCs into a naïve state and maintain them 
there (Gafni et al. 2013; Weinberger et al. 2016). It is important to highlight these aspects of 
pluripotency, as this study works with human iPSCs reprogrammed from foreskin fibroblasts 
(HFFs). Thus, our results reflect the response of stem cells in a primed state. 
 
1.1.4 Clinical applications of iPSCs 
The ability to reprogram easily obtainable cell types, such as skin fibroblasts, into pluripotent 
stem cells and subsequently induce differentiation into less accessible cell types (such as 
neurons) provides new avenues for gene therapy, personalized medicine and basic research 
(Cubillo et al. 2018; Avior et al. 2016; Karagiannis 2019). In fact, some of these avenues are 
already being explored. In 2017, one of the first peer-reviewed papers using iPSC 
transplantation as a treatment described its success in treating age-related macular 
degeneration (Mandai et al. 2017). Currently, clinical trials are underway investigating an iPSC-
derived neuron replacement therapy for Parkinson’s disease (Loring 2018). In regards to basic 
research, differentiation of patient iPSCs into neural cell types has been utilized to study 
Alzheimer’s disease for several years (Penney et al. 2019). Furthermore, reprogramming grants 
researchers the opportunity to study gene expression in different cell types that are genetically 
identical.  
Despite the plethora of clinical applications, the precise mechanisms by which stem cells 
control gene expression to maintain pluripotency and self-renewal or drive differentiation remain 
poorly characterized. Moreover, implantation of iPSCs into primary tissue has shown high 
potential for tumor formation (Yoshihara et al. 2017). Therefore, additional insight into the 
mechanisms governing pluripotency will help to improve the efficiency and accuracy of 
reprogramming and allow the full clinical potential of iPSCs to be met. 
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1.2 Regulation of the transcriptome in stem cells 
Stem cell differentiation events are prevalent throughout the lifetime of an organism. From 
the formation of the germ layers in early development (Rossant and Tam 2017; Stirparo et al. 
2018), to differentiation of HSCs to replenish lost blood cells in adults (Crane et al. 2017); these 
events play a critical role in development, regeneration  and maintenance of tissues and organs. 
The ability of stem cells to self-renew, while remaining poised to rapidly differentiate in response 
to an external cue, requires complex, properly executed maneuvers to modulate the 
transcriptome and ensure the desired outcome is achieved.  
 
1.2.1 Transcriptional regulation 
At the level of transcription, factors like OCT4, SOX2, KLF4, NANOG and others promote 
expression of genes that favor a pluripotent state (Cacchiarelli et al. 2015; Hainer et al. 2019). 
For example, OCT4 promotes the expression of several members of the 
TGFβ/ACTIVIN/NODAL signaling pathway, including NODAL itself, which is crucial for 
maintaining pluripotency in ESCs (Babaie et al. 2007; James et al. 2005). Likewise, NANOG 
drives transcription of ESSRB in stem cells which facilitates self-renewal independent of 
cytokines like Leukemia Inhibitory Factor (LIF) (Festuccia et al. 2012; Latos et al. 2015). 
Alternatively, up-regulation of lineage-specific transcription factors like PAX6 for the ectoderm or 
FOXA2 for the endoderm during differentiation (Kuang et al. 2019), promotes acquisition of 
gene expression programs for specific germ layers (Tsankov et al. 2015; Godoy et al. 2018; 
Stirparo et al. 2018). Concomitantly, substantial chromatin remodeling occurs during 
differentiation which influences the transcription rates of pluripotent and lineage-specific genes 
(Alajem et al. 2015; Kurimoto et al. 2015). Notably, the promoters of many lineage-specific 
genes exhibit bivalent modifications (i.e. both activating (H3K4me3) and repressive 
(H3K27me3) marks are present). This bivalent modification keeps them in a transcriptionally 
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silent state, but poised for immediate action (Fisher and Fisher 2011; Harikumar and Meshorer 
2015). Together, these events provide a foundation for the dynamic transcriptome of stem cells. 
 
1.2.2 Post-transcriptional regulation 
Transcription is an energy-expensive and time-consuming process that relies on multiple 
downstream events (processing, export, translation, decay etc.) to impact cell function. The 
rapid and highly coordinated transcriptome remodeling that occurs during differentiation requires 
extensive post-transcriptional regulation (Zhao et al. 2017a; Serrano-Gomez et al. 2016; 
Eckersley-Maslin et al. 2018). Stem cells utilize a variety of regulatory elements and factors 
including RBPs (Emani et al. 2015; Ju Lee et al. 2017), RNA modifications (Heck and Wilusz 
2019; Geula et al. 2015), miRNAs (Xu et al. 2009; Zeng et al. 2018; Worringer et al. 2014) and 
lncRNAs (Santoni et al. 2012; Wang et al. 2013b; Guttman et al. 2011) to facilitate rapid 
remodeling of the transcriptome when the time is right; but also to act as a preventative 
measure against precocious differentiation. These factors can achieve the desired regulation 
through multiple mechanisms. In this study, we chose to focus on mRNA decay because it is 
integral to remodeling the transcriptome during differentiation (Oh et al. 2018; Zhao et al. 2017b; 
Zhang et al. 2017a) and to restraining expression of lineage-specific genes in pluripotent cells 
(Lloret-Llinares et al. 2018; Lou et al. 2014). Moreover, mRNA decay plays a role in the 
reprogramming of somatic cells into iPSCs (Kami et al. 2018). Despite these findings, relatively 
little is known about the mechanisms and factors that facilitate mRNA decay in pluripotent stem 
cells. Thus, understanding the interplay or networking between the RNA decay machinery and 
other aspects of gene expression in stem cells is needed to further elucidate the depth of 
regulation that occurs. 
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1.3 mRNA decay as a regulatory mechanism1 
Degradation plays a major role in regulating both the quantity and quality of RNA in the cell. 
The abundance of an RNA transcript is a reflection of both its rate of synthesis and degradation. 
Beyond the examples specific to pluripotency and differentiation mentioned above, there are 
numerous reports regarding the regulation of gene expression associated with major cellular 
responses occurring at the level of differential RNA stability (Chen and Shyu 2017; Yamada and 
Akimitsu 2019). There is also a growing body of evidence to suggest cross-communication or 
buffering occurs between transcription and RNA decay that contributes to the homeostasis of 
gene expression (Chavèz et al. 2016). Below, we provide an overview of the mRNA decay 
pathway including the major steps and players involved. See Figure 1.1 for a diagram of the 
mRNA decay pathway. 
 
1.4 The major steps and mechanisms of mRNA decay in eukaryotes1 
1.4.1 Step one: deadenylation/removal of the poly(A) tail 
Deadenylation is the initial, and often rate-limiting step of the traditional exonucleolytic decay 
pathways (Fig. 1.1). Deadenylases are recruited to RNA substrates by a variety of RBPs and 
complexes (Du et al. 2016a; Stowell et al. 2016; Yamaji et al. 2017). There are two enzymatic 
complexes which carry out the majority of cytoplasmic deadenylation in eukaryotes (Wahle and 
Winkler 2013). The Poly(A) Nuclease (PAN) PAN2/PAN3 complex is thought to be responsible 
for preliminary poly(A) trimming (Wolf and Passmore 2014). PAN2 functions as the catalytically 
active subunit, while PAN3 is critical in recruitment of PAN2 to the poly(A) tail and efficient 
poly(A) tail shortening (Jonas et al. 2014; Schäfer et al. 2014; Wolf et al. 2014).  
  
                                                
1 Section 1.3, 1.4 and the associated figure are modified from: The Interplay between the RNA Decay and 




   
 
Figure 1.1:  The multiple pathways for exonucleases to gain access to RNAs targeted for 
degradation. 5’-3’ exoribonucleases (XRN1) require a 5’ monophosphate while 3’-5’ 
exoribonucleases (the exosome) require an accessible 3’ hydroxyl. A 5’ monophosphate can be 
generated in a regulated fashion by the process of decapping, which can be deadenylation [poly(A) 
tail shortening]-dependent or deadenylation-independent. Deadenylation itself generates an 
accessible 3’ hydroxyl for exoribonucleases. In the 3’-5’ exonuclease pathway, the scavenger 
decapping enzyme DCPS acts on short capped oligonucleotides to promote full degradation. Finally, 
rather than remodeling the natural 5’ and 3’ ends of the target mRNA, endoribonucleases, including 
the RISC complex of the RNAi pathway, can cleave a transcript internally and generate fragments 




Subsequently, the bulk of deadenylation is carried out by the CCR4-NOT complex (Collart and 
Panasenko 2017; Tang et al. 2019). While several proteins comprise this complex, the three key 
proteins appear to be NOT1, CCR4 (CNOT6) and CAF1/POP2 (CNOT7). NOT1 serves as the 
structural backbone of the complex (Basquin et al. 2012), whereas CCR4 and CAF1/POP2 are 
the catalytically active deadenylases (Maryati et al. 2015). Recent evidence suggests that CCR4 
and CAF1/POP2 deadenylases can also remove terminal non-adenosine residues, if the 
complex is anchored to the RNA substrate by upstream adenosine tracts (Niinuma et al. 2016). 
Finally, in addition to PAN2/PAN3 and CCR4-NOT, eukaryotic cells also contain a number of 
additional deadenylases which can influence poly(A) tail length (Skeparnias et al. 2017) and 
play roles in small RNA biogenesis. Of these, PARN, the most extensively studied, can interact 
with the 5’ cap of mRNA substrate to enhance enzymatic activity/processivity (Virtanen et al. 
2013; Niedzwiecka et al. 2016). Several studies have reported that polyadenylation, specifically 
alternative polyadenylation (aka APA), is important for pluripotency and reprogramming 
(Brumbaugh et al. 2018; Lackford et al. 2014; Ji and Tian 2009). 
 
1.4.2 Step two: decapping/removal of the 5’ cap to generate a 5’ monophosphate 
In addition to a key role in promoting translation initiation, the 7-methyl-guanosine (m7G) cap 
on mRNAs also serves to protect transcripts from highly active 5’ to 3’ exoribonucleases that are 
present in both the nucleus and cytoplasm of eukaryotic cells (Fig. 1.1) (Jones et al. 2012). 
Thus, the process of decapping is a crucial step in the decay of many mRNAs, and can be 
either deadenylation-dependent or deadenylation-independent. The majority of decapping 
activity is thought to be provided by DCP2, but recent work has identified seven additional 
NUDIX proteins (e.g. NUDT3 and NUDT16) as well as DXO proteins that act on distinct RNA 
subsets (Grudzien-Nogalska and Kiledjian 2017) and alternative cap structures (Jiao et al. 
2017). Typically, at least a portion of these decapping enzymes can be found in membraneless 
compartments of ribonucleoprotein (RNP) complexes known as Processing bodies (P-bodies) 
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(Luo et al. 2018). The well-characterized DCP2 enzyme requires several additional co-factors in 
vivo to effectively access mRNA substrates, as well as attain an optimally active enzymatic 
conformation (Wurm et al. 2017). Decapping cofactors include DCP1, the Lsm1-7 complex, 
PATL1 (Pat1), DDX6 (Dhh1), LSM14 (Scd6) and a set of EDC proteins. 
 
1.4.3 Step three (Option 1): 5’ to 3’ exoribonucleolytic decay in the cytoplasm 
XRN1 is the primary 5’ to 3’ cytoplasmic exonuclease and is well-conserved throughout 
eukaryotes (Fig. 1.1) (Jones et al. 2012). XRN1 preferentially degrades RNAs with a 5’ 
monophosphate end – precisely corresponding to the 5’ termini left following mRNA decapping 
or most endonucleolytic RNA cleavages. XRN1 is a highly processive enzyme that generally 
can only be stalled by rather elaborate RNA structures – for example, three helix junction knot-
like structures found in flavivirus RNAs (Chapman et al. 2014). Interestingly, there is growing 
evidence that XRN1 plays a key role in overall RNA decay and homeostasis of gene expression 
(Chavèz et al. 2016). Repression of XRN1 by stalling on flavivirus structures results in a 
concomitant repression of decapping and deadenylation in the infected cell (Moon et al. 2012, 
2015). This could be due to interactions between XRN1 and other proteins involved in RNA 
decay (Chang et al. 2019). In addition, buffering effects between mRNA transcription and 
degradation rates appear to be mediated by XRN1 in some fashion (Timmers and Tora 2018; 
Singh et al. 2019). 
 
1.4.4 Step three (Option 2): 3’ to 5’ exonucleolytic decay in the cytoplasm 
Deadenylation generates an unprotected 3’ end of an mRNA, which is vulnerable 3’ to 5’ 
decay. This form of decay is performed primarily by a multi-subunit complex called the exosome 
(Fig. 1.1) (Zinder and Lima 2017). The core of the exosome (Exo9) consists of nine protein 
subunits that are highly conserved throughout eukaryotes, but nucleolytically inactive. Exo9 
binds to the catalytically active subunit RRP44 to form the active exosome (Exo10) (Kowalinski 
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et al. 2016; Zinder et al. 2016). Following 3’ to 5’ decay, the m7G cap is removed from the 
remaining short oligonucleotide by the scavenger decapping enzyme DCPS (Liu et al. 2008) 
along with FHIT/Aph1 (Taverniti and Seraphin 2015). The exosome is capable of performing 
specific functions based on association with different co-factors. In the case of stem cell 
differentiation, depletion of either the exosome or its cofactor RBM7 leads to the stabilization of 
lowly expressed transcripts in different cell types (Lloret-Llinares et al. 2018). This suggests 
RBM7 may guide the exosome to these transcripts. However, the precise mechanism remains 
uncharacterized. 
 
1.4.5 An alternative way to induce mRNA decay: endonucleolytic decay 
The generation of an accessible 5’ monophosphate or 3’ hydroxyl for an exoribonuclease is 
the key step in turnover of the body of the mRNA (Fig. 1.1). In addition to deadenylation and 
decapping, an appreciation of the extent that endoribonucleases contribute to general mRNA 
decay has significantly increased over the years. In addition to the well-characterized cleavage 
events that occur during miRNA and siRNA-mediated RNA interference (RNAi) (Park and Shin 
2014), there are numerous other endoribonucleases that target and cleave mRNAs in a 
regulated fashion for subsequent exonucleolytic decay. Because endoribonuclease activity 
significantly modulates the fate of an mRNA, these enzymes are tightly regulated. In fact, cells 
contain a cysteine-rich ribonuclease inhibitor (RNH1) to protect them from the plethora of 
unwanted ‘RNase A’ type ribonucleases secreted by cells in their environment (Thomas et al. 
2016). There are several endoribonucleases that play significant roles in the regulation of 
mRNA stability, and subsequent gene expression, in mammalian cells (Uehata and Takeuchi 
2017; Rath et al. 2015; Tavernier et al. 2017; Shan et al. 2017). Of note for this study is the 
RNase P/MRP complex because of its recent association with cleavage of m6A modified RNAs 




1.5 Elements and factors that facilitate mRNA decay 
mRNA degradation is typically not initiated spontaneously. As touched on above, 
deadenylases, decapping enzymes or endoribonucleases, must be recruited to target 
transcripts by proteins or miRNAs (trans-acting factors) that recognize specific sequence 
elements or post-transcriptional modifications (cis-acting elements). Below we discuss the 
influence several cis-acting elements and the trans-acting factors which recognize them have on 
mRNA decay. 
 
1.5.1 Cis-acting elements 
Cis-acting elements can influence mRNA decay and impact the transcriptome to varying 
degrees based on their prevalence. Ubiquitous modifications like the 5’ cap and poly(A) tail can 
be directly acted upon by mRNA decay pathway enzymes (see section 1.4). Alternatively, the 
specific, and sometimes lengthy, sequence elements recognized by miRNAs and some RBPs 
allow for shared mRNA targets and the co-regulation of several functionally related transcripts 
(~10-500 transcripts may be impacted per miRNA or RBP). Between the 5’ cap/poly(A) tail and 
miRNA/RBP binding sites, reside several other cis-acting elements which are present in 
thousands of transcripts and thus able to regulate a significant portion of the transcriptome in 
response to external signals, such as developmental cues. Several of these cis-acting elements, 
including RNA modifications (Geula et al. 2015), AU-rich elements (AREs) (Yamaji et al. 2017), 
C-rich elements (CREs) (Neff et al. 2012) and pyrimidine tracts (Shibayama et al. 2009) 
modulate pluripotency and differentiation in stem cells by regulating gene expression via mRNA 
decay. Oftentimes, these types of cis-acting elements are located in the 5’ or 3’ untranslated 
regions (UTRs) of transcripts; but some, like RNA modifications, can also be found in the open 
reading frame (ORF) (Meyer et al. 2012; Dominissini et al. 2012). The mechanism and to what 
degree these cis-acting elements can promote or repress mRNA degradation often depends on 
the associated trans-acting factor, some of which are described below. 
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1.5.2 Trans-acting factors 
1.5.2.1 miRNAs mediating mRNA decay 
There are numerous examples of miRNAs modulating gene expression in stem cells to 
promote a pluripotent state or to drive differentiation. The Let-7 family of miRNAs and miR-145 
down-regulate several key pluripotency factors including OCT4, LIN28, MYC, SOX2 and KLF4 
(Xu et al. 2009; Melton et al. 2010). In contrast, expression of miR-138, miR-294 and miR-302 
promotes self-renewal and inhibits differentiation of ESCs (Ye et al. 2012; Wang et al. 2013a).  
To silence and specifically degrade mRNA targets, miRNAs form an RNP complex with 
Argonaute (AGO) proteins and other co-factors called the RNA-induced silencing complex 
(RISC) (O’Brien et al. 2018). Once the RISC is formed, it targets specific mRNAs based on their 
complementarity to the seed sequence of the loaded miRNA (Lewis et al. 2005). Upon binding 
to an mRNA, the RISC represses translation of the target mRNA, but also promotes the 
eventual decay of the mRNA via recruitment of mRNA decay enzymes. For example, the RISC 
co-factor TNRC6A (also known as GW182) serves as a hub for both deadenylase complexes, 
CCR4-NOT and PAN2/3, as well as the exosome to promote 3’ to 5’ degradation (Bartel 2018; 
Huntzinger et al. 2013; Jonas and Izaurralde 2015). Moreover, the RISC can also recruit DCP2 
and its co-factors to enable 5’ to 3’ degradation via XRN1 (Rehwinkel et al. 2005; Behm-
Ansmant et al. 2006; Nishihara et al. 2013). A perfect or near perfect match between a miRNA 
and mRNA target triggers endonucleolytic cleavage via AGO proteins (Song et al. 2004) and 
renders the cleaved mRNA vulnerable to exonucleolytic degradation in both directions. Although 
this can occur in mammals, these events are rare and more commonly occur in plants (Sieburth 
and Vincent 2018). Thus, miRNAs can facilitate all major pathways of mRNA degradation. 
 
1.5.2.2 RBPs mediating mRNA decay 
To date, there are more than 1,500 known RBPs, and varying portions of this population 
play a role in almost every major cellular pathway and function (Hentze et al. 2018; Gerstberger 
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et al. 2014). In terms of mediating degradation, RBPs can influence every facet of the mRNA 
decay pathway (Fenger-Grøn et al. 2005; Webster et al. 2019; Park et al. 2019; Thoms et al. 
2015; Kretschmer et al. 2018). Intriguingly, RBPs can even monitor mRNA decay rates and 
influence transcription accordingly (Gilbertson et al. 2018). When an mRNA is degraded, most 
notably by XRN1, RBPs that were bound to the mRNA, like Cytoplasmic Poly(A) Binding Protein 
1 (PABPC1) and LA-related protein 4 (LARP4), translocate to the nucleus and interact with RNA 
Polymerase II (RNAP II) to influence transcription of the degraded mRNA (Küspert et al. 2015). 
However, the full mechanistic pathway for how this occurs remains uncharacterized. For brevity, 
we focus on a few key examples of RBP-mediated mRNA decay that pertain to some of the cis-
acting elements mentioned above. 
Numerous RBPs interact with AREs. Of these, Hu antigen R (HuR or ELAV1) and 
Tristetraprolin (TTP aka ZFP36) are two well-characterized examples. Intriguingly, there are 
several reports that indicate HuR-mediated stabilization plays a crucial role in stem cell 
maintenance and differentiation (McDermott et al. 2018; Wang et al. 2014c; Carelli et al. 2019). 
Moreover, quiescence of muscle stem cells is modulated by TTP-mediated mRNA decay 
(Hausburg et al. 2015). TTP binds to the sequence UUAUUUAUU, which is considered to be 
the canonical destabilizing element of AREs (Lai et al. 2005; Brewer et al. 2004). Upon binding, 
TTP promotes deadenylation, and subsequent 3’ to 5’ degradation, through direct recruitment of 
the CCR4-NOT complex and the exosome (Lykke-Andersen and Wagner 2005; Hau et al. 
2007). Additionally, TTP can deliver ARE-containing mRNAs to P-bodies for decapping (Franks 
and Lykke-Andersen 2007) and facilitate miRNA-dependent mRNA decay (Jing et al. 2005). 
Conversely, HuR stabilizes ARE-containing mRNAs (Peng et al. 1998) by impeding and even 
replacing TTP interactions (Tiedje et al. 2012), as well as blocking miRNA binding (Wang et al. 
2014c).  
Like AREs, pyrimidine tracts and their associated trans-acting factors polypyrimidine tract-
binding proteins (PTBPs) have several reported roles in stem cell maintenance and 
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differentiation (Li et al. 2014b; Shibayama et al. 2009; Yeom et al. 2018; Vuong et al. 2016). 
One of the more notable examples involves a change in PTBP1 and PTBP2 expression and 
activity during neural differentiation (Li et al. 2014b; Vuong et al. 2016; Suckale et al. 2011; 
Makeyev et al. 2007). PTPB1 expression in pluripotent stem cells helps to repress neural-
specific splicing programs and promote self-renewal. Upon induction of neural differentiation, 
PTBP1 expression is reduced, allowing PTBP2 to take over and initiate a splicing program that 
is critical for neuronal maturation and survival. However, the activities of PTBP1/2 are not 
entirely antagonistic, as they do serve redundant functions in other aspects of regulating gene 
expression (Zheng et al. 2012; Vuong et al. 2016).  
The connection between PTBP functions and mRNA decay is not always as direct 
compared to AREs. Like the above example, many of these mechanisms indirectly mediate 
mRNA decay, primarily through changes in splicing. For example, PTBP1-mediated splicing 
regulates maturation of miR-124, which subsequently influences the expression of neuronal-
specific factors (Yeom et al. 2018; Makeyev et al. 2007). On the other hand, PTBP1 can 
modulate alternative polyadenylation (APA) which directly impacts a transcripts vulnerability to 
the exosome and/or potential binding sites for other decay-associated factors (Domingues et al. 
2016; Castelo-Branco et al. 2004; Le Sommer et al. 2005). In one of the more direct examples, 
interactions between PTBP3 and ZEB1 mRNA result in stabilization of the transcript and help to 
promote the epithelial-mesenchymal transition (EMT) (Hou et al. 2018). Although the exact 
mechanism remains uncharacterized, it is believed the presence of PTBP3 may inhibit binding 
of miRNAs or other RBPs that promote degradation. 
In this thesis, we chose to further explore two groups of RBPs; those which recognize the 
RNA modification m6A, termed m6A readers, and those that bind to CREs, specifically the PCBP 
family. In recent years, there has been mounting evidence that both of these factors are utilized 
by stem cells to regulate gene expression (Geula et al. 2015; Ghanem et al. 2018, 2015). In 
terms of RNA decay, the YTH N6-methyladenosine RNA-binding protein YTHDF2 facilitates the 
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clearance of unwanted mRNAs during certain periods of development (Li et al. 2018b; Ivanova 
et al. 2017; Zhao et al. 2017b). Moreover, our lab and others has previously shown that mRNAs 
containing CREs exhibit differentially stability in pluripotent stem cells compared to differentiated 
fibroblasts (Neff et al. 2012; Huang et al. 2015b); likely due in part to differential expression of 
some of the PCBP proteins. Below, we provide a more detailed look at the current state of m6A 
methylation and the PCBPs. 
 
1.6 The m6A methylation pathway2 
Virtually all RNA species including mRNAs, transfer RNAs (tRNAs), ribosomal RNAs 
(rRNA), miRNAs  and lncRNAs can experience methylation at various positions (m1A, m5C, 2’-
O-methyl etc.). Of these modifications, m6A has the best characterized effects on gene 
expression and was the first shown to modulate mRNA abundance (Dominissini et al. 2012; 
Meyer et al. 2012). m6A modification can modulate the fate of an mRNA at the level of splicing 
(Xiao et al. 2016), cleavage/polyadenylation (Kasowitz et al. 2018), subcellular localization 
(Roundtree et al. 2017; Edens et al. 2019), decay (Wang et al. 2014b) and translation (Wang et 
al. 2015b). Moreover, m6A is the most prevalent internal mRNA modification in many eukaryotic 
species (Bodi et al. 2010; Luo et al. 2014; Lence et al. 2017; Meyer et al. 2012; Dominissini et 
al. 2012). Although m6A was discovered over 40 years ago (Perry and Kelley 1974; Wei et al. 
1976; Desrosiers et al. 1974), its cellular function was only characterized through recent 
advancements in antibody-based precipitation and high-throughput sequencing. Since 2012, 
~10,000 m6A sites have been documented in over a quarter of human transcripts (Meyer et al. 
2012; Dominissini et al. 2012; Chen et al. 2015a). The precise impact m6A marks have on RNA 
metabolism and gene expression is dictated by the actions of methyltransferases (‘writers’), 
                                                
2 Section 1.6 and the associated figures are modified from: Small changes, big implications: The impact of 
m6A RNA methylation on gene expression in pluripotency and development. Biochimica et Biophysica 




demethylases (‘erasers’) and m6A binding-proteins (‘readers’), many of which are now known to 
play roles in pluripotency and development. 
 
1.6.1 The How, Where, When and Why of m6A Writing 
The N6-position of adenosine in RNAs can be methylated by four separate methyltransferase 
activities: CAPAM (also known as PCIF1) targets 2’-O-methyladenosine found adjacent to the 5’ 
cap to produce m6Am (Akichika et al. 2019; Cowling 2019), DIMT1L catalyzes dimethylation of 
two adjacent adenosines in18S rRNA (Zorbas et al. 2015; Lafontaine et al. 1995), whereas 
METTL16 (Warda et al. 2017; Brown et al. 2016; Pendleton et al. 2017; Shima et al. 2017; 
Doxtader et al. 2018; Ruszkowska et al. 2018) and the METTL3/METTL14 (Liu et al. 2014) 
heterodimer are responsible for internal m6A modifications. For brevity, we will be focusing on 
the METTL3/METTL14 methyltransferase which installs the vast majority of internal m6A marks 
on mRNAs and lncRNAs. The remaining methyltransferase activities are described in more 
detail in Heck and Wilusz, 2019. METTL3/METTL14 is part of the surprisingly large m6A writer 
complex which can be divided into two sub-complexes: the m6A-METTL complex (MAC), which 
comprises METTL3 and METTL14 (Liu et al. 2014), and the m6A-METTL-associated complex 
(MACOM), comprising WTAP, ZC3H13, RBM15/15B, VIRMA and HAKAI (Ping et al. 2014; Guo 
et al. 2018; Yue et al. 2018; Knuckles et al. 2018; Růžička et al. 2017) (Fig. 1.2). In order to 
perform catalysis, the m6A writer must be localized appropriately within the cell and directed to 
appropriate sites on each RNA. Furthermore, activity must be regulated such that methylation is 
restricted to the appropriate developmental stage and/or RNA region. We discuss how these 





   
 
 
Figure 1.2: The m6A writer complex. The m6A writer complex targets RNAs as they are transcribed. 
The m6A-METTL complex (MAC; shown in pink), consisting of the METTL3/14 heterodimer, is the 
catalytically active subcomplex which methylates adenosine at sites matching the RRACH consensus. 
WTAP is the major scaffolding protein that connects the MAC and m6A-METTL-associated complex 
(MACOM). The composition and/or activity of MACOM subunits can influence the distribution of m6A 
across a transcript. VIRMA and HAKAI favor 3’ methylation, while RBM15/15B facilitates 5’ 




1.6.1.1 Methyltransferase Activity (How is m6A added?) 
The MAC is responsible for the methyltransferase activity of the writer complex (Liu et al. 
2014; Schöller et al. 2018).  Briefly, this reaction entails the transfer of a methyl group, from an 
S-Adenosyl Methionine (SAM) molecule, onto the sixth nitrogen of the adenosine base. 
METTL3 is the sole catalytic subunit and the only one able to bind the SAM methyl donor (Wang 
et al. 2016b, 2016a; Śledź and Jinek 2016; Huang et al. 2018b). While METTL3 possesses 
weak methyltransferase activity in vitro, the METTL3/METTL14 heterodimer exhibits 
substantially higher catalytic activity (Liu et al. 2014). Although METTL14 does not perform 
catalysis, it is essential for methyltransferase activity, providing structural stability, and 
allosterically enhancing the methyltransferase activity of METTL3 (Schöller et al. 2018; Wang et 
al. 2016b, 2016a). Interactions between METTL3 and METTL14 form a cavity where the RNA 
substrate is bound (Śledź and Jinek 2016; Wang et al. 2016a, 2016b).  
The methyltransferase domains of METTL3 and METTL14 are highly conserved among 
eukaryotes, with functional homologs in Drosophila (Ime4 and Cg7818, respectively) (Hongay 
and Orr-Weaver 2011; Lence et al. 2017), Arabidopsis (Mta and Mtb, respectively) (Zhong et al. 
2008; Růžička et al. 2017) and S. cerevisiae (IME4 and KAR4; although the role of KAR4 
remains uncharacterized) (Clancy et al. 2002; Lence et al. 2018). Consistent with their high level 
of conservation, these proteins are essential for viability in mammals and plants, and play vital 
roles in embryonic development, sex determination and gametogenesis (Bodi et al. 2012; Kan 
et al. 2017; Schwartz et al. 2013; Aguilo et al. 2015; Geula et al. 2015; Wang et al. 2018c; Lin et 
al. 2017; Xu et al. 2017; Haussmann et al. 2016). Depletion of either protein in human cell lines 
results in a marked global decrease in m6A levels (Ping et al. 2014; Liu et al. 2014). 
 
1.6.1.2 Methyltransferase Specificity (Where on the mRNA?) 
When it comes to methylation, not all adenosines are created equal. The context of the 
adenosine is critical in determining where and whether a transcript is modified. MAC target sites 
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are enriched for the short and low complexity consensus m6A motif, RRACH (Rottman et al. 
1994; Liu et al. 2014; Ping et al. 2014). However, the expected occurrence of the RRACH motif 
in RNAs (~1 modification per 85 nucleotides) is much higher than the observed one m6A 
modification per ~1000 nucleotides (Dominissini et al. 2012; Linder et al. 2015; Chen et al. 
2015a; Meyer et al. 2012). Only a fraction of adenosines found within this motif are actually 
modified, supporting the existence of additional layers of regulation. Such regulation likely 
includes selective recruitment of the MAC to specific RNA substrates and is influenced by the 
surrounding sequence context (such as structure, and availability of binding sites for competing 
factors).  
Recent studies are starting to reveal how MAC is recruited to specific RNAs. There is 
evidence for interactions between MAC and chromatin/transcription factors including CEBPZ 
(Barbieri et al. 2017), SMAD2/3 (Bertero et al. 2018) and ZFP217 (Aguilo et al. 2015). These 
interactions facilitate (CEBPZ, SMAD2/3) or repress (ZFP217) m6A modification of transcripts 
derived from promoters dependent on these transcription factors. For example, in stem cells 
SMAD2/3 is activated by TGF signaling and binds promoters of genes involved in early cell 
fate, including NANOG. It then recruits WTAP and MAC to allow RNA methylation. Marking 
these transcripts with m6A helps prime stem cells for a timely exit from pluripotency (Bertero et 
al. 2018). More broadly, an interaction between METTL14 and trimethylated histone H3 
(H3K36me3) may help recruit MAC to nascent RNAs/RNAP II (Huang et al. 2019) and thereby 
promote m6A deposition. These observations suggest that transcripts can be selected for 
modification as they are transcribed and also supports that the epigenome can directly influence 
the epitranscriptome.   
Once MAC is recruited to an mRNA, there is further regulation to determine which sites 
within that transcript will be modified. Specificity is conferred by METTL3 via its two CCCH-type 
zinc finger domains (Huang et al. 2018b) and METTL14 through a C-terminal domain containing 
RGG repeats (Schöller et al. 2018). Recent observations imply that the sequence context, and 
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its match to the preferred consensus, may be a driving factor determining the distribution and 
extent of m6A modification (i.e. the m6A signal is ‘hard-coded’ into the mRNA sequence). In 
further support of this hypothesis, a remarkable number of m6A sites, and the flanking 
sequences, are conserved across vertebrates (Zhang et al. 2019c; Dominissini et al. 2012), and 
in some cases even in organisms as distant as yeast (Garcia-Campos et al. 2019b).  
It is important to note that m6A is not uniformly distributed across the length of the transcript 
(Figure 1.3). There are distinct preferences for the 5’ and 3’ UTRs (Dominissini et al. 2012; 
Meyer et al. 2012; Patil et al. 2016; Liu et al. 2017). Interestingly, the consensus RRACH motif 
is also enriched in these areas, particularly near the stop codon (Zhang et al. 2019c), and 
H3K36me3 chromatin marks also show a skewed enrichment around stop codons (Huang et al. 
2019), which may contribute to enhanced MAC recruitment. In addition, the FTO demethylase 
may prune the methyl group from sites at the 5’ end (Zhao et al. 2014, 2018; Zhou et al. 2015a) 
resulting in an overall enrichment of m6A at the 3’ end of RNAs. In exons, the vast majority of 
m6A marks are located internally, residing at least 50 nucleotides away from splice junctions (Ke 
et al. 2017). Moreover, there is an enrichment of m6A in long (>200 nucleotides) internal exons 
(Ke et al. 2017; Dominissini et al. 2012; Schwartz et al. 2014; Zhang et al. 2019c). The purpose 
and mechanism by which this is achieved is unclear. Interestingly, introns are rarely methylated 
when compared to exons, despite containing nearly three times the amount of sequence in 
chromatin-associated nascent pre-mRNA (Ke et al. 2017; Chen et al. 2015a). One explanation 
for this observation could be that the splicing machinery outcompetes or has priority over the 
m6A writer complex for access to nascent RNA. As well as being concentrated in specific 
regions of the RNA, m6A sites are often found in clusters, similar to DNA methylation sites in 
CpG islands (Meyer et al. 2012; Chen et al. 2015a; Ke et al. 2017; Linder et al. 2015; Zhang et 
al. 2019c). Clustering may be achieved in part through an association between the METTL3 and 
RNAP II that facilitates methylation when transcription slows (Slobodin et al. 2017), but also 
inherently requires that the available consensus sites be clustered.  
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Figure 1.3: Factors influencing the distribution of m6A and m6Am on mammalian mRNAs. The 
overall m6A landscape in physiological conditions is determined primarily by the distribution of 
consensus motifs recognized by the methyltransferases (CAPAM, METTL3/14). However, it can be 
influenced by demethylases such as FTO, which prunes m6A from introns and across the transcript. 
Moreover, certain components of the MACOM, namely RBM15/15B and VIRMA, can favor 
methylation at the 5’ and 3’ ends respectively. Finally, there is evidence that histone modifications can 




Finally, the MAC can be directed to a specific location on an RNA through interaction with 
components of the MACOM, some of which are RBPs. Specifically, VIRMA recruits the m6A 
writer complex to sites near the stop codon and within the 3’ UTR (Yue et al. 2018), while 
RBM15 and RBM15B binding sites are enriched in the 5’ UTR of transcripts (Patil et al. 2016). 
RBM15/15B both bind U-rich sequences through canonical RRMs, whereas VIRMA lacks a 
characterized RNA binding domain, but may be recruited to mRNAs through interaction with the 
cleavage and polyadenylation machinery (Yue et al. 2018). Interestingly, depletion of VIRMA in 
human cells resulted not only in a decrease in m6A marks near the stop codon and within the 3’ 
UTR, but also a significant increase in methylation at 5’ UTRs (Yue et al. 2018). This suggests 
that RBM15/15B and VIRMA may compete for recruitment of the writer complex to the 5’ and 3’ 
UTR regions of a transcript, respectively. HAKAI, an E3 ubiquitin ligase, may also guide 
MACOM to specific sites or modulate activity of the complex, but more work is needed to 
uncover its exact role (Růžička et al. 2017). Changes in expression or activity of proteins like 
these may facilitate developmental changes in the distribution of m6A, such as the switch from 3’ 
UTR to 5’ UTR m6A seen during cerebellum development in mice (Ma et al. 2018).    
To sum up, the MAC is recruited to specific RNAs/RNAP II through interactions with 
histones and transcription factors. m6A is then deposited on RNAP II transcripts in positions that 
are selected in large part on the basis of how close they match the preferred motif for 
METTL3/METTL14. However, the final distribution of m6A is also influenced through recruitment 
and repression of the methyltransferase by RBPs, and histone marks, as well as through 
removal of the modification at the 5’ end by the demethylase, FTO (Zhao et al. 2014; Jia et al. 
2011). As a result, m6A is concentrated towards the 3’ end of RNAs. 
 
1.6.1.3 Methyltransferase Localization 
It is clear that m6A modification occurs early in the life of an mRNA (Ke et al. 2017; Knuckles 
et al. 2017) and this is consistent with the observation that the writer complex accumulates in 
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nuclear speckles. These membraneless organelles congregate near sites of active transcription 
and serve as a reservoir for factors that participate in transcription and pre-mRNA processing 
(Galganski et al. 2017). WTAP, the third subunit of the core methyltransferase, plays no 
characterized role in catalysis or substrate selection but is essential for proper MAC localization 
to nuclear speckles (Liu et al. 2014), as is ZC3H13 (Wen et al. 2018). Importantly, if the MAC is 
not appropriately localized, it does not function: depletion of WTAP or ZC3H13 results in a 
profound global reduction in m6A methylation (Wen et al. 2018; Ping et al. 2014; Liu et al. 2014). 
 
1.6.1.4 Regulating the Writer 
Cells modulate m6A profiles in response to differentiation cues and external signals such as 
heat shock, DNA damage or stress (Batista et al. 2014; Zhou et al. 2015a; Yu et al. 2018; Engel 
et al. 2018; Xiang et al. 2017). The complexity of the m6A writer allows for many levels of 
regulation; changes in abundance of individual subunits, and post-translational modifications 
(PTMs) likely influence activity at different stages of development and differentiation. However, 
to date we have only scratched the surface in identifying how such regulation is achieved. 
METTL3, being the catalytically active subunit, is an obvious target for regulation, and is 
targeted by miRNAs (Du et al. 2017) and SUMOylation (Du et al. 2018). Other subunits appear 
to be dependent on METTL3 for their stability or expression (Sorci et al. 2018) and can also be 
impacted by PTMs (Schöller et al. 2018). However, there are still many knowledge gaps with 
respect to how these events regulate methyltransferase activity and the m6A landscape overall.  
 
1.6.2 m6A erasure 
Modifications of nucleic acids, including the 5’ cap and poly(A) tail on RNA and methylation 
of cytosine in DNA, are generally reversible; their removal is catalyzed by dedicated enzymes 
(decapping enzymes, deadenylases, and T5-methylcytosine hydroxylases, respectively) with 
well-characterized consequences such as decay/inactivation of RNAs and de-repression of 
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gene expression. The m6A modification is also reversible, through the action of two enzymes in 
the α-ketoglutarate-dependent dioxygenase (AlkB) family (ALKBH5 and FTO/ALKBH9). Both 
ALKBH5 and FTO remove internal m6A modifications, and thus can directly oppose the action of 
METTL3. However, as discussed below, ALKBH5 activity is restricted both temporally and 
spatially, suggesting that it is not a global regulator of all methylated mRNAs. A major impact of 
FTO may arise from its ability to target m6Am adjacent to the 5’ cap structure, especially in 
snRNAs (Mauer et al. 2017, 2019). 
Like other AlkB proteins, ALKBH5 and FTO utilize an α-ketoglutarate (αKG) domain to 
recognize the m6A-modified RNA, and also bind Fe(II) and αKG cofactors (Fedeles et al. 2015; 
Jia et al. 2011; Zheng et al. 2013). In addition, they possess a nucleotide recognition domain 
that interacts with the RNA substrate. Upon substrate recognition the demethylases catalyze 
oxidative dealkylation of m6A to regenerate an unmodified adenosine (Zheng et al. 2013; Baltz 
et al. 2012; Feng et al. 2014a; Xu et al. 2014a; Shen et al. 2014). Interestingly, intermediates of 
this reaction have been detected in mRNAs isolated from human cells and mouse tissue. 
Moreover, in vitro assays have indicated the presence of these intermediates attenuates the 
binding affinity of m6A readers (Fu et al. 2013). However, more work is needed to discern if 
there are any major biological effects. The ALKBH5 protein is localized to nuclear speckles and 
is thought to act upon nascent mRNAs (Zheng et al. 2013), whereas FTO shuttles between 
nucleus and cytoplasm (Wei et al. 2018; Zhou et al. 2015a) and can affect both nascent and 
mature transcripts (Jia et al. 2011; Su et al. 2018; Wei et al. 2018; Zhao et al. 2014; Mauer et al. 
2017; Ke et al. 2017). Importantly, although the AlkB protein family is conserved across 
eukaryotic and bacterial domains, ALKBH5 and FTO are found only in vertebrates (Robbens et 
al. 2008; Zheng et al. 2013), although Arabidopsis has two alternative demethylases, ALKBH9B 
(Martínez-Pérez et al. 2017) and ALKBH10B (Duan et al. 2017). The fact that eraser proteins 
are absent from lower eukaryotic organisms, which have both writers and readers of m6A, 
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suggests that demethylation is unlikely to play a general role in reversing all m6A modifications 
but rather may have evolved to act on specific substrates and/or in response to external signals. 
In support of this idea, knockout of ALKBH5 has no discernable effect on overall health in 
mice but results in profound defects in spermatogenesis, leading to male infertility (Zheng et al. 
2013). Although ALKBH5 has the potential to broadly counteract the action of METTL3, it 
appears this is not its primary role in most cell types. Outside of the testes, the impact of 
ALKBH5-mediated demethylation on overall levels of m6A is modest (Zheng et al. 2013) and 
m6A status of mRNAs does not vary greatly as they mature and enter the cytoplasm (Ke et al. 
2017). These two observations again support that only a subset of m6A modifications are 
targeted for removal by ALKBH5. However, it is not clear how selectivity may be achieved as 
the evidence for any sequence preference is weak (Zheng et al. 2013; Zou et al. 2016).  
Although the overall influence of demethylation by ALKBH5 in most normal cells is modest 
based on the robust health of knockout mice (Zheng et al. 2013; Tang et al. 2018), the protein is 
upregulated in hypoxia (Thalhammer et al. 2011) and in certain cancer cells (Zhang et al. 
2017b) and modulates expression of number of transcripts such as TFEB, FOXM1, and 
NANOG (Song et al. 2019; Zhang et al. 2017b, 2016a). Thus, for some transcripts and 
responses ALKBH5 may be important. 
In contrast to ALKBH5, FTO knockout has quite dramatic effects in mice with links to obesity 
and neurogenesis (Robbens et al. 2008; Church et al. 2010; Wu et al. 2018b; Ma et al. 2018) 
although some phenotypes may be due to indirect effects on neighboring genes (Fawcett and 
Barroso 2010; Tung et al. 2014). Since the recent discovery that FTO specifically targets m6Am 
to reverse methylation adjacent to the cap (Mauer et al. 2017), it is not so clear what proportion 
of FTO’s impact on gene expression is due to removal of m6Am versus m6A or even m1A (Wei et 
al. 2018). It should also be noted that MeRIP-seq experiments are, at least in part, at the mercy 
of m6A antibody specificity which currently have difficulties distinguishing between m6A and 
m6Am (McIntyre et al. 2019; Mauer et al. 2017). There is evidence to suggest FTO may prune 
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m6A from the 5’ UTR of specific mRNAs in the nucleus and that this activity is blocked during 
stress (Zhao et al. 2014, 2018; Zhou et al. 2015a; Yu et al. 2018)(see below). This is consistent 
with m6A being more abundant at the 3’ end and around the stop codon in mammals, while 
being prevalent around both the start and stop codons in Arabidopsis (Luo et al. 2014), which 
lack FTO (Robbens et al. 2008; Luo et al. 2014). Conversely, there is also evidence that FTO 
acts on m6A sites outside of the 5’ UTR (Hess et al. 2013; Zhou et al. 2018), suggesting that the 
demethylase activity of FTO is not confined to any one region of transcripts. In addition, FTO 
associates with intronic sequences which may partially explain why introns exhibit significantly 
lower levels of modification than exons (Bartosovic et al. 2017) (Fig. 1.3). However, it is hard to 
distinguish whether effects of FTO on splicing are due to altered function of snRNAs (which 
have m6Am cap structures and are essential components of the splicing machinery) versus 
changes in binding of RBPs that are recruited or repressed by m6A (see Heck and Wilusz, 2019 
for more details).  
Overall, demethylation may have a significant effect on expression and/or processing of 
specific transcripts, or during certain cellular responses, but more research is required to tease 
out when in the RNA life cycle demethylation occurs and how widespread its influence really is. 
This topic has been debated recently (Zhao et al. 2018; Darnell et al. 2018; Mauer and Jaffrey 
2018; Ke et al. 2017; Mauer et al. 2017; Wei et al. 2018). Many of the points and observations 
made in this debate are discussed above; but to summarize, the debate focuses on how 
dynamic m6A truly is and the activity of FTO. One side argues that the vast majority of 
methylation/demethylation events occur on nascent pre-mRNA (Ke et al. 2017; Darnell et al. 
2018). Thus, once an mRNA disassociates with the transcriptional machinery, its m6A profile is 
fairly well determined. Moreover, they propose the primary target of FTO is m6Am, present only 
at the 5’ cap, and not m6A (Mauer et al. 2017; Mauer and Jaffrey 2018), implying there is no 
known demethylase that primarily erases m6A modifications. The opposing side presents 
evidence of FTO activity specifically in the cytoplasm, indicating that demethylation can occur 
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post-transcription (Zhao et al. 2018; Wei et al. 2018). Moreover, FTO targets both m6Am and 
m6A equally in the cytoplasm, but is preferentially to m6A in the nucleus. They also highlight an 
independent study which observed an enrichment of FTO binding sites near the stop codon and 
throughout the 3’ UTR (not m6Am sites) as well as at the transcription start site (like to be m6Am 
sites) (Bartosovic et al. 2017). Ultimately, this debate underscores the fact that more research is 
required to fully understand the nature of m6A dynamics. 
 
1.6.3 How m6A affects RNA fate: Functions of the m6A readers 
Deposition of m6A does not immediately trigger degradation or activate translation. Rather, 
m6A influences RNA secondary structure and association with proteins and other RNAs to direct 
altered processing (Kasowitz et al. 2018; Xiao et al. 2016), export (Roundtree et al. 2017; Edens 
et al. 2019), translation (Wang et al. 2015b; Shi et al. 2017; Li et al. 2017) or decay (Wang et al. 
2014b; Du et al. 2016a; Shi et al. 2017; Wojtas et al. 2017) (Fig. 1.4). The presence of m6A 
favors a single stranded conformation and can therefore disrupt stem-loop structures (Roost et 
al. 2015) in a process termed ‘m6A switching’ (Liu et al. 2015b). In some cases, this can allow 
enhanced binding of proteins like HNRNPC, which, in turn, alters abundance and alternative 
splicing of target mRNAs (Liu et al. 2015a; Zhou et al. 2015b). Alternatively, m6A can block 
proteins from binding (Liu et al. 2017; Wu et al. 2018a; Arguello et al. 2017). For example, 
inhibition of HuR binding, due to the presence of m6A, leaves mRNAs susceptible to miRNA-
mediated degradation (Wang et al. 2014c). Although indirect influences on protein and miRNA 
binding have a significant impact, for brevity, this section will focus on the recruitment of 
proteins that directly recognize m6A (a.k.a. m6A readers) and their effects on RNA metabolism. 
 
1.6.3.1 Reader Recognition of m6A 
The best characterized m6A readers are members of the YTH domain-containing family of 





Figure 1.4: m6A influences mRNA function from cradle to grave. Recognition of m6A by methyl-
reader proteins, bolded, can influence various RNA processes including splicing/cleavage, nuclear 
export, translation and decay. Often, reader proteins interact with or recruit effector proteins, italicized, 
































identified in the splicing factor YT521-B/YTHDC1 (Zhang et al. 2010a; Imai et al. 1998), and is 
now known to confer m6A-dependent RNA-binding activity (Stoilov et al. 2002; Zhang et al. 
2010c). In all cases, the preference for m6A-modified RNA is specified by an aromatic cage that 
forms a hydrophobic pocket around the modified nucleotide (Xu et al. 2014b, 2015; Li et al. 
2014a; Zhu et al. 2014).  
Beyond this, it is not clear whether each YTH protein recognizes a distinct motif that allows it 
to act on a unique population of mRNAs, or if binding is dictated primarily by relative availability 
and affinity of each family member. Furthermore, whether YTH domains can accommodate 
m6Am adjacent to the 5’ cap has not been explored. Although there is some evidence for 
sequence preference outside of the clear requirement for m6A, this must be evaluated critically, 
as experiments involving capture and sequencing of RNAs bound by YTH proteins inevitably 
give a motif that overlaps with that of the MAC (i.e. RRACH) (Hsu et al. 2017; Xiao et al. 2016; 
Wang et al. 2015b, 2014b; Li et al. 2017). For YTHDC1, in vitro and structural analyses support 
that there is a specific interaction with the G at the -1 position, relative to the methylated A, that 
does not occur in other YTH proteins (Xu et al. 2015, 2014b). Intriguingly, another in vitro 
selection assay, using SELEX-based approach, indicated YTHDC1 is highly preferential 
towards the canonical RRACH motif, whereas YTHDF1/2 more readily bind to non-canonical 
m6A-modified motifs (i.e. CUAGA or CUAGU) (Arguello et al. 2019).  
Other interactions between the RNA and YTH domain (Li et al. 2014a; Zhu et al. 2014; 
Wojtas et al. 2017), and possibly regions outside of the YTH domain (Lao and Barron 2019; 
Wang et al. 2014b; Xu et al. 2015), could confer additional sequence specificity. Such 
interactions must be important at some level, as RNAs less than 5 nucleotides long bind poorly 
to YTH proteins compared to longer transcripts (Xu et al. 2015). Additional specificity may also 
be derived from interactions of the YTH proteins with factors associating elsewhere on the RNA. 
For example, YTHDC1 interacts with 3’ end formation factors which could favor binding towards 
the 3’ end of mRNAs (Kasowitz et al. 2018).  
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The subcellular location of the RNA also influences its accessibility to different YTH proteins. 
In the nucleus, YTHDC1 has a much higher concentration (Xiao et al. 2016) whereas the other 
YTH proteins are more abundant in the cytoplasm (Wang et al. 2014b; Shi et al. 2017; Wang et 
al. 2015b; Hsu et al. 2017). At this point, the extent to which the sequence context of an m6A 
site dictates reader binding potential and the subsequent fate of a modified RNA is an area in 
need of further investigation. Moreover, while the YTH domain accommodates m6A, there is 
evidence that these proteins also associate with N1-methyladenosine modified substrates (Dai 
et al. 2018) and that binding can occur independent of METTL3-mediated methylation (Zhang et 
al. 2019b).  
It is also worth considering that multiple YTH proteins are programmed to recognize the 
same or adjacent methylated residues, as YTHDF1-3 have numerous shared targets (Li et al. 
2017; Shi et al. 2017; Patil et al. 2016). These proteins appear to cooperate to modulate 
translation and decay, but it is not clear whether multiple YTH proteins bind simultaneously to 
the RNA substrate at adjacent m6A residues, or if the first YTH protein to bind engages the 
others through protein-protein interactions (Fig. 1.5).  
Although the majority of research on m6A readers and their biological functions focuses on 
YTH proteins, other proteins with different RNA binding domains have been implicated as m6A 
readers. The best supported of these are the insulin-like growth factor 2 mRNA-binding proteins 
(IGF2BP1-3) (Müller et al. 2018; Huang et al. 2018a), the eIF3 complex (Meyer et al. 2015) and 
PRRC2A (Wu et al. 2019). In these cases, there is compelling evidence for preferential binding 
of each factor to m6A modified RNAs, but the structural basis of these interactions is unknown 
as all available crystal structures were derived using unmodified substrates. FMR1, or FMRP, 
has also been implicated as a potential m6A reader (Arguello et al. 2017; Edupuganti et al. 
2017), but binding of FMR1 to m6A sites may be influenced more by the sequence context 







Figure 1.5: Competition and Collaboration between Reader Proteins. There are multiple possible 
mechanisms by which reader proteins interact with each other when binding to m6A including: i). 
Reader proteins bind adjacent m6A and recruit effectors to simultaneously influence multiple aspects 
of metabolism, ii). Reader protein binds m6A and recruits other readers along with effectors, again 
allowing simultaneous impact on multiple pathways, iii). Reader proteins compete for single m6A and 





1.6.1.2 m6A effects on decay 
As mentioned above, m6A readers have been shown to influence numerous aspects of the 
RNA life cycle including processing (Kasowitz et al. 2018; Xiao et al. 2016), export (Roundtree 
et al. 2017) and translation (Wang et al. 2015b; Shi et al. 2017; Li et al. 2017). For brevity, we 
have chosen to only highlight the effects on decay here, as they pertain directly to this study. 
For more detailed information about how m6A impacts other aspects of the RNA life cycle 
please see Heck and Wilusz, 2019.  
Multiple studies have shown that m6A methylated transcripts are less stable than their 
unmodified counterparts (Du et al. 2016a; Wang et al. 2014b; Chen et al. 2015a; Batista et al. 
2014; Geula et al. 2015; Shi et al. 2017), and YTHDF2 is the primary culprit causing this 
destabilization(Wang et al. 2014b). Under physiological conditions, a majority of YTHDF2 
binding sites are found near the stop codon and within the 3’ UTR (Wang et al. 2014b), which 
likely reflects the natural distribution of m6A (Meyer et al. 2012; Dominissini et al. 2012). Upon 
substrate binding, YTHDF2 accelerates the degradation of target transcripts through direct 
recruitment of the CCR4-NOT deadenylase complex (Du et al. 2016a) via an interaction 
between YTHDF2 and the CNOT1 subunit of the deadenylase. As deadenylation is the first and 
rate-limiting step in decay of most mRNAs, modulating this step has a significant effect on 
overall mRNA decay rates (Łabno et al. 2016). At the same time, YTHDF2 can also work with 
the HRSP12 RBP to recruit RNAse P/MRP endonuclease (Park et al. 2019). YTHDF2-mediated 
decay represses transcripts encoding cell cycle regulators such as Cyclin A2 (CCNA2) and 
CDK2 (Wu et al. 2018b), and also clears populations of unwanted mRNAs such as maternal 
transcripts during oocyte maturation (Ivanova et al. 2017) and transcripts favoring self-renewal 
in differentiating hematopoietic stem cells (HSCs) (Li et al. 2018c). YTHDF2 plays an important 
role in clearing RNAs during cell state transitions such as the maternal-to-zygotic (Zhao et al. 
2017b) and the epithelial-mesenchymal transitions (Chen et al. 2017). 
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While YTHDF2 makes the most obvious contribution to m6A dependent mRNA decay, there 
is evidence that other YTH proteins also interface with the mRNA decay machinery. YTHDF2 
and YTHDF3 both enhance deadenylation somewhat when tethered to a reporter mRNA (Du et 
al. 2016a), but this might perhaps be explained by observations that YTH proteins, and 
particularly YTHDF3, can augment the binding of other family members (such as YTHDF2) to 
their substrates (Shi et al. 2017). YTHDC2 is also able to down-regulate its targets, presumably 
by destabilizing them (Hsu et al. 2017), and has been implicated as an RNA stability factor in 
the germline, where it interacts with a meiosis-specific protein known as MEIOC (Abby et al. 
2016; Soh et al. 2017). The interaction of MEIOC and YTHDC2 with mitosis-promoting 
transcripts, including CCNA2, enhances their decay and facilitates a sharp transition into 
meiosis (Bailey et al. 2017; Soh et al. 2017). These experiments indicate a primitive role for m6A 
in meiosis that may be conserved from yeast to humans, as m6A deposition only occurs during 
meiosis in S. cerevisiae (Bodi et al. 2015; Chia and van Werven 2016; Agarwala et al. 2012). 
The exact mechanism by which YTHDC2 influences decay in meiotic cells needs more study. 
While there is strong evidence for direct interaction between YTHDC2 and the 5’-3’ 
exoribonuclease XRN1 (Kretschmer et al. 2018), XRN1 can only act on mRNAs that have 
already been committed to destruction by endonucleolytic cleavage or decapping (Braun et al. 
2012). Furthermore, XRN1 is required for meiosis in S. cerevisiae, but its catalytic activity is 
dispensable (Solinger et al. 1999), suggesting that the interaction with XRN1 may not be directly 
responsible for the ability of YTHDC2 to enhance mRNA turnover. 
The IGF2BP family of proteins also modulate the decay of m6A-modified transcripts but 
unlike YTHDF2 and YTHDC2, IGF2BPs stabilize methylated transcripts (Huang et al. 2018a). In 
some cases, this is achieved through sequestration of methylated mRNAs into stress granules 
(Degrauwe et al. 2016), but stabilization can also be caused by impeding binding of 
destabilizing factors such as miRNAs (Müller et al. 2018). It is also worth noting that m6A on its 
own can also modulate mRNA stability by perturbing binding of factors with overlapping target 
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sites. For example, the presence of m6A impedes HuR binding and thereby favors association 
miRNAs at neighboring sites to enhance decay of developmental transcripts such as IGF2BP3 
and FGF5 (Wang et al. 2014c). 
Regulation of reader activity can be achieved through standard mechanisms including gene 
expression, subcellular localization and PTMs. In terms of gene expression, YTHDF2 is 
repressed by two miRNAs (Yang et al. 2017; Li et al. 2018a), while YTHDC2 is inducible by 
TNFα (Tanabe et al. 2014). Previously mentioned observations of YTHDF2 re-localizing to the 
nucleus during heat shock (Yu et al. 2018; Zhou et al. 2015a) and PTMs on YTHDC1 (Rafalska 
et al. 2004) infer there may be other instances of regulation awaiting discovery. Future studies 
regarding the mechanisms and situations by which reader activity is regulated will provide useful 
insight about the impact m6A has on global gene expression. 
 
1.6.4 How does m6A-mediated mRNA decay influence pluripotency and development? 
To summarize, m6A is added to a large proportion of mRNAs and non-coding RNAs 
(ncRNAs) in many different tissues and cell types and can influence most, if not all, aspects of 
RNA metabolism. It is not surprising then that m6A methylation has a great influence on both cell 
and organism function. However, despite the almost ubiquitous nature of m6A modification, its 
power is observed most clearly in stem cells and during development (Geula et al. 2015; Batista 
et al. 2014; Wang et al. 2018c; Zhang et al. 2017a; Wang et al. 2014c), when large-scale 
coordinated changes in gene expression occur to determine cell fate. The effects of reducing 
m6A methylation are highly cell-type dependent, suggesting that methyltransferase activity, the 
RNA targets it modifies, and/or the activity/abundance of methyl-readers are regulated in a cell-
specific manner. Ultimately though, a common theme is that cell fate decisions are skewed 
following loss of methylation (Geula et al. 2015; Chen et al. 2019; Zhang et al. 2017a; Li et al. 
2018b; Lin et al. 2017; Xu et al. 2017; Wu et al. 2018c; Wang et al. 2018a), suggesting that m6A 
helps maintain stem cells in a balanced state where they are able to self-renew but also primed 
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to rapidly and efficiently differentiate down one or more pathways. When either methylation 
itself, or the activity of methyl-readers, is perturbed, the balance tips and cells are committed to 
a specific fate or permanently detained in the self-renewal program. The effects of m6A-
mediated mRNA decay on developmental decisions appear to occur through at least three 
mechanisms, which are discussed below.  
 
1.6.4.1 Tipping the balance of dosage-sensitive master regulators 
In many cases, methylation of mRNAs encoding one or two dosage sensitive master 
regulators (generally signaling or transcription factors) is pivotal. If expression of these key 
targets rises above, or falls below a threshold, it pushes the cell to differentiate, or alternatively 
into a permanent state of self-renewal or quiescence. A good example of this occurs during 
myeloid differentiation. Loss of METTL3 results in activation of quiescent HSCs to a proliferative 
state (Yao et al. 2018), while METTL14 (Weng et al. 2018a) and YTHDF2 (Li et al. 2018c; Wang 
et al. 2018b) are required for self-renewal of active HSCs – as silencing either gene favors 
myeloid differentiation. Two key targets of METTL14 in this process are the MYB and MYC 
transcription factor mRNAs whose expression is down-regulated following METTL14 depletion 
(Weng et al. 2018a). Moreover, upstream of this, m6A deposition on the NOTCH1 mRNA can 
promote its destabilization via YTHDF2 and repress Notch signaling. This favors the endothelial-
hematopoietic transition (Lv et al. 2018; Zhang et al. 2017a). 
 
1.6.4.2 Clearing unwanted mRNAs from the transcriptome 
During differentiation and development, massive changes in gene expression occur which 
require that existing transcripts are cleared to make way for those being induced to specify the 
new cell type. Recent studies have found that m6A methylation, through recruitment of the 
decay promoting factor YTHDF2, plays vital roles in clearing unwanted transcripts. During the 
maternal-zygotic transition in zebrafish, YTHDF2 associates with over one third of maternally 
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loaded mRNAs and induces their decay (Zhao et al. 2017b). Similarly, maternal mRNA 
clearance during mouse oocyte maturation is disrupted following loss of YTHDF2 (Ivanova et al. 
2017). Interestingly, newly transcribed zygotic mRNAs are m6A methylated, but their abundance 
is not generally affected by removal of YTHDF2 (Zhao et al. 2017b). Further investigation will be 
needed to determine what distinguishes the maternally supplied methylated mRNAs from those 
derived from the zygotic genome. Evidence suggests that there are multiple redundant 
mechanisms for maternal mRNA clearance which ensures robustness and reduces the 
influence of random variation (Sha et al. 2019). 
YTHDF2 also clears mRNAs during differentiation events in downstream development. For 
example, timely differentiation of neural progenitor cells (NPCs) is dependent on YTHDF2-
mediated clearance of several m6A-modified transcripts that encode factors involved in negative 
regulation of neural development including NRP2, NRXN3, FLRT2, PTPRD and DRD2 (Li et al. 
2018b). Because of this, loss of YTHDF2 in mice results in delayed neurogenesis and reduced 
neurite outgrowth.  
 
1.6.4.3 Potentiating transcriptional changes for sharp transitions 
It is clear that m6A is deposited on many mRNAs, and thus has a widespread impact on 
overall gene expression. In this respect, m6A modification is reminiscent of miRNA-mediated 
regulation. miRNAs fine tune gene expression, buffer against noise and confer robustness on 
biological systems (Ebert and Sharp 2012); all roles that can also be attributed to methylation. 
Specifically, while transcriptional changes are central to initiating cell fate transitions during 
development, methylation and its downstream effects are key to ensuring these transitions are 
carried through in a sharp and coordinated fashion. To this end, methylation is used to facilitate 
neuroectoderm differentiation through a mechanism activated by TGF signaling (Bertero et al. 
2018). TGF signaling is required to maintain a pluripotent state and functions by activating 
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SMAD2/3 transcription factors. The MAC is recruited by activated SMAD2/3 to its target genes, 
resulting in enhanced methylation and destabilization of several mRNAs whose transcription is 
induced by TGF signaling, including that encoding the pluripotency factor NANOG (Bertero et 
al. 2018). It is well known that unstable transcripts respond more rapidly to external cues (Crisp 
et al. 2017; Eichelbaum and Krijgsveld 2014), thus by destabilizing its target mRNAs, 
methylation facilitates sharper down-regulation of pluripotency factors when TGF signaling is 
inhibited. This in turn allows timely exit from pluripotency and efficient entry into the 
neuroectoderm differentiation program. 
 
1.7 Poly(C)-binding Proteins 
The second pair of cis-acting element and associated trans-acting factors investigated in 
this thesis is CREs and the PCBP family (Makeyev and Liebhaber 2002; Leidgens et al. 2013). 
As mentioned above, our lab and others have reported that mRNAs containing CREs exhibit 
differential stability in pluripotent stem cells and differentiated fibroblasts (Neff et al. 2012; 
Huang et al. 2015b). Below, we provide more detailed information about the PCBPs and their 
known roles in self-renewal and differentiation. 
The four members of the protein family, PCBP1-4 (aka αCP1-4 or HNRNPE1-4), are 
evolutionarily related and expressed rather broadly in both human and mouse tissues (Makeyev 
et al. 1999; Makeyev and Liebhaber 2000; Leffers et al. 1995). PCBPs can influence gene 
expression at various levels including transcription (Choi et al. 2008; Thakur et al. 2003), 
splicing (Ji et al. 2018), translational silencing (Wang et al. 2010; Ostareck et al. 2001) or 
enhancement (Bedard et al. 2004; Thomson et al. 2005) and mRNA decay (Chen et al. 2018; 
Hwang et al. 2017; Ho et al. 2013; Han et al. 2013b). In terms of biological outcomes, PCBPs 
have roles in regulation of iron levels within the cell (Yanatori et al. 2016; Leidgens et al. 2013; 
Li et al. 2012), immune response (Zhou et al. 2012; You et al. 2009) and, most importantly for 
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this study, proliferation and differentiation (Ghanem et al. 2015; Zhang et al. 2015b; Ye et al. 
2016; Pio et al. 2004; Li et al. 2016).  
 
1.7.1 Structure and binding capabilities of PCBPs 
1.7.1.1 Domain and sequence conservation 
PCBP1 and PCBP2 are closely related with nearly a 90% amino acid sequence similarity 
(Tommerup and Leffers 1996). This is largely due to the fact PCBP1 is an intronless, 
retrotransposed derivative of PCBP2 (Makeyev et al. 1999). In contrast, PCBP3 is more 
divergent and PCBP4 is the most distantly related to PCBP2 with only 48% amino acid 
sequence similarity (Makeyev and Liebhaber 2000; Chkheidze and Liebhaber 2003). The 
common thread which ties these proteins together is the presence of three HNRNPK homology 
(KH) domains (Makeyev and Liebhaber 2000). To this end, the general structure of the PCBPs 
is fairly similar with the first two KH domains occurring consecutively near the N-terminus  
followed by a variable length of intervening amino acid sequence and the third KH domain 
located at near the C-terminus (Sidiqi et al. 2005; Du et al. 2007, 2005; Fenn et al. 2007; Du et 
al. 2008). 
 
1.7.1.2 Subcellular localization 
In addition to the KH domains, all of the PCBPs contain at least one nuclear localization 
signal (NLS) present within the third KH domain, dubbed NLS II (Chkheidze and Liebhaber 
2003). PCBP1 and 2 also possess a second NLS, NLS I, that is located within the variable 
sequence between KH domains two and three. As a result, PCBP1 and 2 localize to both the 
nucleus and the cytoplasm, whereas PCBP3 and 4 are primarily cytoplasmic (Chkheidze and 




1.7.1.3 Nucleotide binding and other interactions 
As would be expected, the KH domains are critical for recognition and binding of CREs. 
Structural analyses characterizing the interactions between different PCBP KH domains and the 
human C-rich telomeric DNA (5’-AACCCTA-3’) have indicated the PCBPs are capable of 
binding to sequence motifs with as few as three cytosine residues (Du et al. 2005; Fenn et al. 
2007; Du et al. 2007). I.e. the ACCC or CCCT element of the C-rich strand. Moreover, this 
interaction can occur with RNA or single stranded DNA as the target. Several stabilizing forces 
including hydrogen bonding, electrostatic interactions and van der Waals contacts act in concert 
to modulate the interaction. Intriguingly, there is also evidence that PCBP-RNA/DNA 
interactions may alter protein conformation, thereby revealing protein-protein interaction 
surfaces for PCBP-binding partners (Du et al. 2007, 2008). In an unbound state, the first two KH 
domains exist in a pseudodimer. However, the two KH domains must disassociate from each 
other to bind a DNA/RNA target. This disassociation results in the conformational changes 
necessary to reveal interaction surfaces for PCBP-binding partners. 
 
1.7.2 PCBP-mediated mRNA decay 
To date, multiple mechanisms have been reported for how PCBPs both promote and 
repress mRNA decay. 
 
1.7.2.1 Stabilization of PCBP targets 
PCBP1 has been shown to stabilize mu opioid receptor (MOR) mRNA by binding to CREs in 
the 3’ UTR (Hwang et al. 2017). Phosphorylation of PCBP1 via protein kinase A (PKA) enables 
PCBP1 to recruit poly(A)-binding protein (PABP) and AU-rich element RNA-binding protein 1 
(AUF1, also known as HNRNPD), both of which have previously been shown to enhance mRNA 
stability (Al-Khalaf and Aboussekhra 2019; Yi et al. 2018), to MOR mRNA. Likewise, PCBP1 
interacts with CREs in the 3’ UTR of endothelial nitric oxide synthase (eNOS) mRNA and 
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enhances stability by blocking potential binding sites for miR-765 (Ho et al. 2013). Other 
examples of PCBP1 (Shi et al. 2018a), PCBP2 (Xin et al. 2011; Chen et al. 2018) and PCBP4 
(Scoumanne et al. 2011) promoting the stabilization of target transcripts have also been 
reported. However, the mechanisms by which stabilization occurs are not fully characterized. 
 
1.7.2.2 Destabilization of PCBP targets 
Conversely, there are several reports that describe how interactions with PCBP2 
destabilizes target transcripts (Zhang et al. 2015a; Han et al. 2013b; Ren et al. 2016). In two of 
these instances, PCBP2 interacts with CREs in the 3’ UTRs of transcripts to facilitate 
degradation (Han et al. 2013b; Zhang et al. 2015a). However, the precise mechanism(s) by 
which this occurs remain(s) elusive. Despite this, there are characterized mechanisms for how 
PCBP2 activity is regulated. Phosphorylation of PCBP2 by the MAP kinase, ERK1/2, increases 
protein stability and subsequent abundance (Chang et al. 2007), thus allowing for increased 
PCBP2 activity. On the other hand, miR-328, which is itself C-rich, can be used as a decoy to 
soak up PCBP2 and decrease its activity (Eiring et al. 2010; Saul et al. 2016). These same 
regulatory mechanisms can also influence the other members of the PCBP family (Hong 2017; 
Choi et al. 2009). 
 
1.7.3 How do CREs and PCBPs influence pluripotency and development? 
When considering the roles of PCBPs in pluripotency and development, it is important to 
note there are numerous links between aberrant expression of PCBPs and cancer 
growth/progression (Ye et al. 2016; Pio et al. 2004; Chen et al. 2015b, 2018; Zhang et al. 
2015b). Although these are not direct ties to pluripotency or development, they could be 
indicative of a larger role for the PCBPs. With that being said, there are several reported 
instances of PCBPs playing a direct role in pluripotency and development. For instance, our lab 
has previously observed that mRNAs containing CREs are differentially expressed in iPSCs 
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compared to HFFs (Neff et al. 2012). Moreover, this differential expression is likely due to the 
destabilization of CRE-containing mRNAs in iPSCs. This observation has been reported by 
other labs as well when comparing murine ESCs and differentiated fibroblasts (Huang et al. 
2015b), indicating this mechanism is conserved in mammals.  
Beyond the influence on mRNA stability, it has been observed that knockout of PCBP1 in 
mice is lethal by day E8.5, but death can occur as early as E3.5 (Ghanem et al. 2015). 
Intriguingly, this lethality is believed to arise due to a problem during the transition from a naïve 
to primed pluripotent state (Nazarov et al. 2019). However, the precise mechanism remains 
uncharacterized. Similarly, PCBP2 knockout also results in embryonic lethality, due to 
cardiovascular and hematopoietic abnormalities (Ghanem et al. 2015). However, PCBP2 null 
embryos survive until day E13.5. These differences in timing and manifestation of embryonic 
death suggest that, despite being evolutionary conserved and containing a high percentage of 
amino acid similarity, these two proteins play distinct roles in development (Ghanem et al. 
2015). Indeed, there is additional evidence for this hypothesis as PCBP1 plays an important role 
in myoblast maintenance/differentiation (Espinoza-Lewis et al. 2017) whereas PCBP2 promotes 
erythropoiesis (Ghanem et al. 2018). Depletion of PCBP1 leads to muscle defects (Espinoza-
Lewis et al. 2017). Mechanistically, PCBP1 directly interacts with AGO2 to modulate miRNA 
maturation and that inhibition of PCBP1 led to a reduction in muscle miRNA production and 
ultimately muscle defects (Espinoza-Lewis et al. 2017). Alternatively, PCBP2 promotes 
definitive erythropoiesis by modulating splicing of the hematopoietic master regulator, RUNX1 
(Ghanem et al. 2018). The examples above illustrate the diverse nature in which PCBPs can 
influence pluripotency and development. However, these findings represent only bits and pieces 
of complete function of PCBPs during development and underscore the fact that more research 




1.8 Rationale and Hypotheses 
1.8.1 m6A-mediated mRNA decay in stem cells 
Multiple studies have indicated that m6A methylation is crucial in early development and the 
maintenance of pluripotent stem cells (Geula et al. 2015; Aguilo et al. 2015; Batista et al. 2014; 
Wen et al. 2018; Bertero et al. 2018). Global m6A levels are relatively high in pluripotent stem 
cells and their reduction impairs both self-renewal and differentiation capabilities. To this end, 
mRNAs encoding several of the major pluripotency factors are methylated in pluripotent stem 
cells (Wang et al. 2014c; Batista et al. 2014; Aguilo et al. 2015; Bertero et al. 2018). Despite 
this, relatively little is known regarding the expression and activity of individual readers in 
pluripotent stem cells. Each m6A reader influences different aspects of the RNA life cycle, thus 
characterizing the expression and activity of individual readers in stem cells is critical to our 
understanding of how m6A modulates pluripotency and differentiation. Previous studies have 
indicated YTHDF2, which is primarily associated with facilitating mRNA decay (Wang et al. 
2014b; Du et al. 2016a), plays an important role in the clearance of unwanted mRNAs in other 
cell-state transitions that occur during development (Chen et al. 2017; Zhao et al. 2017b; 
Ivanova et al. 2017; Li et al. 2018b). Based on this information, we hypothesized that YTHDF2 
has a prominent role in mediating the influence of m6A methylation on pluripotency and 
differentiation in stem cells. One major goal of this dissertation was to test this hypothesis at a 
molecular/mechanistic level. 
 
1.8.2 The influence of CREs on mRNA decay in stem cells 
Previous work from our lab and others demonstrated that mRNAs containing CREs are 
differentially regulated in pluripotent stem cells compared to differentiated fibroblast cells (Neff 
et al. 2012; Huang et al. 2015b). Several RBPs recognize and bind to CREs including the PCBP 
family of proteins (Makeyev and Liebhaber 2002; Leidgens et al. 2013). Of note, PCBP2 is 
essential for early development and hematopoiesis (Ghanem et al. 2015, 2018) as well as 
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myeloid cell differentiation (Eiring et al. 2010). Given that self-renewal is a common 
characteristic shared between pluripotent stem cells and cancer cells, it is also relevant that 
PCBP2 expression is altered in several forms of cancer (Chang et al. 2007; Chen et al. 2018; 
Perron et al. 2018; Han et al. 2013b). Thus, PCBP2 is of particular interest in regards to the 
regulation of gene expression in stem cells. In terms of function, PCBP2 regulates several steps 
of RNA metabolism (Xia et al. 2015; Yanatori et al. 2016; Ji et al. 2013, 2018; Smirnova et al. 
2019) including decay (Han et al. 2013b; Zhang et al. 2015a). Based on the evidence outlined 
here, we hypothesized that PCBP2 helps to regulate differentiation and self-renewal of 
pluripotent stem cells by modulating the stability of mRNAs containing CREs. Therefore a 




Chapter 2: Materials and Methods 
 
 
2.1 Cell culture and transfection 
2.1.1 Induced pluripotent stem cells 
A matched set of male HFFs and reprogrammed iPSCs were purchased from System 
Biosciences. iPSCs were grown on MatriGel coated plates (Corning). In accordance with 
manufacturer protocols, MatriGel was diluted in DMEM/F12 (+ L-glutamine, + 15 mM HEPES, - 
phenol red; Gibco) for application onto plates. iPSCs were cultured in either exclusively mTesR1 
media (STEMCELL Technologies) or a combination of mTesR1 and StemFlex (Thermo Fisher 
Scientific) media with no antibiotics at 37°C in 5% CO2. Briefly, the combination culture 
consisted of passaging iPSCs in StemFlex for the first 1-2 days (to increase yield), then switch 
back to mTesR1 and changed daily for the remainder of the culturing period. Cells were 
passaged every 7 days using either ReLeSR (STEMCELL Technologies) or manual passage by 
visual selection. iPSCs were cryopreserved in mTeSR1 or StemFlex media with 10% dimethyl 
sulfoxide (DMSO), cooled overnight to -80°C and stored long-term in liquid nitrogen. 
 
2.1.1.1 Differentiation/induction of iPSCs 
Differentiation/induction of iPSCs was performed using an assortment of media from 
STEMCELL Technologies (see Table 2.1 for details). iPSCs were passaged onto new MatriGel 
coated plates in StemFlex and left to attach overnight. Approximately 24 hours after passaging, 
media was removed and replaced with a lineage-specific media. Cells were cultured in lineage-
specific media for up to 7 days, depending on manufacturer and experimental protocols, with 
media changed daily. 
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2.1.2 Human foreskin fibroblasts 
HFFs were cultured in DMEM (4.5g/L glucose) supplemented with 2 mM L-glutamine, 0.1 
mM non-essential amino acids, 10% Fetal Bovine Serum (FBS; Atlas Biologicals) and 0.37% 
sodium bicarbonate with penicillin (50 units/mL) and streptomycin (50 µg/mL; Hyclone) 
antibiotics at 37°C in 5% CO2. Media was changed every 2 to 4 days and cells were passaged 
at a 1:2 or 1:3 ratio every 5 to 7 days. To passage cells, media was removed, cells were 
washed with 1X sterile phosphate buffer saline (PBS, Corning) and incubated with a 1:1 ratio of 
sterile PBS to 0.25% trypsin/EDTA (Thermo Fisher Scientific-Hyclone) at 37°C until cells 
detached. Media was then added to quench the trypsin reaction. Cells were collected via 
centrifugation at 300 x g for 5 minutes before being resuspended in media for plating. HFFs 
were cryopreserved in 50% media, 40% FBS, and 10% DMSO, cooled overnight to -80°C, and 
stored long-term in liquid nitrogen. 
 
2.1.3 HeLa cells 
HeLa cells were cultured in DMEM (4.5g/L glucose) supplemented with 2 mM L-glutamine, 
10% NewBorn Calf Serum (NBCS; Peak Serum) and 0.37% sodium bicarbonate with penicillin 
(50 units/mL) and streptomycin (50 µg/mL) antibiotics at 37°C in 5% CO2. Media was changed 
daily or every 2 days and cells were passaged at a 1:3 to 1:10 ratio every 2-4 days, depending 
on cell confluency and experimental planning. To passage cells, media was removed, cells were 
washed with 1X PBS and incubated with a 1:1 ratio of sterile PBS to 0.25% trypsin/EDTA at 
37°C until cells detached. Media was then added to quench the trypsin reaction. Cells were 
collected via centrifugation at 500 x g for 5 minutes before being resuspended in media for 
plating. HeLa cells were cryopreserved in 50% media, 40% FBS, and 10% DMSO, cooled 




2.1.4.1 Transfection of siRNAs 
Transient knockdown (KD) was achieved by transfecting cells with siRNAs supplied by 
Millipore Sigma (see Table 2.2 for detailed information about the siRNAs used). Transfections of 
iPSCs were carried out using Stemfect transfection reagent (Stemgent) in accordance with 
manufacturer’s recommendations. Alternatively, jetPRIME transfection reagent (Polyplus) was 
used to transfect HeLa cells. Cells were transfected at a 50 µM concentration of siRNAs daily 
for 2-6 days, depending on the experiment, and harvested approximately 24 hours after the final 
transfection. 
 
2.1.4.2 Transfection of plasmids 
Reporter plasmids were transfected into iPSCs, HFFs and HeLa cells using different 
transfection reagents optimized for each cell type. iPSCs were transfected with TransIT®-LT1 
transfection reagent (Mirus) and Opti-MEM™ I (Thermo Fisher Scientific) in accordance with the 
‘Reverse Transfection of Human Induced Pluripotent Stem (iPS) Cells’ protocol 
(https://www.mirusbio.com/assets/misc_technical_documents/reverse-transfection-of-human-
ips-cells-with-transit-lt1-transfection-reagent.pdf) with the following exceptions: i. no ROCK 
inhibitor was used, ii. the protocol was scaled down from a 6- to 96-well plate format, iii. 
ReLeSR (STEMCELL Technologies) was used instead of Accutase™. HFFs were transfected 
with a combination of Lipofectamine LTX (Thermo Fisher Scientific) and FuGene HD (Promega) 
in Opti-MEM™ I in accordance with a previously published protocol (Ishiguro et al. 2017). 
Briefly, a ratio of 1 µL LTX reagent to 1 µL FuGene HD reagent to 1 µg of plasmid was used 
during complex formation. HeLa cells were transfected via jetPRIME transfection reagent 
(Polyplus) in accordance with the manufacturer’s recommendation. A 3 µL reagent/µg of 
plasmid ratio was used during transfection. DNA and siRNA co-transfection HeLa cells was 
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performed using jetPRIME in accordance with manufacturer’s protocols. In all cases, cells were 
assayed or harvested approximately 24 hours after the final transfection. 
 
2.2 Plasmids and cloning 
2.2.1 YTHDF2 3’ UTR luciferase reporter plasmids 
Luciferase reporter plasmids used the Renilla Luciferase psiCHECK™-1 (Promega) as a 
backbone with XhoI and NotI as the upstream and downstream restriction sites, respectively. 
Fragments of the YTHDF2 (NM_016258.3) 3’ UTR were amplified from cDNA using PfuUltra II 
Fusion High-fidelity DNA Polymerase (Agilent). Primers (see Table 2.3) for each insert were 
designed with a 4 base pair overhang to allow for maximum restriction enzyme (RE) digestion. 
Following PCR amplification, inserts were size-selected and gel purified using the Wizard® SV 
Gel and PCPR Clean-Up kit (Promega) in accordance with manufacturer’s protocols. The 
backbone and inserts were then subjected to digestion via XhoI and NotI FastDigest REs 
(Thermo Fisher Scientific) at 37°C for approximately 25 minutes. Samples were then cleaned 
via phenol/chloroform extraction, ethanol (EtOH) precipitated and resupsended in nuclease free 
water. Backbone and insert DNA concentrations were quantified via spectrophotometry using a 
Nanodrop2000 (Thermo Fisher Scientific). Inserts were then ligated into the backbone via a T4 
DNA Ligase reaction (New England Biolabs) at 16°C overnight. A 1:3 backbone to insert ratio 
was used for the ligation reaction. DH5α E. coli competent cells were transformed with the 
ligation reactions via heat shock, plated on Luria broth agar plates, with ampicillin as a selective 
marker, allowed to grow overnight at 37°C. Selected colonies were screened by PCR using the 
same primers from the cDNA amplification step. Positive colonies were selected and plasmid 
DNA was purified using the ZymoPURE II Plasmid Maxiprep kit (Zymo Research) and verified 
by Sanger sequencing (Genewiz). 
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2.2.2 HERV-H long non-coding RNA over-expression plasmids 
For over-expression constructs, p3XFLAG-CMV™-10 (Millipore Sigma) was used as the 
backbone for LINC01356 and pcDNA™3.1(+) (Thermo Fisher Scientific) was used as the 
backbone for LINC00458. Both of these vectors use the cytomegalovirus (CMV) promoter, 
bovine growth hormone (BGH) polyadenylation signal and contain BamHI and EcoRI restriction 
sites in the multiple cloning sequence. In the case of LINC01356 and p3XFLAG-CMV™-10, 
BamHI was used as the upstream RE and EcoRI the downstream. For LINC00458 and 
pcDNA™3.1(+), it was vice versa. Full length LINC01356 and LINC00458 transcripts were 
amplified from cDNA using PfuUltra II Fusion High-fidelity DNA Polymerase. The primers used 
can be found in Table 2.3. The remainder of the cloning process was as described above in 
section 2.2.1.  
 
2.3 RNA Isolation 
RNA isolation was performed using TRIzol Reagent (Thermo Fisher Scientific) in 
accordance with manufacturer’s protocols. Total RNA was treated with DNase I (Thermo Fisher 
Scientific) for 30 minutes as 37°C. When necessary, removal of plasmid DNA was achieved by 
treating RNA samples with TURBO DNase (2 units/µg of RNA; Ambion) in 50 µL reactions for 
45 minutes at 37°C. Removal of DNase enzymes was achieved by phenol/chloroform/isoamyl 
alcohol (25:24:1) extraction and EtOH precipitation. RNA purity and quantity was assessed via a 
NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific) and RNA was stored at -80°C. 
 
2.4 Reverse transcription 
Reverse transcription (RT) was performed in 20 µL reactions using Improm-II Reverse 
Transcriptase (Promega) with slight modifications to the manufacturer’s protocol. Specifically, 
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the reaction was primed with 0.5 µg of a 3:1 mixture of random hexamers:oligo (dT)20 and 
RiboLock (Thermo Fisher Scientific) was included as an RNase inhibitor. 
 
2.5 Reverse transcription digital PCR 
For reverse transcription digital PCR (RT-dPCR), cDNA was diluted such that the template 
copy number was between 10 and 100,000 and used in dPCR reactions with QX200 ddPCR 
EvaGreen Supermix (Bio-Rad) and transcript-specific primers. Detailed information about the 
primers used for each transcript can be found in Table 2.4. Droplet generation was performed 
using a QX200 Droplet Generator (Bio-Rad) in accordance with manufacturer’s protocols. 
Droplets were transferred to a 96-well plate and heat sealed with pierceable foil using the PX1 
PCR Plate Sealer (Bio-Rad). A 2-step amplification was performed in a C1000 Touch Thermal 
Cycler with 96-Deep Well Reaction Module (Bio-Rad) with annealing/extension at 60°C for 60 
seconds and denaturation at 95°C for 30 seconds and a 2.5°C/second ramp rate. Fluorescence 
of each droplet was interrogated using the QX200 Droplet Reader (Bio-Rad) and transcript copy 
numbers were determined using the QuantaSoft™ Software (Bio-Rad). Transcript copy 
numbers were normalized to GAPDH across compared samples and expression changes were 
reported as relative mRNA abundance or fold-change. 
 
2.6 Protein preparation 
Protein from cell lysates was prepped in one of two ways. In both cases, cell lysates were 
quantified via Pierce™ Rapid Gold BCA kit (Thermo Fisher Scientific) in accordance with 




2.6.1 Protein isolation using RIPA buffer 
Cells were collected and pelleted by centrifugation at 1000x g and 4°C for 5 minutes and 
washed twice in 10 mL of cold PBS. After the second wash, cells were re-suspended in 100-500 
L of RIPA buffer (50 mM Tris-Cl pH 7.5, 1% NP40, 0.5% Sodium Deoxycholate, 0.05% SDS, 1 
mM EDTA, 150 mM NaCl, 1 mM PMSF and 1mM DTT), with Protease Inhibitor Cocktail 
(Millipore Sigma) and incubated for 10 minutes at 4C with gentle rotation. Cells were then lysed 
via sonication with 5x10 second pulses at 6-7W output with 1 minute of rest on ice in between. 
After lysis, cell debris was pelleted via centrifugation at ~15,000 g for 10 minutes at 4°C and 
supernatant was transferred to a new tube. 
 
2.6.2 Protein isolation using TRIzol 
Protein was prepared from TRIzol samples in accordance with manufacturer’s protocols. 
Briefly, any residual nucleic acids were precipitated out of the organic phase via EtOH and 
centrifugation and the supernatant was transferred to a new tube. Protein was precipitated using 
isopropanol and pelleted via centrifugation. The protein pellet was washed 3x with 0.3M 
guanidine hydrochloride in 95% EtOH before a final wash with EtOH. The pellet was then left to 
air dry to remove any residual EtOH before being resuspended in 3:1 8M urea to 1% SDS 
solution. 
 
2.7 Western blotting 
20-40 µg of whole cell lysate was mixed with 6X Laemmli buffer (0.5 M Tris-HCl pH 6.8, 
50% glycerol, 12% SDS, 9% DTT and 0.06% bromophenol blue), denatured at 95°C for 5 
minutes and cooled on ice for approximately 5 minutes. Proteins were then resolved on an 8% 
polyacrylamide gel containing SDS, transferred to an Immobilon® PVDF membrane (EMD 
Millipore) and probed with primary antibodies at room temperature for 2 hours (see Table 2.5 for 
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details). Membranes were washed, then incubated for 1 hour at room temperature with HRP-
conjugated anti-rabbit (1/5000; Bio-Rad) or anti-mouse (1/5000; Santa Cruz Biotechnology) 
antibodies. After washing, membranes were treated with SuperSignal® West Dura Extended 
ECL reagent (Thermo Fisher Scientific) and luminescence was assessed on the ChemiDoc 
XRS+ system (Bio-Rad) or the Azure Sapphire Biomolecular Imager (Azure Biosystems). Band 
intensities were assessed using ImageLab software (Bio-Rad) and normalized to GAPDH. 
 
2.8 4-Thiouridine (4sU) labeling and half-life analysis 
4sU labeling and subsequent half-life analysis was performed as described in (Russo et al. 
2017). Briefly, cells were labeled with 4sU at concentration of 400 M for 4 hours. RNA was 
collected and isolated using TRIzol reagent. Prior to fractionation, a 4sU-labeled synthetic 
transcript (Dharmacon) with the following sequence: 5′-
AUUUAGGUGACACUAUAGGAUCCUCUAGAGUCGACCUUCUCCCUAUAGUGAGUCGUAUU
AGCA[4-S-U]CAG-3′, was spiked into samples to assess fractionation efficiency. 20-40 g of 
total RNA and was labeled with MTSEA-biotin-XX (Biotium) and fractionated using MACS 
streptavidin magnetic beads (Miltenyi Biotec). Transcript abundance was measured using RT-
dPCR, and half-life was calculated based on the ratio of labeled to unlabeled RNA (Rädle et al. 
2013). 
 
2.9 RNA immunoprecipitation (RIP) 
iPSCs were detached from 10-cm plates using ReLeSR (STEM CELL Technologies), 
pelleted by centrifugation at 1000x g at 4°C for 5 minutes and washed twice in 10 mL of cold 
PBS. After the second wash, cells were re-suspended in 10 mL of cold PBS and RNA-protein 
crosslinking was performed by adding 0.3% formaldehyde. Cells were incubated in the 
crosslinking solution for 10 minutes at room temperature with gentle rocking. 1.4 mL of 2M 
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glycine (pH 7.0) was added to quench the crosslinking reaction. Cells were then pelleted at 
1000x g and 4°C for 5 minutes and washed twice in 10 mL of cold PBS. Cell pellets were stored 
at -80°C until further processing. 
Cell pellets were thawed and re-suspended in 1 mL of low stringency (LS) RIPA buffer (50 
mM Tris-HCl pH 7.5, 1% NP40, 0.5% Sodium Deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM 
NaCl, 1 mM PMSF and 1mM DTT) with Complete Mini EDTA-free Protease Inhibitor Cocktail 
tablets (Millipore Sigma) and RiboLock RNase inhibitor (Thermo Fisher Scientific). Cells were 
incubated in LS RIPA buffer for 10 minutes at 4°C with gentle rotation and then lysed by passing 
through a 25 gauge needle 10-12 times. Samples were spun down at ~15,000 g for 10 minutes 
at 4°C. Cell extracts (supernatant) were transferred to new tubes and were precleared by 
incubation with 20 µL of magnetic protein G beads (New England BioLabs) for 60 minutes at 
4°C with gentle rotation. Beads were removed from the extracts using a magnetic stand. After 
preclearing, a 100 µL aliquot was set aside to serve as the input. Then, 450 µL samples were 
incubated with 20 µL of either YTHDF2- or PCBP2-specific or IgG (control; see Table 2.5) 
antibodies with rotation at 4°C for 60 minutes. After incubation, 20 µL of magnetic protein G 
beads was added and samples were again incubated with rotation at 4°C for 60 minutes. Beads 
were then retrieved and resuspended in 500 µL of high stringency (HS) RIPA buffer (50 mM 
Tris-HCl pH 7.5, 1% NP40, 1% Sodium Deoxycholate, 0.1% SDS, 1 mM EDTA, 1 M NaCl, 1 M 
Urea, 1 mM PMSF and 1mM DTT), with Complete Mini EDTA-free Protease Inhibitor Cocktail 
tablets and RiboLock RNase inhibitor included, and incubated with rotation at 4°C for 5 minutes. 
This was repeated for a total of five washes. To reverse the crosslinking, beads were re-
suspended in 100 µL of TEDS buffer (50 mM Tris-Cl pH 7.0, 5 mM EDTA, 1% SDS, 10 mM 
DTT) and 50 µL of TEDS buffer was added to Input samples. IP and Input samples were then 
incubated at 70°C for 45 minutes. 300 and 450 µL of TRIzol was added to IP and Input 
samples, respectively. Samples were stored at -80°C until RNA could be extracted (see Section 
2.3 RNA Isolation). Upon completion of RNA isolation, RNA samples were suspended in 4 µL of 
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water and the full volume was taken into the reverse transcription reaction. RT-dPCR was used 
to measure RNA abundances in YTHDF2 or PCBP2 IP, IgG IP and Input samples. Percent of 
Input (PoI) was determined and fold enrichments were calculated as YTHDF2 or PCBP2 
PoI/IgG PoI for a specific mRNA. Protein samples were obtained from independent RIPs and 
protein abundance was assessed via western blot to measure RIP efficiency. 
 
2.10 Immunofluorescence staining 
Circular coverslips were placed on 6- or 10-cm dishes and coated with MatriGel prior to 
seeding. Cells were seeded, cultured and treated in accordance with previously described 
protocols (See section 2.1 Cell Culture and Transfection). After treatment, coverslips were 
collected and washed twice in 1 mL of PBS. Cells were fixed in a 3.7% formaldehyde PBS 
solution for 10 minutes at room temperature with slight agitation. After fixing, cells were washed 
twice in 1 mL of PBS and permeabilized in 70% EtOH overnight at 4C. Cells were blocked by 
incubating in 1 mL of blocking buffer (20 mg/mL Bovine Serum Albumin Fraction V and 0.02% 
Triton X-100) overnight at 4C. Following blocking, cells were probed with a 1:100 dilution of 
primary antibody in blocking buffer and placed in a humidity chamber at 37C for two hours (See 
Table 2.5 for details). Cells were washed five times with PBS-T (0.02%) for 1 minute with slight 
agitation. Cells were then probed with Alexa Fluor®568-conjugated anti-rabbit (Abcam) or anti-
mouse (Abcam) at a 1:500 dilution in blocking buffer and placed in a humidity chamber at 37C 
for two hours. After incubation, cells were again washed five times with PBS containing 0.1% 
Tween-20 (PBS-T) for 1 minute with slight agitation. Slides were then mounted using one drop 
(~100 L) of ProLong® Diamond Antifade Mountant with DAPI (Life Technologies) and left to 
cure in the dark at room temperature overnight. Slides were visualized using an Olympus IX71 
inverted fluorescent microscope at 100X magnification using the 31000 DAPI/Hoechst filter 
(EX360, EM460) to visualize DAPI and the 41002 TRITC (Rhodamine)/Cy3 filter (EX535, 
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EM610) to visualize Alexa568. Images were captured using a Q Imaging Retiga 2000R camera. 
Background fluorescence was determined by measuring slides probed with secondary antibody 
only and the minimum threshold of images was adjusted accordingly. Nucleus size was 
analyzed via ImageJ (Schneider et al. 2012). 
 
2.11 MazF digestion and analysis 
MazF digestion and analysis was performed according to a published protocol (Garcia-
Campos et al. 2019a) with some modification.  Briefly, 100 ng of total RNA was digested by 20 
units of MazF enzyme (Takara Bio, Cat# 2415A) supplemented with 4 µL 5X MazF buffer (200 
mM sodium phosphate, pH 7.5, 0.05% Tween-20), 0.8 µL DMSO and 0.5 µL RNase inhibitor 
(Thermo Fisher Scientific) in a 20 µL reaction. Samples were denatured at 70°C for 5 minutes 
then incubated at 37°C for 30 minutes. Digested RNA was purified by 
phenol/chloroform/isoamyl alcohol (25:24:1) extraction and EtOH precipitation, then subjected to 
RT-dPCR as previously described (See sections 2.3 RNA Isolation, 2.4 RT and 2.5 dPCR) with 
one exception. 100% random hexamer was used to prime the reaction instead of 3:1 mixture of 
random hexamers:oligo (dT)20. Three primer sets were designed to create different products 
from the same transcript. The ACA product contained two unprotected ACA motifs, the control 
product contained no ACA motifs and the m6A product contained the methylated ACA motif of 
interest. Methylation ratios were generated using the formula: m6A product abundance/Control 
product abundance. To compensate for enzymatic efficiency between samples and RT 
efficiency across different areas of the transcript, a normalization ratio was generated using the 
same formula, but with samples lacking MazF. The same analysis protocol was employed with 
the ACA product to generate a background ratio. This background ratio was subtracted from the 
methylation ratio in order to get a more accurate quantification of methylation status. 
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2.12 Luciferase assays 
For assessment of luciferase activity, cells were seeded equally into 96-well µClear® plates 
(Greiner Bio-One; 5,000 HeLa cells per well, 3,000 HFFs per well, or an equal volume of 
resuspended iPSCs). For RNA abundances, cells were seeded into 6-well plates (Greiner Bio-
One). Cells were transfected (see Section 2.1.4) with a 4:1 ratio of Renilla luciferase 
experimental construct to Firefly luciferase control (pGL4.13; Promega). Approximately 24 hours 
after transfection, cells were assessed for luciferase activity or collected in TRIzol to measure 
RNA abundances (see sections 2.3-2.5 for RNA measurement). Luciferase assays were 
performed using the Dual-Glo® Luciferase Assay System kit (Promega) and activity was 
quantified on a Victor™ X5 Plate Reader (PerkinElmer). Data analysis of luciferase activity of 
experimental constructs was performed according to previously published protocols (Van Etten 
et al. 2013) and compared to an empty vector control. To ensure the observed differences were 
due to changes in translation efficiency and not influenced by mRNA abundance, luciferase 
activity for each construct was normalized to the mRNA abundance. Data were reported as 
relative Renilla luciferase activity. 
 
2.13 In vitro transcription 
To create a template for the in vitro transcription reaction, the first 300 nucleotides of the 
YTHDF2 3’ UTR was amplified using PfuUltra II Fusion High-fidelity DNA Polymerase and a 
forward primer with the SP6 promoter sequence (see Table 2.3). A size-matched control was 
also created by digesting the empty pGEM4 plasmid with Slm1. In both cases, the templates 
were gel purified via the Wizard® SV Gel and PCPR Clean-Up kit (Promega) in accordance with 
manufacturer’s protocols and validated via Sanger sequencing (Genewiz). In vitro transcriptions 
were performed using SP6 RNA Polymerase (Fermentas) in the presence of Biotin-14-CTP 
(Thermo Fisher Scientific) and incubated for 75 minutes at 37°C to generate biotinylated RNAs. 
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Reactions then were incubated with DNase I (Thermo Fisher Scientific) to remove template 
DNA and cleaned up via phenol/chloroform extraction, EtOH precipitated and quantified via 
spectrophotometry using a Nanodrop 2000c (Thermo Fisher Scientific). 
 
2.14 RNA pulldown and mass spectrometry 
The full in vitro transcription reactions generated from section 2.13 were incubated with 100 
µL of MACS streptavidin magnetic beads (Miltenyi Biotec) for 10 minutes at room temperature 
with slight agitation (~300 rpm) to bind the RNAs to the column. Immediately following the 10 
minute incubation, 350 µL of pre-cleared HeLa cell extracts (prepared as described in (Ford et 
al. 1999; Sokoloski et al. 2008)) supplemented with 5 µL of liquid protease inhibitor (Sigma-
Millipore) was added to each reaction and incubated at 4°C for 60 minutes with rotation. Shortly 
before the completed incubation period, magnetic bead columns were equilibrated with 100 µL 
of 2X Equilibration Buffer provided in the µMACs kit. Incubated samples were added to 
individual columns and the Flow Through was collected and stored at -80°C. Columns were 
washed 5X with 1 mL of Binding/Wash buffer (10 mM HEPES pH 7.0, 10% Glycerol, 1 mM 
EDTA, 0.5% Triton X-100, 20 u/mL RNase, 1 mM DTT and 50-300 mM KCl). A Binding/Wash 
buffer with a concentration of 250 mM KCl was used for the samples submitted for mass 
spectrometry analyses. Flow through from the washes was discarded. RBPs were eluted by 
adding 200 µL of Binding/Wash buffer with 1M NaCl while the column was still on the magnetic 
stand and collected in a 1.5 mL tube. Eluted RBP samples were quantified via Pierce™ Rapid 
Gold BCA kit (Thermo Fisher Scientific). To assess the optimal concentration of KCl, equal 
volumes of each sample were electrophoresed into a 10% SDS PAGE gel, silver stained and 
visualized on the ChemiDoc XRS+ system (Bio-Rad). For mass spectrometry submission, 
approximately 50 µg of each sample was briefly electrophoresed into a 10% SDS PAGE gel, 
excised from the gel and submitted to the Proteomics and Metabolomics Facility at Colorado 
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State University. Trypsin digestion and LC-MS/MS protein identification were performed in 
accordance with previously published protocols (Michalski et al. 2019). Scaffold  4 software 
(Proteome Software) was used to analyze the mass spectrometry data (Searle 2010). 
 
2.15 Nuclear/Cytoplasmic fractionation 
Nuclei and cytoplasm were separated as described previously (Weil et al. 2000). Briefly, 
cells were removed from culture plate and into ice cold PBS via manual scraping, collected via 
centrifugation (500 x g for 5 minutes), resuspended in NP40 lysis buffer (0.5% NP-40, 10 mM 
Tris-HCl pH 8.5, 1.5 mM MgCl2, 10 mM EDTA, 140 mM NaCl) and incubated on ice for 5-
10 minutes. A small amount of each sample was stained with trypan blue and visualized using a 
microscope to ensure adequate cell lysis. Once lysis was confirmed, nuclei were pelleted via 
centrifugation at 500 x g for 5 minutes at 4°C. The cytoplasm (supernatant) was transferred into 
a new tube and an equal volume of TRIzol was added. The nuclei pellet was then washed twice 
with NP40 lysis buffer before being lysed in 500 µL of TRIzol. RNA was isolated as described in 
section 2.3 (RNA Isolation). The RNA from the nucleus and cytoplasm was resuspended in an 
equal volume such that an equal number of cells were represented in 1 µl regardless of RNA 
concentration. The relative abundance of each transcript in the nuclear and cytoplasmic 
fractions was then determined via RT-dPCR (see Sections 2.4 and 2.5 for details) and reported 
as percent RNA in the nucleus. tRNA and 45S pre-ribosomal RNA were used as controls to 
ensure efficient fractionation was achieved. 
 
2.16 Quantification of miRNA abundance 
miRNA abundance was measured by RT-dPCR performed in accordance with a previously 
described protocol (Git et al. 2010; Neff et al. 2012). Briefly, approximately 1 µg of total RNA 
was polyadenylated via the Poly(A) Tailing Kit (Ambion) according to the manufacturer’s 
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protocol in a 25 µL reaction. RNA was then cleaned via phenol:chloroform extraction and EtOH 
precipitation and cDNA was synthesized according to previously described protocols (See 
section 2.4 RT) using 500 ng of oligo (dT) adapter (Integrated DNA Technologies Inc.). cDNA 
was then treated with RNase H (Fermentas) for 1 hour at 37°C. Approximately 1 ng of cDNA 
was added to each reaction for RT-dPCR analysis with human 5S rRNA used as a reference 
transcript. Detailed information about the primers used for each transcript can be found in Table 
2.6. 
 
2.17 Transcript alignment and analysis 
Sequences used for HERV-H lncRNAs were based on the NCBI Reference Sequences. 
RefSeq number for each transcript are listed in Table 2.7. The consensus HERV-H sequence 
used was generated from Vargiu et al., 2016. Sequence analysis was performed via Geneious 
Prime 2019.1.1 (https://www.geneious.com). HERV-H lncRNAs were aligned to the HERV-H 
consensus sequence using BLASTN (Altschul et al. 1997) and the Pairwise/Multiple Alignments 
function of Geneious Prime, both under default parameters. 
 
2.18 RNA sequencing 
2.18.1 Library preparation and sequencing runs 
Sequencing libraries were prepared from Control, YTHDF2 or PCBP2 siRNA-treated iPSC 
total RNA samples (See section 2.3 RNA Isolation, above) as follows. First strand cDNA was 
generated from 500 ng of total RNA using the SMARTer™ PCR cDNA Synthesis Kit (Takara 
Bio) in a 10 µL reaction per manual instructions. Reactions were incubated at 42°C for 90 
minutes to achieve full-length cDNA synthesis. Second strand synthesis was performed using 
the Advantage 2 PCR kit (Takara Bio) in a 50 µL reaction with the following thermocycler 
conditions: 95°C for 15 seconds, 65°C for 30 seconds, 68°C for 6 minutes. Extension time was 
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set at 6 minutes to accommodate the full-length cDNA synthesis performed during first strand 
synthesis. Amplification of cDNA was performed for 4-6 cycles. PCR products were isolated 
using 90 µL of Agencourt AMPure XP Beads (Beckman Coulter) and eluted in 40 µL of TE 
buffer. DNA concentrations were quantified via the Qubit 3.0 fluorometer (Thermo Fisher 
Scientific) using the dsDNA HS kit (Thermo Fisher Scientific). DNA was tagmented using Tn5 
transposase generously provided by Dr. Mark Stenglein. Preparation of the enzyme and 
reactions conditions were performed in accordance with a previously published protocol (Picelli 
et al. 2014). 5 ng of dsDNA, 2 µL of Tn5 Tagmentation Enzyme at a 12.5 µM concentration and 
a 5X TAPS-DMF buffer (see (Picelli et al. 2014) for recipe) were combined in a final volume of 
20 µL. Reactions were incubated at 55°C for 10 minutes to achieve dsDNA fragments of 
approximately 200-300 base pairs in length. Reactions were terminated by adding 2.5 µL of 
0.2% SDS and incubating at room temperature for 5 minutes. Tagmented DNA (5.8 µL) was 
used as a template for addition of full-length adapters in a 4-primer PCR reaction. This reaction 
was performed using the KAPA HiFi HotStart ReadyMix (KAPA Biosystems). For details on the 
tagmentation primers and index oligos used see Table 2.8. PCR products were isolated using 
AMPure XP beads and eluted in 40 µL of TE buffer. A portion of each library was visualized on 
the Agilent TapeStation 2200 using D1000 ScreenTape (Agilent) and reagents to verify a 
median product size of 200-300 base pairs, and concentrations were measured fluorometrically 
via Qubit. Equal masses of DNA, 10 ng, from each sample were pooled, concentrated with 
AMPure XP beads and eluted in 40 µL of TE buffer. A portion of the pooled library was run on 
the Agilent TapeStation 2200 using D1000 ScreenTape and to ensure a median product size of 
200-300 base pairs. Final library quantification was performed by the Colorado State University 
NGS Core using the Illumina library quantification kit (KAPA Biosystems) per manufacturer’s 
protocols. Libraries were sequenced on an Illumina NextSeq 500 instrument using single-end 1 
x 75 sequencing from a NextSeq 500/550 High Output Kit v2 (75 cycles) (Illumina) on two 
separate runs. The mean number of reads per sample was 25-50 million. Base calling was done 
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via RTA v2.0, and files were converted to fastq using bcl2fastq v2.20.0.422, consistent with 
standard Illumina protocols. 
 
2.18.2 Quality control and alignment of RNA-seq reads 
Quality of sequence reads was assessed via FastQC v0.11.5. Reads were trimmed of 
adapter sequences and filtered for low-complexity or low-quality reads via Trimmomatic v0.32 
(Bolger et al. 2014).  rRNA reads were filtered out using Bowtie2 v2.3.4.3 (Langmead and 
Salzberg 2012) and a reference fasta file of mature 5S, 18S and 28S rRNA sequence obtained 
from NCBI RefSeq (mature_rRNA.fasta.gz). Filtered reads were mapped to the hg19 genome 
using TopHat2 v2.0.12 (Kim et al. 2013) under default parameters. Read counts from aligned 
reads were calculated using HTSeq v0.11.1 (Anders et al. 2015) with the parameters --mode = 
union --stranded=no --minaqual=20, Samtools v1.9 (Li et al. 2009) and the hg19 genome 
feature file obtained from GENCODE (hg19, Ensembl 74, hg19_gene_annotations.gtf.gz). It is 
important to note we obtained only eight million raw reads from one of the six day PCBP2 KD 
replicates. This is below the 10 million raw read threshold we set and approximately half the 
number of raw reads generated from the other replicates in the run. For these reasons, this 
replicate was removed from downstream analyses. Raw and processed RNA-seq data 
generated in this study, as well as the genome feature file and rRNA fasta file used, were 
uploaded to the NCBI Gene Expression Omnibus (GEO) database under the accession number 
GSE133898 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE133898) for YTHDF2 
KD experiment and GSE139626 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139626) for PCBP2 KD experiments. 
 
2.18.3 Computational analyses of RNA-seq data 
There were minor differences in the computational analyses workflow between the PCBP2 
and YTHDF2 datasets. For the PCBP2 dataset, differential expression analysis was performed 
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followed by functional annotation of the differentially expressed genes. For the YTHDF2 dataset, 
a source of unwanted variation was detected. To remove the unwanted variation, the raw count 
data underwent more extensive normalization via the RUVSeq package (Risso et al. 2014). 
Normalized count data was then subjected to differential expression analysis followed by 
functional annotation and overlap analysis. 
 
2.18.3.1 Differential expression analysis 
Raw read count data was filtered for detectable genes (> 5 counts per sample) and 
analyzed for differential expression using DESeq2 v1.22.1 (Love et al. 2014) under default 
parameters. The quality of datasets was assessed via principle component analysis (PCA) and 
calculation of sample-to-sample Euclidian distances on variance-stabilized, log-transformed 
count data. Differentially expression thresholds were set at Benjamin-Hochberg corrected p-
value < 0.05 for and log2-fold change > 1.0 for up-regulated genes and log2-fold change < 1.0 
for down-regulated genes. Transcripts that met both thresholds were classified as differentially 
expressed. Gene symbol, Entrez Gene ID and gene biotype were retrieved using the biomaRt 
package v2.38.0 (Durinck et al. 2009) and the hsapiens_gene_ensembl dataset. Hierarchical 
clustering of differentially expressed genes was performed and plotted on Z-scored intensity 
values using the heatmap.2 function of the gplots package v3.0.1 (Warnes et al. 2016). 
Distances were calculated based on the Pearson correlation coefficient and clustering was 
performed using the unweighted pair group method with arithmetic mean. 
 
2.18.3.2 Removal of unwanted variation via RUVSeq 
To remove the unwanted variation, filtered count data was normalized via the RUVSeq 
package using the RUVr option in accordance with the published protocol (Risso et al. 2014). 
PCA was performed and Euclidian distances were measured on the normalized data to confirm 
the removal of unwanted variation. 
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2.18.3.3 Functional annotation analysis 
Gene enrichment analysis was performed using the online functional annotation tool DAVID 
v6.8 (Huang et al. 2009a, 2009b).  Separate lists of Ensembl Gene IDs corresponding to 
differentially expressed transcripts, either up- or down-regulated, were uploaded and mapped to 
DAVID gene IDs. Functional annotation cluster was performed to determine overrepresented 
Gene Ontology biological processes, cellular components and molecular functions. Analysis of 
overrepresented tissue expression profiles was also performed for the up-regulated list. The top 
four to five non-redundant terms from each analysis, defined by the lowest FDR corrected p-
values were reported along with the number of genes associated with each term and the fold 
enrichment over background. 
 
2.18.3.4 Overlap analysis 
Data for transcripts previously reported to be m6A-modified via m6A RIP-seq in hESCs 
(Batista et al. 2014) or bound by YTHDF2 via PAR-CLIP seq in HeLa cells (Wang et al. 2014b) 
were obtained through publically available datasets. Lists of gene names for transcripts up-
regulated, down-regulated, m6A-modified and YTHDF2-bound along with all genes detected in 
each experiment were imported into R v3.5.1 (R Core Team 2018). Overlap analysis was 
performed using the packages plyr v1.8.4 (Wickham 2011), VennDiagram v1.6.20 (Chen 2018) 
and futile.logger v1.4.3 (Rowe 2016). Background filtering was performed to ensure only genes 
that were detected in both experiments were included in the overlap analysis. P-values were 
calculated via hypergeometric test using the phyper function of the stats package.   
 
2.18.4 Data availability 
The accession numbers for the RNA-seq datasets reported in this study are as follows: 
YTHDF2 KD- GEO: GSE133898; PCBP2 KD- GEO: GSE139626. 
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2.19 General quantification and statistical analysis 
Three independent replicates were performed for each experiment unless noted otherwise. 
Statistical analyses were performed using GraphPad Prism 8 software (GraphPad Software, 
Inc.) For RIP analyses, a one-tailed t-test was employed. For all other comparisons, a false 
discovery rate (FDR) or q-value was calculated using the two-stage step-up method of 
Benjamini, Krieger and Yekutieli (Benjamini et al. 2006) to correct for multiple comparisons, 
unless noted otherwise. p-values from t-tests and q-values from FDR tests of less than 0.05 




Table 2.1: Stem cell differentiation medias. 
 
Stem Cell Differentiation Media Lineage STEMCELL Tech. 
Catalog Number 
STEMdiff™ Neural Induction Medium Neuroectoderm Cat# 05839 
STEMdiff™ Mesoderm Induction Medium Mesoderm Cat# 05221 
STEMdiff™ Definitive Endoderm Kit Endoderm Cat# 05110 
STEMdiff™ Trilineage Differentiation Kit All 3 germ layers Cat# 05230 
 
Table 2.2: siRNA sequences used for knockdown experiments. All siRNAs were purchased 
from Sigma-Millipore. 
 
siRNA target Sequence (5’ to 3’) Previous Validation/Catalog Number 
Negative Control Proprietary SIC001-10NMOL 
YTHDF2 AAGGACGUUCCCAAUAGCCAA (Wang et al. 2014b) 
METTL3 CUGCAAGUAUGUUCACUAUGA (Liu et al. 2014) 
WTAP GCAACAACAGCAGGAGUCU SASI_Hs01_00039282 
IGF2BP1 CAGUAUGUGGGUGCCAUUA SASI_Hs01_00074473 
IGF2BP3 GUUGUAAAUGUAACCUAUU SASI_Hs01_00207964 
HNRNPQ CUAUCGUGGUGGAUAUGAAGA (Ryu et al. 2019) 
PCBP2 #1 CCCACUAAUGCCAUCUUCA SASI_Hs01_00082600 
PCBP2 #2 GCAUUAGCCUGGCUCAAUA SASI_Hs01_00082601 
LINC01356 AAGACAGGAAUAUCAGGUCUC Custom Designed 
LIN28B AUUUAAAAAAUCUUCCAAAG SASI_Hs01_00042202  
 
Table 2.3: Primers used for cloning. 
 
Target Fragment Forward Primer Sequence Reverse Primer Sequence 













































































Table 2.4: Primers used for RT-dPCR. 
 
Gene Target Forward Sequence Reverse Sequence 
GAPDH AAGGTGAAGGTCGGAGTCAA AATGAAGGGGTCATTGATGG 







METTL3 AGCCTTCTGAACCAACAGTCC GGCTTTCATGCACTCCTCCT 
WTAP GCTTCTGCCTGGAGAGGATTC GATCTGTGTACTTGCCCTCCA 
ST6GALNAC4 GAGCGCATGATGGCCTACTG CTGACCATCCCATAGACCACG 
FBLN2 CAGACCCCAACTCTGTCCAT  GCAGCTCTTCTCCTGCAAGT  
NGFR TGTCTATTGCTCCATCCTGGC CTGTTGGCTCCTTGCTTGTTC 
CHAC1 GTGGTGACGCTCCTTGAAGAT TTACCTGCTCCCCTTGCACT 
WDR62 GGGTAGACGTGGCACAGG TGGAAGAGCTCTGACCACAC 
NLGN3 CTGATCTCGGGGATTCGGG GTAGAGAGCAGGTCGTCCAAG 
TSPYL4 ATGAACGCAGATCCTCTGGC GTGTTCCCTTCCCGGTTTCT 
TOR1AIP2 TTTACGATTTAAAACTTCGCCAGAA GAGTCTGGGAATGCGTCACA 
SYNGAP1 CAAAATCGATGGATGAGAGCCG AGCCGCTCTTTCAGTGAGTG 
LINGO1 ACATGCGATTGGTGACCGAG CGAGCCTGACAGCACTGAG 
OPCML ATGACGAAGGTCCGTACACC ACAGGTGTCTCCATGTCACAG 
EPHA8 CTCACGTATCCGGCTCATGG TCGCGCAGGGTAAACTTGAT 
CREBBP CTCAGCTGTGACCTCATGGA AGGTCGTAGTCCTCGCACAC 
SCLM2 GATCGGTGGGACAGAATTTCG CTCCTCCCAGTGGAAATCATCC 
PAX6 TCAGAGCCCCATATTCGAGC CAAAGACACCACCGAGCTGA 
FOSB GACTCCTTCGGCAGTCCAC TCCTGGCTGGTTGTGATCG 
NANOG CCTATGCCTGTGATTTGTGG TTCTCTGCAGAAGTGGGTTG 
OCT4 GGCAACCTGGAGAATTTGTT GTGCATAGTCGCTGCTTGAT 
KLF4 ACCAGGCACTACCGTAAACACA GGTCCGACCTGGAAAATGCT 
SOX1 AAAATACTGGAGACGAACGCC AAGAAAACGCTTTCCGCTTCC 



















YES1 TCCTGCTGGTTTAACAGGTGGTG TGCTTCCCACCAATCTCCTTCC 
PODXL CAGAGTGAGAAGCAGCTCGT GGAACAGATGCCAGCCGTAT 
FSCN1 TCAGAGCTCTTCCTCATGAAGCT GTCCAGTATTTGCCTGTGGAGTC 
GAP43 CCATGCTGTGCTGTATGAGAAG CCAGGTGATGCTGTGACTCAT 
SYT1 GGCAAAACCCTAGTGATGGC TACGTAGCGAAGGGAGAAGC 
PCBP2 GCTGCACCAGTTGGCAATGCAA AGCCTTTCACCTCTGGAGAGCTGG 
RGS5 CCACCTGCCAAAATGTGCAA CAGCGAGGTTTTCTGGGTCT 
CTGF CTCGCGGCTTACCGACTG GGCTCTGCTTCTCTAGCCTG 
EGR1 ACCTGACCGCAGAGTCTTTTC GCGGCCAGTATAGGTGATGG 
KLK5 CCTGCACCCACATCTTTCTCT CATGGCCGCTGCACCTTATT 
HESX1 CCTGCAGCTCATCAGGGAAA CCACCACGCTAGGGATGAA 
PTBP2 ATTTTCTCGCCGCTTGTGTG CAGATCCTCTCTTCACGCCA 
HMGB2 TCTGAGGAAAAGCTCGCACC ACATGGTCTTCCATCTCTCCG 
LIN28B GCACATTAGACCATGCGAGC CTTTGCTAGCCCCGCCTTC 
CDH9 TGTAGGCAAGCTTCACACTGA AGCCTTGGCACGAAGAATGT 





45S GAACGGTGGTGTGTCGTT GCGTCTCGTCTCGTCTCACT 
Global HERV-H TGGTGCCGTGACTCGGAT GCTGAGTCCGAAAAGAGAGTC 
LINC01356 CCCTGTCCTCCTGCTCTTTG CATCTGTGATGGTCCAGGGG 
LINC00458 AGACTGACACTGCCCAATCG AGTTCAGTCCAGAAGAAAAAGTCCT 
LINC678 GGCAATGGTCAGGTGGAGT GCCCAAGCAGAAATCAGACAC 
LNCPRESS2 TGAAGGTGCTGCTAGTTGGAG CATTGACGACACTCTTGCTGT 
ERVH48 TCGGACTCTCACTGCAGTTG CTCTAGTCGCCTCTCTGTGC 
ESRG TGGTCTCTTCACACAGACGC CAGGCTGGTTGGAGTTTTGC 
















Type WB Dilution 
Factor (if 
applicable) 
IF Dilution Factor 
(if applicable) 
YTHDF2 ProteinTech 24744-1-AP rabbit 
polyclonal 
1:1000 in TBS-T 1:100 
GAPDH Millipore MAB374 mouse 
monoclonal 
1:5000 in PBS-T NA 
METTL3 ProteinTech 15073-1-AP rabbit 
polyclonal 
1:1000 in PBS-T NA 
WTAP ProteinTech 60188-1-Ig mouse 
monoclonal 










1:500 in PBS-T 1:100 
TRA-1-60 Abcam ab16288 mouse 
monoclonal 
NA 1:100 















YTHDF3 Abcam ab103328 rabbit 
polyclonal 
1:250 PBS-T NA 









1:2000 PBS-T NA 
HNRNPQ Abcam ab10687 mouse 
monoclonal 





1:1000 PBS-T 1:100 
PCBP1 Abnova H00005093 mouse 
polyclonal 
1:1000 PBS-T NA 
PCBP3 Sigma HPA030247 rabbit 
polyclonal 
1:1000 PBS-T NA 
 
 
Table 2.6: Oligonucleotides used for quantification of miRNAs. 
 
Oligonucleotide Sequence (5’ to 3’) 
Poly(T) adapter GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTT(A/G/C)(A/G/
C/T) 
Universal Reverse GCGAGCACAGAATTAATACGACTC 




Table 2.7: NCBI Reference Sequence numbers for HERV-H lncRNAs. 
 









Table 2.8: Oligonucleotides used in library preparation and RNA-sequencing. 
 
General Oligonucleotides 






Sequencing Run Indexes 
Sample ID Read1 (i5) index Read2 (i7) index 
3/21/2017 Run 
YTHDF2 KD 1 TCACAACG AAGACCTA 
YTHDF2 KD 2 CCTTACAG GAACGGTA 
YTHDF2 KD 3 TCCTCCTG GTCCAACA 
9/14/2017 Run 
Control 1 GTAGTACG TCGTCTCA 
Control 2 GTCTTCTG ACAGGCTA 
Control 3 TGAATCCG GTGACTGA 
YTHDF2 KD 4 TCACAACG AAGACCTA 
8/15/2018 Run 
6 day Control 1 GAATTGCG ACTGTGGA 
6 day Control 2 GTGAGGAG GGTTAAGA 
6 day PCBP2 KD 1 GAGACCAG TCGTTGGA 
6 day PCBP2 KD 2 TACGCTAG TCCGTATA 
6 day PCBP2 KD 3 GACTGGAG GTGTCCTA 
2 day Control 1 CTACCTCG GTACGTCA 
2 day Control 2 GTTAAGCG TGCAGTTA 
2 day PCBP2 KD 1 GAGTGTTG TACATGCA 
2 day PCBP2 KD 2 GAGCTCTG GATGATGA 





Chapter 3: YTHDF2 destabilizes m6A-modified neural-specific mRNAs to restrain 




The ability of stem cells to maintain a state of self-renewal, yet also rapidly differentiate in 
response to external signals requires complex and coordinated control of global gene 
expression. Although transcriptional changes are integral to this control, stem cells also utilize 
post-transcriptional regulation to achieve rapid remodeling of the transcriptome during 
differentiation (Zhao et al. 2017b; Ivanova et al. 2017; Oh et al. 2018; Kami et al. 2018; Lloret-
Llinares et al. 2018). The RNA modification m6A is one post-transcriptional mechanism used by 
stem cells utilize to regulate gene expression (Batista et al. 2014; Geula et al. 2015; Heck and 
Wilusz 2019; Chen et al. 2015c; Zhang et al. 2017a; Li et al. 2015). m6A is by far the prevalent 
internal modification RNA species can experience with ~10,000 m6A sites documented in over a 
quarter of human transcripts (Meyer et al. 2012; Dominissini et al. 2012; Chen et al. 2015a). 
m6A modifications are deposited, or written, onto RNAs by the methyl-writer complex which can 
be divided into two sub-complexes; the MAC, consisting of METTL3, the catalytically active 
subunit of the complex, and METTL14 (Liu et al. 2014), and the MACOM, comprising WTAP, 
ZC3H13, RBM15/15B, VIRMA and HAKAI (Ping et al. 2014; Guo et al. 2018; Yue et al. 2018; 
Knuckles et al. 2018; Růžička et al. 2017). Conversely, m6A can also be erased by one of two 
demethylases, ALKBH5 or ALKBH9/FTO (Zheng et al. 2013; Jia et al. 2011). Although the 
overall impact of demethylation remains open for debate (Ke et al. 2017; Mauer et al. 2017; 
Darnell et al. 2018; Zhao et al. 2018). Importantly, the ultimate impact of m6A methylation is 
dependent on which m6A-binding proteins (readers) interact with the modified RNA. The best-
characterized of m6A readers are the YTH (YT521-B homology) family of proteins which 
consists of YTHDF1-3 as well as YTHDC1 and 2 (Patil et al. 2018). Readers influence the fate 
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of m6A-modified RNAs at the level of cleavage/polyadenylation (Kasowitz et al. 2018), splicing 
(Xiao et al. 2016), subcellular localization (Roundtree et al. 2017), translation (Wang et al. 
2015b) and decay (Wang et al. 2014b). 
METTL3 knockout in mice is lethal by embryonic day 8.5 (E8.5) (Geula et al. 2015) 
demonstrating that methylation is essential for early development. In fact, m6A methylation is 
important at the very earliest steps as it is needed for pluripotency in both human and mouse 
ESCs (Batista et al. 2014; Wang et al. 2014c; Geula et al. 2015; Wen et al. 2018; Chen et al. 
2015c; Aguilo et al. 2015; Bertero et al. 2018). Moreover, a reduction in global m6A levels alters 
the self-renewal and differentiation capabilities of ESCs (Batista et al. 2014; Wang et al. 2014c; 
Geula et al. 2015; Wen et al. 2018). This is likely in part because mRNAs encoding core 
pluripotency factors such as SOX2, KLF4, NANOG and MYC (but not OCT4) are m6A-modified 
(Wang et al. 2014c; Batista et al. 2014; Aguilo et al. 2015; Bertero et al. 2018) leading to altered 
mRNA stability, translation, export and/or splicing when m6A modification is reduced. The 
studies described above largely focused on the influence of m6A and methyltransferase 
activities and did not address which m6A readers execute the coordinated, global changes in 
gene expression that are necessary to facilitate rapid remodeling of the transcriptome in 
response to external cues. Characterizing the impact of reader activity is critical to our 
understanding of how m6A influences pluripotency and development.   
Relatively little is known regarding which m6A readers are active in the early embryo and 
specifically in embryonic stem cells. Of the YTH domain family of proteins, only YTHDF2 and 
YTHDC1 are embryonic lethal when knocked out, suggesting they play a prominent role in early 
development (Li et al. 2018b; Kasowitz et al. 2018). However, it is not clear whether these 
factors mediate the effects of m6A on pluripotency, as their role in stem cells has not been 
characterized. In differentiated cells, YTHDC1 modulates splicing and export from the nucleus 
(Xiao et al. 2016; Kasowitz et al. 2018; Roundtree et al. 2017), whereas YTHDF2 facilitates the 
degradation of m6A-modified transcripts by recruiting deadenylases and endonucleases (Wang 
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et al. 2014b; Du et al. 2016a; Park et al. 2019). Previous studies have suggested YTHDF2 plays 
an important role in developmental transitions such as the maternal-to-zygotic transition (Zhao 
et al. 2017b; Ivanova et al. 2017), epithelial-mesenchymal transition (Chen et al. 2017) and 
differentiation of NPCs (Li et al. 2018b), where it facilitates the clearance of “old” RNAs to allow 
establishment of a new gene expression pattern.  Based on the evidence outlined above, we 
hypothesized that YTHDF2 mediates the influence of m6A methylation on pluripotency and 
differentiation in pluripotent stem cells.  
Here, we report that YTHDF2 helps to maintain a pluripotent state by targeting a group of 
key m6A-modified transcripts encoding neural-specific factors for degradation. When neural 
differentiation is induced, expression of YTHDF2 decreases along with the level of m6A 
modification on neural transcripts. This leads to stabilization and increased abundance of neural 
transcripts which helps to drive differentiation. Depletion of YTHDF2 in self-renewing iPSCs 
leads to inappropriate expression of neural markers and loss of pluripotency. However, 
depletion of YTHDF2 during neural induction disrupts expression of both pluripotency and 
neural-specific factors. Taken together, our findings reveal pluripotent stem cells rely on 
YTHDF2 to restrain expression of neural-specific factors in order to maintain a pluripotent state 
until a signal to differentiate is received. 
 
3.2 Results 
3.2.1 YTHDF2 is required for pluripotency in human iPSCs 
YTHDF2 protein expression is approximately seven-fold higher in iPSCs than in genetically 
matched HFFs (Fig. 3.1A, B). This dramatic difference in expression between somatic and 
pluripotent cell types coupled with previous evidence indicating m6A plays an important role in 
pluripotency (Batista et al. 2014; Wang et al. 2014c; Geula et al. 2015; Wen et al. 2018; Chen et 
al. 2015c; Aguilo et al. 2015; Bertero et al. 2018) invited further investigation. Therefore, we 
depleted YTHDF2 in iPSCs using a previously validated siRNA (Wang et al. 2014b). We treated 
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cells with siRNA over a period of five days and evaluated the effects on pluripotency. Efficient 
knockdown (KD) was verified at both protein and mRNA levels (Fig. 3.2A, B). Intriguingly, we 
observed cell and colony morphological changes. As seen in Figure 3.4.2C, YTHDF2 depletion 
resulted in a loss of the structural integrity of the colony and the edges of the colony became 
poorly-defined. Moreover, cells were no longer tightly packed within the colony, and individual 
cells and cell borders could be more easily visualized. These changes are all consistent with 
differentiation (Nagasaka et al. 2017; Wakao et al. 2012). Other cellular changes linked to 
differentiation, like enlargement of the nuclei (Rozwadowska et al. 2013) and reduced 
expression of pluripotency markers TRA1-60 (Grigor’eva et al. 2019; Vilà-González et al. 2019) 
and SSEA4 (Zhang et al. 2018b) were also observed (Fig. 3.2D, E and Fig. 3.3).  In summary, 
iPSCs depleted of YTHDF2 exhibit phenotypes consistent with loss of pluripotency. 
  
 
Figure 3.1: YTHDF2 protein is highly expressed in iPSCs. A: Western blot to detect YTHDF2 in 
three independent iPSC and HFF extracts. GAPDH was used as a loading control. B: Quantification 
of (A). Asterisks indicate significant difference in the relative mean protein expression between iPSC 







Figure 3.2: Depletion of YTHDF2 in iPSCs results in morphological changes. A: Representative 
western blot using iPSC extracts to demonstrate effective depletion of YTHDF2. GAPDH was used as 
a loading control. Percent protein remaining calculated from three independent biological replicates is 
indicated below the lanes. B: RT-dPCR analysis of YTHDF2 mRNA abundance in siRNA negative 
control and YTHDF2 depleted samples normalized to GAPDH mRNA. Asterisks indicate significant 
difference in mean abundance between control and YTHDF2 KD samples (***p-value<0.0005). C: 
Bright field images of siRNA negative control and YTHDF2-depleted iPSC colonies. Scale bars 
indicate 100 µm. D, E: iPSCs were subjected to five days of treatment with negative control or 
YTHDF2 siRNAs. The nucleus was stained with DAPI. (D) Nucleus size of siRNA negative control or 
YTHDF2 depleted cells (n=50) was quantified via ImageJ. *p-value <0.05. (E) The indicated protein 






Figure 3.3: Depletion of YTHDF2 in iPSCs results in enlargement of the nucleus. Images used to 
quantify the nucleus size from 50 cells each in control and YTHDF2 KD samples. Set 1 (A) and set 2 
(B) represent two independent replicates. Quantification was performed using ImageJ, results can be 
seen in Fig. 3.1D. 
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3.2.2 YTHDF2 depletion affects transcripts required for neural development 
To gain insights into the specific transcripts affected by YTHDF2 and learn more about the 
phenotype adopted following YTHDF2 knockdown, we performed RNA-sequencing on control 
and YTHDF2-depleted cells. The dataset was normalized using the RUVSeq package (Risso et 
al. 2014) and differential expression was determined via DESeq2 (Love et al. 2014) (Fig. 3.4). 
We observed 1689 and 1066 transcripts were up- or down-regulated, respectively (Fig. 3.5A, 
Table S1). As expected, YTHDF2 itself exhibited a large decrease in expression. To better 
understand the structure of the dataset, we performed hierarchical clustering of the differentially 
expressed genes. Our analysis revealed up-regulated transcripts displayed more consistent 
levels of expression between biological replicates and more robust differences between 
treatment and control samples when compared to the down-regulated group of transcripts (Fig. 
3.4D). This is consistent with YTHDF2 function as a destabilizing RBP, in that depletion is 
expected to result in increased abundance of target RNAs.  
To identify mRNAs that are likely to be direct targets of YTHDF2, we compared our sets of 
differentially expressed transcripts with transcripts that are m6A methylated in human embryonic 
stem cells (Batista et al. 2014). Lists were filtered so only genes were detected in both datasets 
were used in the analysis (Fig. 3.6). Importantly, almost 70% of the transcripts that were up-
regulated following YTHDF2 knockdown were m6A methylated, far more than expected by 
chance (Fig. 3.5B). This, and the fact that only 46% of down-regulated RNAs showed evidence 
of m6A methylation (Fig. 3.5D) are consistent with previous observations that YTHDF2 
recognizes m6A and recruits RNA decay enzymes (Du et al. 2016a; Park et al. 2019; Wang et 
al. 2014b). Notably, transcripts with more than 1 m6A site show a significantly greater change in 
abundance following YTHDF2 knockdown than those with 0 or 1 sites (Fig. 3.5F). This is 
consistent with recent evidence that recruitment of multiple YTHDF2 proteins may be required 






Figure 3.4: Normalization of RNA-seq data by RUVseq package to remove unwanted sources 
of variation. A: PCA plot of raw read counts generated by the RUVseq package (Risso et al., 2014). 
Control samples are labeled in red (C) and YTHDF2 depleted samples are labeled in blue (KD). B: 
RNA-seq samples were normalized using the RUVr function of the RUVseq package (Risso et al., 
2014) under default parameters. PCA plot of dataset after normalization shows a distinct separation 
between control (red) and YTHDF2 KD (blue) replicates as compared to the raw data in A. C: 
Distance matrix showing the Euclidean distances between RNA-seq replicates. Replicates with a 
lower distance (darker blue) are more closely correlated in terms of gene expression. Distances were 
calculated from log-stabilized normalized read counts of all detected transcripts (>5 read counts per 
replicate). D: Hierarchical clustering of differentially expressed genes was performed on RUVr 
normalized read counts and plotted according to Z-scored intensity values. Areas of red or yellow to 






Figure 3.5: YTHDF2 depletion affects transcripts required for neural development. A: Volcano 
plot generated from sequencing data showing the adjusted p-value (y-axis) plotted against the fold 
change (x-axis) for individual genes. Differentially expressed genes are shown in green (differential 
expression: read counts>5, Benjamini-Hochberg adjusted p-value<0.05 and log2-fold change>1.0, 
represented by grey dotted lines). B-E: Venn diagrams showing the overlap between transcripts up-
regulated (B and C) or down-regulated (D and E) following YTHDF2 depletion and transcripts 
previously shown to be m6A methylated in hESCs (B and D; Batista et al., 2014) or bound by YTHDF2 
(C and E; Wang et al., 2014). P-values were determined using a hypergeometric test. F: Boxplot of 
the log2 fold change in expression (YTHDF2 KD/Control), taken from results generated by DESeq2, 
vs. number of m6A sites. Transcripts were binned based on the number of m6A sites identified in 
Batista et al., 2014. The central line of the box plot represents the median log2 fold change expression 
value. n denotes the number of genes in each bin. Binned groups were compared using an unpaired 
two-sided Student’s t-test (****p-value<0.0001). G-I: Functional annotation clustering of biological 
process (G), cellular component (H) and tissue expression (I) performed by DAVID on genes up 
regulated following YTHDF2 depletion. Annotation clusters with the highest enrichment according to 
FDR p-value are listed. The number of genes in each cluster is shown next to the respective bar and 
fold enrichment over background is given in parenthesis. J: RT-dPCR analysis of mRNA abundances 
in control and YTHDF2 depleted samples normalized to GAPDH. Data is reported as fold change 
(YTHDF2 KD/Control). Asterisks indicate significant difference in mean abundance between control 





Figure 3.6: Background filtering for overlap analysis. All transcripts detected in the YTHDF2 KD 
RNA-seq dataset was filtered against all transcripts detected in the m6A-seq dataset (left) or YTHDF2 
RIP-seq dataset (right). Only transcripts present in both datasets, 11597 and 9728 for m6A-seq and 




Overall, these data suggest that a significant proportion of m6A methylated transcripts in 
iPSCs are targeted by YTHDF2 and that the primary outcome of YTHDF2 binding is reduced 
RNA abundance, likely through destabilization. We also compared our set of differentially 
expressed transcripts to those previously shown to be bound by YTHDF2 in HeLa cells (Wang 
et al. 2014b). Again, only transcripts that were detected in both datasets were used in the 
analysis (Fig. 3.6). Consistent with the results above, RNAs up-regulated following depletion of 
YTHDF2 in iPSCs were enriched among the set of transcripts bound by YTHDF2 (Fig. 3.5C). 
Moreover, there was no significant overlap between the list of down-regulated transcripts and 
YTHDF2 association (Fig. 3.5E). This is again expected given that YTHDF2 association results 
in destabilization of mRNAs.  
To learn more about the pathways and processes that might be affected by depletion of 
YTHDF2, we performed Gene Ontology (GO) term analyses via DAVID v8 (Huang et al. 2009a, 
2009b). Among the down-regulated genes, which are unlikely to be directly targeted by 
YTHDF2, we observed some enrichment of transcripts encoding proteins located in the nucleus 
and/or associated with mitosis but there was no overt connection to pluripotency or 
development (Fig. 3.7). In contrast, analysis of GO-terms associated with up-regulated 
transcripts revealed an intriguing link with neural differentiation/development in several 
categories. Several of the top hits for biological processes (Fig. 3.5G) and cellular component 
(Fig. 3.5H) have strong associations with neural development. Furthermore, over half of the up-
regulated transcripts (857 out of 1689) are commonly expressed in the brain (Fig. 3.5I). These 
results coincide with previous reports that m6A methylation (Yoon et al. 2017; Wang et al. 
2018c; Ma et al. 2018; Zhuang et al. 2019; Chen et al. 2019), and YTHDF2 (Li et al. 2018b), 
play a role in modulating neural development in mammals. Based on these observations and 
the fact that up-regulated transcripts are more likely to be directly targeted by YTHDF2, we 
further characterized several of the most dramatically increased transcripts that encode factors 





Figure 3.7: Validation and functional annotation clustering of genes down-regulated following 
YTHDF2 depletion in iPSCs. A: RT-dPCR analysis of SCML2 mRNA abundances in control and 
YTHDF2 depleted samples normalized to GAPDH. SCML2 was chosen because it exhibited one of 
the most robust decreases in abundance according to analysis of RNA-seq data. Data is reported as 
fold change (YTHDF2 KD/Control). Asterisks indicate significant difference in mean abundance 
between control and YTHDF2 KD samples (*p-value<0.05). B-D: Functional annotation clustering of 
biological process (B) and cellular component (C) performed by DAVID on genes down-regulated 
following YTHDF2 depletion. Annotation clusters with the highest enrichment according to FDR p-
value are listed. The number of genes in each cluster is shown next to the respective bar and fold 




As can be seen in Fig. 3.5J, we were able to independently reproduce our sequencing results, 
with statistical significance, for a majority of the identified transcripts (10 out of 13). In summary, 
our results are consistent with the idea that YTHDF2 plays a role neural differentiation by 
modulating expression of mRNAs encoding factors associated with neural development. 
 
3.2.4 YTHDF2 interacts with neural-associated transcripts 
As an m6A reader, YTHDF2 interacts with target transcripts by binding to m6A via its YTH 
domain (Zhu et al. 2014; Li et al. 2014a; Xu et al. 2015).  Upon closer examination, all of the 
neural-associated transcripts we identified possess one or more m6A site(s) as defined via m6A-
seq experiments performed on human and/or mouse samples (Zheng et al. 2018). We 
performed RNA immunoprecipitations (RIPs) in iPSCs to assess whether the neural-associated 
transcripts we identified were selectively bound to YTHDF2. Briefly, YTHDF2-specific and IgG 
control antibodies were used to retrieve YTHDF2 and associated mRNAs from iPSC extracts 
following formaldehyde crosslinking. Western blot analysis of Input, IgG immunoprecipitation 
(IP) and YTHDF2 IP samples revealed YTHDF2 protein was detectable in Input and YTHDF2 IP 
samples, but not in the IgG IP sample (Fig. 3.8A), demonstrating effective isolation of YTHDF2. 
RNA was isolated from input, IgG IP and YTHDF2 IP samples and mRNA abundance assessed 
via RT-dPCR. GAPDH mRNA which has been previously established as a non-methylated 
transcript that does not bind YTHDF2 (Wang et al. 2014b; Batista et al. 2014) showed no 
enrichment over IgG, while CREBBP mRNA, which is known to bind YTHDF2, was significantly 
enriched and served as a positive control (Wang et al. 2014b) (Fig. 3.8B). Interestingly, all of the 
neural-associated transcripts were highly enriched (>6 fold over IgG) and were significantly 






Figure 3.8: YTHDF2 binds to neural-associated transcripts and modulates their half-lives in an 
m6A-dependent manner. A: Representative western blot showing YTHDF2 protein abundance in 
Input, IgG IP and YTHDF2 IP samples from RIP experiment. B: RT-dPCR analysis of transcript 
abundance in IgG and YTHDF2 IP samples. Data is represented in a violin plot as fold enrichment 
over IgG (YTHDF2 IP/IgG IP). Blue dots indicated individual replicate values (n=3-4). Asterisks 
indicate significant difference in mean fold enrichment between GAPDH and specified transcripts (*p-
value<0.05). C, D: Half-lives from siRNA negative control and YTHDF2 KD (C) or siRNA negative 
control and METTL3/WTAP KD (D) samples. Data is reported as fold change (YTHDF2 KD/Control). 
Asterisks indicate significant difference in mean half-life between control and YTHDF2 KD samples 




Overall, these results further validate the findings from our RNA-seq experiment and indicate 
that YTHDF2 directly binds to several neural-associated transcripts in pluripotent stem cells. 
 
3.2.5 YTHDF2 modulates the half-lives of neural-associated transcripts in m6A dependent 
manner 
As previously stated, YTHDF2 facilitates the degradation of target transcripts upon binding 
(Wang et al. 2014b; Du et al. 2016b). Therefore, we predicted the set of neural-associated 
transcripts we identified should be stabilized following YTHDF2 depletion. We assessed 
changes in half-life using 4-thiouridine (4sU) to label and eventually isolate nascent RNAs 
(Russo et al. 2017). Half-lives were inferred based on the ratio of total to nascent RNA for each 
transcript (see Materials and Methods for details). As predicted, depletion of YTHDF2 resulted 
in stabilization for almost all of the neural-associated transcripts tested (Fig. 3.8C). This 
indicates that YTHDF2 targets neural-specific m6A-modified transcripts in order to facilitate their 
degradation.  
If YTHDF2 is specifically targeting these transcripts through m6A, then loss of m6A should 
mimic the effect of YTHDF2 depletion. To investigate this, we simultaneously depleted the 
catalytically active subunit of the methyltransferase complex METTL3 and the major scaffolding 
subunit WTAP (Fig. 3.9A). Previous studies have shown that depletion of either protein reduces 
global levels of m6A (Ping et al. 2014; Schwartz et al. 2014; Batista et al. 2014; Yoon et al. 
2017; Wang et al. 2018a). As predicted, knockdown of METTL3 and WTAP increased the 
mRNA half-life for the vast majority (eight out of ten) of the transcripts (Fig. 3.8D). Based on 
these observations, we conclude that when a cell is in a pluripotent state, YTHDF2 targets 






Figure 3.9: Validation of METTL3 and WTAP siRNA-mediated knockdown efficiency and MazF 
experimental design. A: Representative western blots showing effective depletion of METTL3 or 
WTAP from iPSC extracts. GAPDH was used as a loading control. Percent protein remaining 
calculated from three independent biological replicates. In both cases, statistical significance, p-
value<0.05, was achieved for the difference in mean protein abundance between control and 
knockdown samples. B: RT-dPCR analysis of METTL3 or WTAP mRNA abundances in control and 
knockdown samples normalized to GAPDH. Asterisks indicate significant difference in mean mRNA 
abundance between control and knockdown samples (*p-value<0.05). C: Cartoon depiction of MazF 
experimental design. MazF cuts RNA at all ACA motifs but is inhibited by the presence of m6A. RT-
dPCR analysis is performed to quantify the abundance of the specified products. From there, a 
methylation ratio (i.e. percent methylated) can be determined by calculating the m6A product 
abundance/Control product abundance. A background ratio can also be estimated by calculating the 





3.2.6 YTHDF2 expression decreases during neural differentiation 
If stem cells are utilizing YTHDF2 to suppress neural-associated transcripts, as suggested 
by our results above (Fig. 3.5 and 3.8) then YTHDF2 expression or activity may decrease to 
favor differentiation down the neural pathway into multipotent NPCs. To investigate this idea, we 
induced differentiation of iPSCs into NPCs and measured the levels of YTHDF2 protein over 
time. OCT4, a major pluripotency factor, and PAX6, a marker for neural differentiation (Zhang et 
al. 2010b), were used as controls to demonstrate that differentiation was occurring. As shown in 
Figures 3.10A, by day six expression of OCT4 protein was almost abolished (Fig. 3.10B) while 
PAX6 protein expression increased >50-fold (Fig. 3.10C). Notably, YTHDF2 protein expression 
exhibited a steady decline throughout the time course with a >60% reduction in protein 
expression by day six (Fig. 3.10A,D). In summary, YTHDF2 protein expression decreases as 
iPSCs differentiate into NPCs. 
 
3.2.7 Stability of YTHDF2 target transcripts increases during neural differentiation 
Based on the changes in mRNA half-life and abundance we observed following YTHDF2 
depletion in iPSCs (Fig. 3.5 and 3.8) and the decrease in YTHDF2 expression over the course 
of neural induction (Fig. 3.10A,D), we predicted the group of neural-associated transcripts we 
identified as targets of YTHDF2 would exhibit increases in half-life and abundance during neural 
differentiation. To investigate, we induced neural differentiation for 6 days and then labeled with 
4sU for four hours before isolating and processing RNA as before. Neural differentiated samples 
were compared to non-induced (pluripotent) controls. We observed stabilization for nine out of 
ten neural-associated transcripts (Fig. 3.10E). Interestingly, stabilization did not uniformly result 
in elevated mRNA abundance reflecting that other types of regulation are likely also at play (Fig. 
3.10F). Overall, these results show that differentiation of iPSCs into NPCs results in stabilization 
of several neural-associated transcripts, and a decrease in YTHDF2 expression during neural 





Figure 3.10: Changes in YTHDF2 expression and m6A abundance after neural differentiation 
increase mRNA half-life and abundance of neural-associated transcripts. A: Representative 
western blot of YTHDF2, OCT4 and PAX6 protein expression at 0, 2, 4 and 6 days after neural 
induction. GAPDH was used as a loading control. B-D: Expression OCT4 (B), PAX6 (C) and YTHDF2 
(D) over the time course was normalized to GAPDH and the abundance at the 0 day time point was 
set to 100% for each replicate. Asterisks indicate significant difference between the given time point 
and 0 days induction (*p-value<0.05, **p-value<0.005, ***p-value<0.0005). E: Half-lives from non-
induced (control) and six day neural induced samples. Data is reported as fold change (Neural 
Induced/Control). Asterisks indicate significant difference in mean half-life between control and neural 
induced samples (*p-value<0.05, **p-value<0.005). Non-significant p-values are given above bars. F: 
RT-dPCR analysis of mRNA abundances, normalized to GAPDH, from samples that underwent no 
induction (control) or six days of neural induction. Data is reported as fold change (Neural 
Induced/Control). Asterisks indicate significant difference in mean abundance between control and 
neural induction samples (*p-value<0.05, **p-value<0.005). G: The methylation ratio of WDR62 from 
samples that underwent no induction (non-induced) and six days of neural induction quantified by 
MazF-dPCR. Asterisks indicate significant difference in mean methylation ratio between non-induced 




3.2.8 Neural-specific targets of YTHDF2 also undergo a decrease in m6A deposition upon 
neural differentiation 
Previous studies have shown global m6A abundance and expression of the catalytically 
active subunit of the m6A writer complex, METTL3, decreases during differentiation (Wang et al. 
2018a; Geula et al. 2015; Aguilo et al. 2015). To explore whether this might also influence 
expression of YTHDF2 substrates, we evaluated methylation during differentiation by modifying 
a recently published protocol which utilizes the MazF endoribonuclease to quantify m6A 
abundance at a specific site (MazF-RT-dPCR) (Garcia-Campos et al. 2019a).  Briefly, MazF 
cleaves RNA at ACA motifs and is blocked by N6-adenosine methylation. Thus, following 
treatment with MazF, RNA regions containing m6A remain intact while unmethylated regions are 
cleaved and no longer detected by RT-dPCR. The fraction of methylated RNA can be 
determined by comparing the abundance of a region containing an m6A site with the abundance 
of a different region lacking ACA (Fig. 3.9C). Unfortunately, many of the neural transcripts 
associated with YTHDF2 did not contain m6A sites that were amenable to this analysis (i.e. did 
not have the ACA sequence or had multiple ACA sequences in close proximity) but we identified 
one m6A site near the stop codon of the WD40 repeat domain 62 (WDR62) transcript which was 
suitable. Interestingly, we observed an approximate 2-fold drop in m6A deposition at this 
WDR62 m6A site after 5 days of neural induction when compared to non-induced iPSCs (Fig. 
3.10G). In Fig. 3.10E/F above, we observed a 3- and 2-fold increase in mRNA half-life and 
abundance, respectively, for WDR62 transcripts after neural induction. Thus, upon neural 
induction, an increase in WDR62 mRNA abundance correlates with both decreased expression 
of YTHDF2 protein and reduced m6A deposition. 
 
3.2.9 YTHDF2 depletion disrupts neural differentiation of iPSCs 
We observed above that extended YTHDF2 depletion in iPSCs increased the size of the 
nucleus (Fig. 3.2D and Fig. 3.3) and abrogated expression of two pluripotency markers, TRA-1-
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60 and SSEA4 (Fig. 3.2E). Both of these observations suggest depletion of YTHDF2 results in 
loss of pluripotency. Moreover, YTHDF2 binds to and regulates transcripts associated with 
neural development (Fig. 3.5). We therefore wondered if YTHDF2 depletion influences 
differentiation down the neural lineage. As an initial test, we again depleted YTHDF2 in iPSCs 
for 5 days and used immunofluorescence (IF) to examine the protein expression of three neural-
specific markers, PAX6, NES (Nestin) and SOX1 (Malchenko et al. 2014; Feng et al. 2014b). 
Intriguingly, the intensity of staining for the membrane-bound protein Nestin appears to 
increase, as does the intensity and presence of the transcription factor SOX1 in YTHDF2 
depleted cells compared to controls (Fig. 3.11A). However, we were unable to detect expression 
of PAX6 protein in control or YTHDF2 depleted samples although mRNA was present (Fig. 
3.12). These results suggest YTHDF2 depletion in iPSCs can induce some aspects of the 
neural gene expression program but cannot completely mimic the effects of neural induction. 
If YTHDF2 depletion favors neural differentiation, we hypothesized this influence might be 
potentiated upon neural induction when compared to non-YTHDF2 depleted controls. To 
evaluate this, we depleted YTHDF2 prior to inducing differentiation and treated with siRNAs 
again the day neural induction began. We measured the abundances of several pluripotency 
factor mRNAs (OCT4 and NANOG), and neural-specific factors (PAX6, SOX1 and Nestin). Prior 
to neural induction, OCT4 and NANOG were unaffected by YTHDF2 depletion, whereas PAX6, 
SOX1 and Nestin exhibited modest decreases in mRNA abundance (Fig. 3.11B). In contrast, we 
observed a substantial increase in mRNA abundance for PAX6 at both 2 and 5 days after neural 





Figure 3.11: YTHDF2 depletion disrupts neural differentiation of iPSCs. A: iPSCs were treated 
with negative control or YTHDF2-targeting siRNA for five days. The indicated protein was detected by 
immunofluorescence staining. The nucleus was stained with DAPI. Scale bars indicates 10µm. B: RT-
dPCR analysis of mRNA abundances in control and YTHDF2 depleted samples prior to neural 
induction (0 days). Data is reported as fold change (YTHDF2 KD/Control). Asterisks indicate 
significant difference in mean abundance between control and YTHDF2 KD samples (*p-value<0.05). 
C-G: mRNA expression of pluripotency (OCT4 and NANOG) and neural specific (PAX6, SOX1 and 
Nestin) factors over the course of neural differentiation was quantified via RT-dPCR and normalized to 
GAPDH. Abundance at the 0 day time point was set to 100%. Asterisks indicate significant difference 







Figure 3.12: PAX6 is undetectable in control or YTHDF2-depleted iSPCs. iPSCs were subjected 
to five days of treatment with negative control or YTHDF2 siRNAs. PAX6 was detected by 
immunofluorescence staining using an Alexa Fluor®568-conjugated secondary antibody. The nucleus 
was visualized by staining with DAPI. Merged (right) and TRITC only (left) images are presented. 




Moreover, expression of both OCT4 and NANOG were significantly reduced after 5 days of 
neural induction in YTHDF2 depleted cells compared to controls, with NANOG also being 
significantly reduced after only 2 days of induction (Fig. 3.11D, E). There was no significant 
effect on SOX1 or Nestin expression during neural induction (Fig. 3.11F, G). Thus, it appears 
that depletion of YTHDF2 in iPSCs leads to precocious differentiation with loss of pluripotency 
and up-regulation of some neural specific factors. Depletion of YTHDF2 prior to and during 
neural differentiation disrupts the coordination necessary to achieve precise cell state transitions 
resulting in aberrant expression of pluripotency and neural-specific factors.   
 
3.3 Discussion 
In the experiments described above, we have shown that YTHDF2 is important for 
pluripotency. Through RNA sequencing, we discovered that mRNAs encoding factors 
associated with neural development are up-regulated following YTHDF2 knockdown. YTHDF2 
directly interacts with many of these neural-associated mRNAs, presumably targeting them for 
degradation in an m6A-dependent manner. Over the course of neural differentiation, YTHDF2 
expression is decreased and at the same time neural-associated mRNAs are stabilized. At least 
one transcript, WDR62, experiences reduced m6A methylation during differentiation which could 
also contribute to stabilization. Reducing expression of YTHDF2 before neural induction disrupts 
the differentiation process resulting in aberrant expression of both neural and pluripotency 
factors. Overall, our data support the notion that YTHDF2 is a key m6A reader in pluripotent 
cells that specifically restrains neural differentiation.  
Previous studies have reported YTHDF2 influences maintenance and differentiation of 
multipotent stem cells from various lineages (Yao et al. 2019; Wang et al. 2018b; Li et al. 2018c, 
2018b; Zhang et al. 2017a; Paris et al. 2019).  Here, we show that YTHDF2 plays a role at the 
earliest stages of development; in pluripotent stem cells. Although mRNAs encoding both 
pluripotency factors and neural-specific factors can be m6A-modified (Batista et al. 2014), we 
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find little evidence that YTHDF2 directly influences expression of pluripotency factors, as only 
neural-specific mRNAs are enriched in the set of transcripts up-regulated by YTHDF2 
knockdown. This is consistent with YTHDF2 being required primarily to clear neural-specific 
transcripts as they are produced, thereby allowing the pluripotency gene expression program to 
dominate. Indeed, a similar observation was reported during the endothelial-to-hematopoietic 
transition in zebrafish where YTHDF2 facilitates the clearance of endothelial-specific genes 
notch1a and rhoca to promote hematopoietic stem cell reprogramming (Zhang et al. 2017a).  
Maintaining neural-specific mRNAs in an unstable state also facilitates their rapid and 
coordinated upregulation following induction of the neural differentiation program, as unstable 
mRNAs reach a new steady state more rapidly when transcription changes (Bertero et al. 2018). 
When YTHDF2 is artificially depleted, iPSCs appear to acquire some features of the neural cell 
gene expression program while simultaneously being poorly primed for differentiation down the 
neural pathway upon induction. These outcomes can both be explained by increased stability of 
neural-specific transcripts seen when either YTHDF2 or m6A itself are reduced. Importantly, 
once the neural gene expression program has been successfully engaged, long-term 
stabilization of neural transcripts may occur naturally through down-regulation of both YTHDF2, 
and methylation.  
Interestingly, other studies also indicate that YTHDF2 and m6A are particularly important for 
neural gene expression programs. Specifically, YTHDF2 depletion in mice compromises neural 
development, and generates NPCs with reduced abilities to proliferate and differentiate (Li et al. 
2018b). These effects correlate with stabilization of neural-specific mRNAs targets. 
Furthermore, knockout of METTL14 or depletion of METTL3 in embryonic mouse brains alters 
expression of m6A-modified mRNAs encoding factors important for neurogenesis and neural 
differentiation (Yoon et al. 2017). Finally, deletion of METTL14 in mouse NPCs reduced 
proliferation and induced premature differentiation (Wang et al. 2018c). It is unclear how 
methylated neural-specific transcripts might be selected by YTHDF2 given that a broad 
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spectrum of transcripts are m6A-modified (Batista et al. 2014). A similar situation exists when 
m6A-modified maternal mRNAs are cleared from oocytes, while leaving zygotic m6A-modified 
transcripts intact (Ivanova et al. 2017; Zhao et al. 2017b). It is possible that neural RNAs are 
somehow marked during transcription or other steps of RNA processing, perhaps by 
modification of the YTH protein or by recruitment of additional factors. Alternatively, it may be 
that the sequence context and/or distribution of m6A sites in neural-specific and other affected 
RNAs is more favorable for YTHDF2 binding. 
Recent reports have indicated that m6A modification, and subsequent binding of YTHDF 
proteins, potentiates the phase separation potential of mRNAs into ribonucleoprotein (RNP) 
granules (Gao et al. 2019; Fu and Zhuang 2019; Ries et al. 2019). Moreover, the effects are 
exacerbated by the presence of multiple m6A modifications and YTHDF protein binding events. 
YTHDF2 specifically was found to shuttle bound mRNAs to Processing bodies (P-bodies) under 
endogenous conditions (Ries et al. 2019); presumably facilitating their degradation as previously 
described (Wang et al. 2014b). However, under stress conditions like heat shock, sodium 
arsenite or endoplasmic reticulum stress, YTHDF2 re-localized, with its bound mRNA, to stress 
granules (SGs) in a range of cell types (Ries et al. 2019). Once partitioned into these SGs, 
YTHDF2 does not facilitate mRNA degradation like in P-bodies, but rather transcripts sit in a 
state of suspended animation. Perhaps a similar phenomenon occurs during differentiation in 
which YTHDF2 relocalizes to RNP granules formed in response to differentiation being 
induced? Indeed there is evidence of RNP granules formation that is specific to a cell type or 
process such as germ granules (Knutson et al. 2017; Dodson and Kennedy 2019) and neuronal 
RNA granules (Mitsumori et al. 2017; Van Driesche and Martin 2018). Moreover, a handful of 
studies have previously suggested RNP granules may play a role in differentiation (Gao and 
Keene 1996; Lin and Tarn 2009). In the context of YTHDF2, it would seem more efficient for the 
cell to utilize the same protein to regulate transcript expression prior to and localization 
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immediately following induction. Future studies investigating the localization and PTMs of 
YTHDF2 prior to and immediately following neural induction may shed some light on this idea. 
Among the neural-specific targets of YTHDF2 we identified, WDR62, CHAC1 and NGFR 
stand out as encoding key factors for neural development. WDR62 regulates neurogenesis via 
the JNK1 signaling pathway (Xu et al. 2014c) and its depletion disrupts mitotic progression and 
induces death of NPCs, which ultimately results in primary microcephaly (Nicholas et al. 2010; 
Bilgüvar et al. 2010; Chen et al. 2014). Moreover, WDR62 has been implicated in the 
specification of neural and glial progenitor cells during human pluripotent stem cell 
differentiation (Alshawaf et al. 2017). CHAC1 facilitates neurogenesis by antagonizing the Notch 
signaling pathway (Chi et al. 2012, 2014), which plays an important role in early 
neurodevelopment (Zhang et al. 2018c). Finally, the nerve growth factor receptor, NGFR has 
multiple roles throughout neural development and is a marker for in vitro differentiation of 
hESCs into NPCs (Pruszak et al. 2007; Lee et al. 2007). NGFR targets have been implicated in 
embryonic stem cell survival (Pyle et al. 2006) and neural lineage definition (Bibel et al. 2004). 
By targeting these key neural-specific transcripts, YTHDF2 can play a major role in coordinating 
gene expression changes during neural development. 
In conclusion, the ability of m6A modification to influence self-renewal and neural 
differentiation of iPSCs is achieved through recruitment of YTHDF2 to neural-specific 
transcripts. Destabilization of neural-specific mRNAs is important for preventing inappropriate 
activation of neural gene expression and to permit rapid and coordinated differentiation upon 








As described above (see Chapters 1 and 3), m6A influences RNA metabolism in many 
different tissues, cell types and cellular responses. However, its regulatory potential is most 
prevalent and well-studied in stem cells and during development (Geula et al. 2015; Batista et 
al. 2014; Wang et al. 2018c; Zhang et al. 2017a; Wang et al. 2014c; Heck and Wilusz 2019). In 
addition to the biological impact m6A has on stem cell and developmental biology, it is also 
important to understand how m6A deposition and the activity of m6A readers change throughout 
the course of development. Global levels of m6A modification are relatively high in ESCs and 
decrease as cells differentiate (Batista et al. 2014; Aguilo et al. 2015). Consistent with this 
observation, the two MAC subunits, METTL3 and METTL14, are highly expressed in pluripotent 
and multipotent stem cells in comparison to differentiated cell types (Aguilo et al. 2015; Weng et 
al. 2018a). MAC co-factors like ZFP217 and SMAD2/3 also experience altered expression over 
the course of differentiation (Aguilo et al. 2015; Bertero et al. 2018), which may influence m6A 
deposition on certain transcripts.  
Examination of m6A distributions and the expression profiles of the writers and erasers is 
key to understanding how m6A impacts pluripotency and development. However, just as 
important, if not more so, is the characterization of reader expression profiles and activities 
during differentiation, as the readers are directly responsible for the fate of modified mRNAs. 
Beyond our work in Chapter 3 regarding YTHDF2, little is known about the expression profiles 
of YTH-domain readers in iPSCs or during differentiation. A previous study describing the 
transcriptomes of hESCs during differentiation into each of the three germ layers indicated there 
are only subtle changes in abundances of mRNAs encoding the YTH family of readers (Gifford 
et al. 2013). Likewise, global proteomic profiling during differentiation of human iPSCs (Hurrell 
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et al. 2019) and ESCs (Rigbolt et al. 2011) has noted modest decreases in expression of YTH 
family proteins. However, none of these results have been independently verified. In regards to 
other developmental processes, YTHDC1 and 2 proteins are up-regulated during 
gametogenesis (Kasowitz et al. 2018; Hsu et al. 2017), whereas YTHDF1 is temporally and 
spatially regulated during neural development (Shi et al. 2018b; Weng et al. 2018b). In general, 
these studies demonstrate that regulation of readers can occur, but stop short of characterizing 
the mechanisms involved.  
In contrast to the modest change in mRNA abundance, we reported in Chapter 3 that YTHDF2 
protein expression is dramatically increased in iPSCs when compared to HFFs (Fig. 3.1). Non 
YTH-domain readers, like the IGF2BP family of proteins, are also significantly up-regulated in 
pluripotent stem cells compared to differentiated cell types (Conway et al. 2016) despite 
exhibiting little difference in mRNA abundance (Gifford et al. 2013). These observations are 
consistent with m6A reader abundance being modulated at the level of translation or protein 
stability. 
The 3’ UTR often plays an important role in regulating translation as elements/motifs within 
this region can provide access points for miRNAs or RBPs (Harvey et al. 2018; Vasudevan et al. 
2007; Iwakawa and Tomari 2015). Two miRNAs, miR-145 and miR-493, have previously been 
implicated in repressing YTHDF2 expression in HeLa cells (Yang et al. 2017; Li et al. 2018a) 
and several binding sites for RBPs can be predicted or have been observed through CLIP-Seq. 
. Based on the evidence outlined above, we hypothesized that elements in the 3’ UTR of 
YTHDF2 mRNA contribute to the observed differences in YTHDF2 protein abundance in iPSCs 
and HFFs, presumably through recruitment of miRNAs or RBPs. 
Here, we report that YTHDF3, which can partner with YTHDF2 to modulate mRNA decay, is 
only mildly downregulated during differentiation. We verified that changes in YTHDF2 
expression are mediated at the protein level in iPSCs, as mRNA levels change little during 
differentiation. We failed to observe any substantial change in YTHDF2 expression following 
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over expression of miR-145 suggesting that miR-145 is not responsible for repression of 
YTHDF2 in HFFs. Using luciferase reporter assays we located sequence elements in the first 
300 nucleotides of the YTHDF2 3’ UTR  that are sufficient to enhance translation of YTHDF2 
mRNA. Through biotinylated RNA pulldowns followed by mass spectrometry (MS), we identified 
30 proteins that interact with this region of the YTHDF2 3’ UTR. We investigated three of these 
proteins, IGF2BP1, IGF2BP3 and HNRNPQ (aka SYNCRIP), as well as m6A modifications as 
putative factors enhancing YTHDF2 mRNA translation, but were unable to find evidence that 
any of these factors are involved. Taken together, our findings reveal YTHDF2 protein is highly 
expressed in pluripotent stem cells and this is achieved through elements in the 3’ UTR that 
facilitate enhanced translation. 
 
4.2 Results 
4.2.1 YTHDF2, but not YTHDF3, experiences dramatic changes in protein expression following 
differentiation of iPSCs  
In Chapter 3, we observed that YTHDF2 protein expression was up-regulated approximately 
7-fold in iPSCs compared to HFFs (Fig. 3.1). Moreover, YTHDF2 protein expression was 
reduced approximately 60% during differentiation down the neural lineage (Fig. 3.10). We 
therefore wondered: i) if other m6A readers experienced a similarly high expression in 
pluripotent cells, and ii) does YTHDF2 expression change following differentiation down other 
lineages? To address the first question, we chose to focus on YTHDF3, as there is previous 
evidence that YTHDF3 also facilitates mRNA decay (Shi et al. 2017). We measured YTHDF3 
protein expression in iPSCs and HFFs and observed a nominal increase in expression of 
YTHDF3 in iPSCs (Fig. 4.1A). However, this increase was neither statistically significant nor as 
substantial as the change in YTHDF2 expression (Fig. 4.1B). To investigate the second 
question, we measured expression of YTHDF2 in iPSCs induced to differentiate down the 






Figure 4.1: YTHDF2, but not YTHDF3, protein expression is differentially expressed between 
cell states. A: Western blot to detect YTHDF3 in three independent iPSC and HFF extracts. GAPDH 
was used as a loading control. Asterisk represents non-specific band. B: Quantification of (A). P-value 
listed is for comparison in the relative mean protein expression between iPSC and HFF samples. C: 
Representative image of western blots to detect YTHDF2 in untreated and mesoderm-induced iPSC 
extracts. GAPDH was used as a loading control. D: Quantification of (C). Asterisks indicate significant 
difference in the relative mean protein expression between iPSC and HFF samples (*p-value<0.05). 
E-F: RT-dPCR analysis of YTHDF2 mRNA abundance in untreated iPSC and HFF (E) or mesoderm-




 following five days of mesoderm induction (Fig. 4.1C,D). Thus, YTHDF2 is down-regulated 
during differentiation of iPSCs into two out of the three germ layers. These observations, 
coupled with our findings from Chapter 3 and previous studies (Li et al. 2018b; Wang et al. 
2018b), suggest that YTHDF2 is a key reader of m6A modification in pluripotency and 
development down multiple lineages. 
  
4.2.2 YTHDF2 is regulated at the level of translation or protein turnover 
As a first step to determine how YTHDF2 abundance is elevated in stem cells, we measured 
YTHDF2 mRNA abundance in iPSCs and HFFs via RT-dPCR. As predicted from RNA-seq 
experiments (Gifford et al. 2013), YTHDF2 mRNA abundance exhibited no change between 
HFFs and iPSCs (Fig. 4.1E). Similarly there was no change in YTHDF2 mRNA levels following 
differentiation down the mesoderm lineage (Fig. 4.1F). Based on these results, we inferred that 
the increased expression of YTHDF2 in iPSCs is mediated at the level of translation or protein 
stability. 
 
4.2.3 YTHDF2 3’UTR is sufficient to enhance translation in iPSCs and HeLa cells 
It is well-known that the 3’ UTR contains elements that can influence mRNA metabolism 
including translation efficiency. Therefore, we evaluated the capacity of the YTHDF2 3’ UTR to 
regulate translation via a luciferase reporter system. Briefly, the YTHDF2 3’ UTR was cloned 
into a Renilla luciferase reporter plasmid immediately downstream of the Renilla ORF. The 
YTHDF2 3’ UTR construct or an empty vector control were then transfected into cells along with 
a Firefly luciferase plasmid to control for transfection efficiency. Renilla luciferase activity was 
also adjusted to account for differences in mRNA abundance (Fig. 4.2A). As predicted, the 
presence of the YTHDF2 3’ UTR significantly increased the relative luciferase activity compared 
to an empty vector control by approximately 6-fold in iPSCs and showed no significant effect in 





Figure 4.2: The YTHDF2 3’ UTR enhances translation in iPSCs and HeLa cells. A: Diagram of the 
workflow for our luciferase assay. Samples were transfected with an experimental Renilla luciferase 
construct that contained different 3’ UTRs and a Firefly luciferase construct to normalize for 
transfection efficiency. Approximately 24 hours after transfection, cells were assessed for luciferase 
activity or mRNA abundance. Renilla luciferase activity was normalized to transfection efficiency and 
mRNA abundance and reported as relative luciferase activity. B: Relative Renilla luciferase activity of 
HFF, iPSC or HeLa cells transfected with an empty vector control or full length YTHDF2 3’ UTR 





Interestingly, we also observed that the YTHDF2 3’ UTR enhances translation in HeLa cells 
(Fig. 4.2B). Although they are not pluripotent, HeLa cells have some characteristics, like self-
renewal, in common with iPSCs. More importantly, HeLa are much easier to work with in terms 
of cost, maintenance and transfection efficiency. Thus, we chose to utilize HeLa cells as a 
model system to explore how the 3’ UTR of YTHDF2 promotes translation.  
 
4.2.4 miR-145 is not a significant regulator of YTHDF2 translation in iPSCs or HeLa cells 
During the course of this study, a regulatory role for miRNA-145-5p (miR-145) on YTHDF2 
expression in human embryonic kidney 293 (HEK293) cells was reported (Yang et al. 2017). 
Two miR-145 binding sites are located in the 3’ UTR of YTHDF2 (Fig. 4.3A). This caught our 
attention, as a previous study reported that miR-145 expression increases during differentiation 
of ESCs and miR-145 negatively regulates expression of the major pluripotency factors OCT4, 
SOX2 and KLF4 (Xu et al. 2009). Moreover, inhibition of miR-145 enhances iPSC 
reprogramming (Barta et al. 2016). Based on these observations, we hypothesized miR-145 
negatively regulates YTHDF2 expression and the change in YTHDF2 protein levels between 
iPSCs and HFFs is due to increased abundance of miR-145 in HFFs. Indeed, preliminary data 
suggests miR-145 expression is significantly higher in HFFs compared to iPSCs (Appendix 1). If 
YTHDF2 were regulated by the same mechanism as some of the major pluripotency factors, it 
would be another piece of evidence that YTHDF2 plays a crucial role in stem cell maintenance. 
To address this, we evaluated the impact of miR145 on the YTHDF2 3’UTR reporter in HeLa 
cells. We predicted that transfection of a miR-145 mimic would abrogate the effects of the 
YTHDF2 3’ UTR had on luciferase activity. miR-145 over-expression was verified via RT-dPCR 
(Fig. 4.3B). Additionally, we measured the mRNA abundance of three known targets of miR-145 
(Huang et al. 2015a) in control and miR-145 over expression samples (Fig. 4.3C) and saw a 






Figure 4.3: Over expression of miR-145 in HeLa or iPSCs does not significantly influence 
YTHDF2 expression. A: Diagram of the YTHDF2 3’ UTR with the relative position and target 
sequence of the two miR-145 binding sites. B: RT-dPCR analysis of miR-145 abundance in iPSCs 
transfected with a miRNA control or miR-145 mimic normalized to 5S rRNA. Asterisks indicate 
significant difference in the relative mean abundance. (***p-value<0.0005). C: RT-dPCR analysis of 
three miR-145 targets in iPSCs transfected with a miRNA control or miR-145 mimic normalized to 
GAPDH. No statistical analysis was performed because this is preliminary data and n=1. D: Relative 
Renilla luciferase activity of HeLa cells transfected with different combinations of empty vector control 
or full length YTHDF2 3’ UTR constructs and miRNA control or miR-145 mimic. Asterisks indicate 
significant difference in the relative mean luciferase activity. (**p-value<0.005). E: Representative 
image of western blots to detect YTHDF2 in miRNA control or miR-145 mimic transfected iPSC 
extracts. GAPDH was used as a loading control. F: Quantification of (E). No significant difference was 
observed in the relative mean protein expression between miRNA control and miR-145 mimic 
samples. G: RT-dPCR analysis of YTHDF2 mRNA abundance in miRNA control or miR-145 mimic 
transfected iPSC samples normalized to GAPDH mRNA. Asterisks indicate significant difference in 




Surprisingly, the luciferase activity generated by the YTHDF2 3’ UTR reporter was unaffected by 
transfection of miR-145 mimic (Fig. 4.3D). We also measured endogenous YTHDF2 protein 
expression and mRNA abundance in iPSCs following transfection of miR145 mimic or control 
miRNA. Over expression of miR-145 in iPSCs had no effect on YTHDF2 protein expression 
(Figures 4.3E,F) and induced only a slight (~10%) decrease in mRNA abundance (Fig. 4.3G). 
Thus, our results do not support the notion that miR-145 is a major player in regulation of 
YTHDF2 expression in iPSCs or HeLa cells. 
Analysis of the YTHDF2 3’ UTR sequence in TargetScan (Agarwal et al. 2015) revealed 
miR-145 is not the only miRNA capable of binding; other miRNAs including miR-19-3p, miR-
130-3p, miR-141-3p and miR-181-5p also have potential binding sites within the YTHDF2 3’ 
UTR. Although miRNAs are typically thought of as negative regulators of translation, as was 
observed in Yang et al., 2017, it is important to note there is evidence that miRNAs can promote 
translation as well (Vasudevan et al. 2007). Thus, YTHDF2 expression may be influenced, in 
either direction, by up-regulation of one or a combination of these miRNAs during differentiation. 
To determine if any miRNAs had a major influence on YTHDF2, we assessed YTHDF2 protein 
expression in control and DICER KD HeLa cell lines (Russo et al. 2018). DICER is required for 
miRNA maturation (Bernstein et al. 2001). We predicted a change in YTHDF2 protein 
expression following DICER KD would indicate at least one, if not more, miRNA(s) had a 
regulatory effect on YTHDF2 expression. As can be seen in Appendix 2, there was no 
significant difference in YTHDF2 protein expression between control and DICER KD samples. 
In summary, miR-145 and/or other miRNAs may repress YTHDF2 translation in some cell 
types, including HEK293 (Yang et al. 2017) and perhaps HFFs. However, based on the 
observation that excess miR-145 does not down-regulate YTHDF2 in Hela or iPSCs, differential 




4.2.5 The first 300 nucleotides of the YTHDF2 3’ UTR enhances translation in HeLa cells 
We took a systematic approach to narrow down the region of the YTHDF2 3’UTR 
responsible for enhancing translation. We created Renilla luciferase constructs with overlapping 
200 nucleotide segments that spanned the YTHDF2 3’ UTR (Fig. 4.4A). As can be seen in 
Figure 4.4A, the first two segments, 0-200 and 100-300, significantly enhanced luciferase 
activity, albeit, not to the same extent as the full length 3’ UTR. Interestingly, the 200-400 and 
400-600 segments somewhat repressed luciferase activity.  
The results from our initial assays showed the 0-200 and 100-300 segments of the YTHDF2 
3’ UTR increased luciferase activity, but not to the same extent as the full length 3’ UTR (Fig. 
4.4A). This suggested there may be multiple elements interspersed throughout the first 300 
nucleotides that enhance translation in an additive manner. To further explore this, we created 
two additional luciferase constructs containing the 100-200 and 0-300 nucleotide regions. We 
hypothesized that if there were multiple elements enhancing luciferase activity in first 300 
nucleotides, then the 0-300 region would fully recapitulate the activity of the full length 3’ UTR. 
As predicted, the insertion of the 0-300 region of the YTHDF2 3’ UTR enhanced luciferase 
activity to the same degree as the full length 3’ UTR (Fig. 4.4B). Moreover, each smaller 
fragment (0-200, 100-200 and 100-300) exhibited partial increase in luciferase activity. Taken 
together, these results indicated there are likely multiple elements in the first 300 nucleotides of 
the YTDHF2 3’ UTR that facilitate translation. 
In an attempt to identify promising candidates that might enhance translation of YTHDF2, 
we performed a motif analysis of the 0-300 region using the online platforms RBPDB (Cook et 
al. 2011) and ATtRACT (Giudice et al. 2016). This analysis yielded a plethora of RBPs that had 
validated or predicted binding sites within the region. Moreover, there were also two m6A sites 
according to the m6AVar database (Zheng et al. 2018), which can be bound by all three YTHDF 







Figure 4.4: The first 300 nucleotides of the YTHDF2 3’ UTR enhance Renilla luciferase 
activity. A-B: Relative Renilla luciferase activity of HeLa cells transfected with an empty 
vector control or various regions of the YTHDF2 3’ UTR. Asterisks indicate significant 
difference in the relative mean luciferase activity between the specified construct and the 
empty vector control. (*p-value<0.05, **p-value<0.005, ***p-value<0.0005). Black dotted line 
































Due to the large number of candidates these analyses produced, we opted for an experimental 
approach in an effort to narrow down the list of candidates.  
 
4.2.6 Several RBPs specifically interact with the first 300 nucleotides of the YTHDF2 3’ UTR 
To explore what RBPs were specifically interacting with the first 300 nucleotides of the 
YTHDF2 3’ UTR, we performed biotinylated RNA pulldowns coupled with mass spectrometry 
(MS). Briefly, an RNA consisting of the 0-300 nucleotide region and a size matched control 
derived from plasmid sequences were synthesized via in vitro transcription with biotin-CTP. The 
biotinylated RNAs were incubated with HeLa cytoplasmic cell extracts and protein-RNA 
complexes were isolated using magnetic streptavidin beads. After washing at increasing KCl 
concentrations RNPs were retrieved by a final wash with 1M NaCl, separated by SDS-PAGE 
and visualized through silver staining (Fig 4.5A). Ultimately, a 250 mM KCl wash buffer 
concentration was selected because it was stringent enough to remove a majority of the 
background bands seen in the control lane, yet had little impact on the specific interactions seen 
only in the YTHDF2 3’ UTR lane. When comparing the 250 mM KCl samples prior to submission 
for MS, we noted the YTHDF2 3’ UTR RNA had a strong interaction with a protein(s) migrating 
at approximately 70 kDa (Fig. 4.5B). Analysis of the MS data revealed ~40 RNA-protein 
interactions for 0-300 region of the YTHDF2 3’ UTR, 30 of which were unique to the YTHDF2 3’ 
UTR RNA and not seen in the control (Fig. 4.5C). The 30 proteins that uniquely bound to the 
YTHDF2 3’ UTR were filtered to remove keratin contaminants, and were compared to the 
Crapome database of common MS contaminants (Mellacheruvu et al. 2013). Detailed 
information about the proteins identified including size, Crapome results and spectral counts can 
be found in Table 4.1. We evaluated the identified proteins based on a set of criteria that took 
into account Crapome results (present in <50% of database experiments), known functions 
connected to translation, protein size (preference was given to those ~70 kDa based on Fig. 






Figure 4.5: RNA pulldown coupled with mass spectrometry reveals 30 RBPs specifically 
interact with the YTHDF2 3’ UTR. A: Silver-stained SDS PAGE gel of RNA pulldown experiments 
using either a size-matched control or 0-300 nucleotide region of the YTHDF2 3’ UTR performed with 
varying concentrations (100-300 mM) of KCl wash buffer. B: Detailed view of the 250 mM KCl wash 
buffer lanes. Asterisk indicates an RBP interaction around 70 kDa that is specific to the YTHDF2 3’ 
UTR RNA. D: Sequence of the first 300 nucleotides of the YTHDF2 3’ UTR. IGF2BP binding sites are 
highlighted in green, underlined sites indicate CLIP-seq validation, m6A sites are highlighted in red, 










Spectral Counts  
(YTH2 3’ UTR) 
ACTB ACTB_HUMAN 41.7 363/411 164 
NHP2 D6RC52_HUMAN 17.2 29/411 6 
HSPA8 sp|P11142|HSP7C_HUMAN 70.8 396/411 13 
HNRNPAB D6R9P3_HUMAN 36.2 206/411 14 
HNRNPA1 F8W6I7_HUMAN 38.7 268/411 22 
HNRNPD D6RAF8_HUMAN 38.4 216/411 27 
HNRNPM A0A087X0X3_HUMAN 77.5 220/411 49 
HNRNPU A0A1W2PP35_HUMAN 90.5 280/411 7 
IGF2BP1 sp|Q9NZI8|IF2B1_HUMAN 63.4 114/411 31 
IGF2BP3 sp|O00425|IF2B3_HUMAN 63.7 87/411 38 
ILF2 B4DY09_HUMAN 43 152/411 31 
HNRNPR sp|O43390-
2|HNRPR_HUMAN 
70.9 188/411 193 
EIF2AK2 sp|P19525-
2|E2AK2_HUMAN 
62 14/411 9 
ILF3 sp|Q12906-2|ILF3_HUMAN 95.3 158/411 80 
DDX21 sp|Q9NR30-
2|DDX21_HUMAN 
87.3 179/411 20 
TGF sp|Q92734-2|TFG_HUMAN 55.9 44/411 23 
YBX3 sp|P16989-
2|YBOX3_HUMAN 
40 179/411 51 
SYNCRIP sp|O60506-
3|HNRPQ_HUMAN 
69.6 197/411 617 
SSB LA_HUMAN 46.8 102/411 245 
YBX1 YBOX1_HUMAN 35.9 233/411 66 
NCL NUCL_HUMAN 76.6 261/411 169 
SEC13 A8MXL6_HUMAN 35.5 61/411 3 
PURA PURA_HUMAN 34.9 27/411 7 
TPM2 sp|P07951|TPM2_HUMAN 32.8 113/411 4 
TUBA1B sp|P68363|TBA1B_HUMAN 50.1 389/411 39 
TUBB Q5JP53_HUMAN 49.5 382/411 37 
TUBB4B TBB4B_HUMAN 49.8 376/411 25 
  
Table 4.1: Proteins that specifically interacted with the first 300 nucleotides of the YTHDF2 3’ 
UTR. Detailed information including gene symbol, accession number, protein size (in kDa), number of 
times protein was found in Crapome database experiments and number of spectral counts in YTHDF2 
3’ UTR sample. 
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motif analysis (Fig. 4.5D). Based on these conditions, we identified IGF2BP1, IGF2BP3 and 
HNRNPQ as the most promising candidates. 
 
4.2.7 IGF2BP1 and IGF2BP3 are expressed highly in iPSCs 
We followed up on IGF2BP1 and IGF2BP3 (hereafter referred to as IGF2BP1/3) first due to 
their molecular weight (~63.4 and 63.7 kDa, respectively; Fig. 4.5B), as well as existing 
evidence that they may bind the YTHDF2 3’ UTR (Cook et al. 2011) and are upregulated in 
hESCs (Conway et al. 2016). The IGF2BP family has also previously been implicated in stem 
cell maintenance (Degrauwe et al. 2016). Interestingly, the IGF2BP family of proteins binds m6A 
methylated transcripts to promote mRNA stability and translation (Huang et al. 2018a).  
Our RNA sequencing data from Chapter 3 showed that IGF2BP1/3 mRNAs are in the top 
15th percentile of expression for all genes expressed in iPSCs (See GSE133898). Western blots 
show that both IGF2BP1/3 proteins are expressed in iPSCs and essentially undetectable in 
HFFs (Fig. 4.6A,B). These findings, coupled with our results, lead to the intriguing notion that 
YTHDF2, a protein which targets m6A methylated transcripts for degradation, might itself be 
regulated by the same epigenetic modification. It is important to note there is a third member of 
the IGF2BP family, IGF2BP2. Initially we focused on IGF2BP1/3, as they were present in our 
MS data, and are expressed highly in hESCs compared to differentiated fibroblasts, whereas 
IGF2BP2 protein expression does not change (Conway et al. 2016). 
 
4.2.8 Depletion of IGF2BP1/3 has a modest effect on YTHDF2 protein expression 
Sequence analysis of the 0-300 region of the YTHDF2 3’ UTR revealed there were six 
potential IGF2BP1/3 binding sites. Of these, previous PAR-CLIP and eCLIP sequencing 
experiments identified peaks at the two m6A sites and the underlined consensus binding motifs 
(Fig. 4.5D) (Hafner et al. 2010; Huang et al. 2018a; Dunham et al. 2012). Intriguingly, one of 






Figure 4.6: IGF2BP1/3 are highly expressed in iPSCs and feature multiple binding sites in the 
first 300 nucleotides of the YTHDF2 3’ UTR. A: Western blot to detect IGF2BP1/3 in three 
independent iPSC and HFF extracts. GAPDH was used as a loading control. Asterisk represents non-
specific band. B: Quantification of (A). Asterisks indicate significant difference in the relative mean 




bind to this section in the presence or absence of m6A. To efficiently evaluate both IGF2BP1/3, 
we depleted their expression via siRNA-mediated knockdown in HeLa cells. We performed 
individual and combined depletions of IGF2BP1/3 because of the homology between them (73% 
amino acid sequence identity), which results in some redundant function (Bell et al. 2013). 
Knockdown efficiency of IGF2BP1/3 varied for each siRNA treatment compared to a negative 
siRNA control (Fig. 4.7A-D). However, the siRNA targeting IGF2BP3 elicited the highest 
knockdown efficiency of both IGF2BP1/3 at >80% and >60%, respectively. Thus, this was the 
treatment we were most interested in. If translation of YTHDF2 mRNA in HeLa cells is 
enhanced by recruitment of one or both of IGF2BPs, then we would expect to see a decrease in 
YTHDF2 protein expression following knockdown. We observed a modest (~25-30%) but 
statistically significant decrease in YTHDF2 expression following treatment with the siRNA 
targeting IGF2BP3, but no statistically significance in samples treated with the siRNA targeting 
IGF2BP1 or the combined siRNAs (Fig. 4.8A,B). This was not unexpected, as the knockdown 
efficiency of both IGF2BP1/3 was most robust with IGF2BP3 siRNA. However, this is a small 
change compared to the difference in YTHDF2 expression between iPSCs and HFFs (Fig. 3.1). 
We also assessed the luciferase activity produced from our reporter containing the full length 
YTHDF2 3’ UTR following IGF2BP KD and observed no significant changes in luciferase activity 
(Fig. 4.8C). Thus, these findings suggest that IGF2BP1/3 are not the primary factor(s) 
enhancing translation of YTHDF2. 
 
4.2.9 Depletion of m6A deposition also has a modest effect on YTHDF2 protein expression 
Although the nominal reduction in YTHDF2 protein expression following IGF2BP1/3 
depletion cannot explain the difference in YTHDF2 expression between iPSCs and HFFs (Fig. 
3.1), m6A might influence translation of YTHDF2 mRNA through a different reader protein. To 
investigate this idea, we interfered with m6A deposition in HeLa cells via siRNA-mediated 






Figure 4.7: Depletion of IGF2BP1/3 or the methyltransferase components METTL3 and WTAP 
in iPSCs. A-D: A and C are representative image of western blots to detect IGF2BP1 and IGF2BP3, 
respectively, in iPSC extracts transfected with a negative control or IGF2BP1, IGF2BP3 or both 
siRNA(s). GAPDH was used as a loading control. B and D are quantification of (A) and (C), 
respectively. Asterisks indicate significant difference in the relative mean protein expression between 
negative control and target-specific samples (*p-value<0.05, **p-value<0.005). E: Western blots to 
detect METTL3 or WTAP in iPSC extracts transfected with a negative control or combination of 
METTL3 and WTAP siRNA(s). GAPDH was used as a loading control. Percent protein remaining is 






Figure 4.8: Depletion of IGF2BP1/3 or METTL3 and WTAP has a modest effect on YTHDF2 
expression. A: Representative image of western blots to detect YTHDF2 in iPSC extracts transfected 
with a negative control or IGF2BP1, IGF2BP3, both or METTL3 and WTAP siRNA(s). GAPDH was 
used as a loading control. B: Quantification of (A). Asterisks indicate significant difference in the 
relative mean protein expression between negative control and target-specific samples (*p-
value<0.05, **p-value<0.005). C: Relative Renilla luciferase activity of HeLa cells transfected with a 
construct containing the first 300 nucleotides of the YTHDF2 3’ UTR and a negative control or 
IGF2BP1, IGF2BP3, both or METTL3 and WTAP siRNA(s). No significant difference was observed in 




We validated the knockdown efficiency of concurrent METTL3 and WTAP siRNA treatment 
compared to a negative siRNA control via western blots (Fig. 4.7E). If enhanced translation of 
YTHDF2 mRNA is m6A-dependent, then we would predict inhibiting methylation via METTL3-
WTAP knockdown would decrease YTHDF2 protein expression. Again, we observed a modest 
(~30%) but statistically significant decrease in YTHDF2 expression following siRNA treatment, 
similar to that of IGF2BP3 depletion (Fig. 4.8A,B). Moreover, we observed no significant change 
in the luciferase activity produced from our reporter containing the full length YTHDF2 3’ UTR 
following METTL3-WTAP depletion (Fig. 4.8C). These findings, coupled with our results above 
(section 4.3.8), indicate that neither IGF2BP1/3 nor m6A methylation are solely responsible for 
enhancing translation of YTHDF2. 
 
4.2.9 YTHDF2 expression is not influenced by changes in HNRNPQ expression 
Finally, we evaluated HNRNPQ as a potential regulator of YTHDF2 translation. Like 
IGF2BP1/3, HNRNPQ is approximately 70 kDa in size and promotes translation (Svitkin et al. 
2013). Moreover, HNRNPQ also has several predicted binding sites within the first 300 
nucleotides of the YTHDF2 3’ UTR (Fig. 4.5C). We knocked down HNRNPQ in HeLa cells and 
achieved a ~75% decrease in expression when compared to a negative control siRNA (Fig. 
4.9A,B). Again, we predicted that if HNRNPQ enhanced the translation of YTHDF2 mRNA we 
would expect to see a decrease in YTHDF2 expression following depletion of HNRNPQ. 
Regrettably, we observed no change in endogenous YTHDF2 expression following depletion of 
HNRNPQ when compared control samples (Fig. 4.9C,D). Moreover, there was no change in 
luciferase activity of the full length YTHDF2 3’ UTR construct (Fig. 4.9E). In sum, HNRNPQ 







Figure 4.9: Depletion of HNRNPQ has no effect on YTHDF2 expression. A-D: A and C are 
representative image of western blots to detect HNRNPQ and YTHDF2, respectively, in iPSC extracts 
transfected with a negative control or HNRNPQ siRNA. GAPDH was used as a loading control. B and 
D are quantification of (A) and (C), respectively. Asterisks indicate significant difference in the relative 
mean protein expression between siRNA negative control or HNRNPQ depleted samples (**p-
value<0.005). No significant decrease was observed in D. E: Relative Renilla luciferase activity of 
HeLa cells transfected with a construct containing the first 300 nucleotides of the YTHDF2 3’ UTR and 
a negative control or HNRNPQ-targeting siRNAs. No significant difference was observed in the 





In the experiments described above, we identified a 300 nt region of the YTHDF2 3’ UTR 
which enhances translation and presumably is responsible for increased expression of YTHDF2 
in iPSCs. We showed that YTHDF3, which can also facilitate degradation of m6A-modified 
transcripts (Shi et al. 2017), has relatively constant protein abundance throughout 
differentiation. Moreover, the transition out of a pluripotent state down either the neural or 
mesoderm lineage reduces YTHDF2 protein expression. YTHDF2 protein expression (Fig. 3.1), 
but not mRNA abundance, is dramatically higher in iPSCs compared to HFFs. This suggests 
YTHDF2 is being regulated at the level of translation or protein stability. To this end, we 
discovered that the 0-300 nucleotide region of the YTHDF2 3’ UTR contains elements which 
enhance the translation of a luciferase reporter RNA. Through MS, we identified 30 RBPs that 
uniquely associate with this region of the YTDHF2 3’ UTR. Based on our MS data and previous 
reports in the literature (Yang et al. 2017; Huang et al. 2018a), we screened several potential 
candidates as regulators of YTHDF2 expression including miR-145, m6A methylation, 
IGF2BP1/3 and HNRNPQ. Some of these factors had a modest effect on YTHDF2 expression, 
however, none were potent enough to be considered the primary mechanism of mediating 
translation of YTHDF2. Overall, our data support the idea that YTHDF2 is a key m6A reader that 
is up-regulated in pluripotent stem cells via translational mechanisms to help iPSCs maintain a 
pluripotent state until a differentiation signal is received. 
Although the candidates we have screened so far as regulators of YTHDF2 translation have 
exhibited a modest effect at best, we do need to address some caveats in the experiments 
which do not allow us to rule them out completely. The previous study which characterized miR-
145 as a regulatory of YTHDF2 found that both mRNA and protein expression were affected by 
miR-145 expression (Yang et al. 2017). This finding is contrary to our observations that 
YTHDF2 protein expression fluctuates but mRNA abundance remains unchanged between 
iPSCs and differentiated cell types. Moreover, the experiments Yang et al., 2017 were 
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performed exclusively in cancer cell lines, whereas our experiments were done in a combination 
of stem cell and cancer cell lines. Indeed, there are differences in gene expression between the 
two cell types (Cantz et al. 2008; Sánchez et al. 2016; Ye et al. 2015), which can influence 
regulatory mechanisms. Thus, the lack of a decrease in YTHDF2 mRNA abundance following 
overexpression of miR-145 in iPSCs we observed may be due to factor(s) that regulate 
YTHDF2 in addition to miR-145. Moreover, these factor(s), presumably enhancing YTHDF2 
translation in iPSCs, may be highly abundant and/or able to outcompete miR-145, even upon 
over expression. 
In regards to the follow up experiments on our MS data, the level of depletion we achieved 
for IGF2BP1/3, HNRNPQ and/or METTL3 and WTAP was perhaps not enough to elicit a 
biological effect. Indeed, our sequencing analysis and previous reports have suggested the 
IGF2BP family are highly expressed in stem cells. Thus, even though we achieved ~70% 
knockdown of both proteins (Fig. 4.7), there may be enough protein still remaining to regulate 
YTHDF2. Future experiments using knockout cell lines generated via CRISPR/Cas9 would likely 
provide better insight into this matter. Additionally, IGF2BP2 may also influence YTHDF2 
expression. Although our MS results indicated only IGF2BP1/3 uniquely interacted with the 
YTHDF2 3’ UTR, there is almost 60% amino acid sequence identity between the three proteins 
(Bell et al. 2013), which results in a fair amount of target overlap according to previous CLIP-seq 
experiments (Huang et al. 2018a; Conway et al. 2016). Moreover, the IGF2BP proteins are able 
to heterodimerize with each other (Nielsen et al. 2004), suggesting that even if IGF2BP2 does 
not directly bind to YTHDF2 mRNA, it may still have an effect on its regulation. Based on this 
information, future experiments should take into account all the IGF2BP proteins when 
assessing the potential to regulate YTHDF2.  
Similar to the IGF2BPs, the ~75% knockdown efficiency of HNRNPQ we achieved may not 
be enough to impact translation of YTHDF2. We did observe in preliminary data that the mRNA 
abundance of two known targets of HNRNPQ, GAP43 and SYT1, was down- and up-regulated, 
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respectively, as expected based on previous reports (Williams et al. 2016; Mizutani et al. 2000) 
(Appendix 3). This suggests there was some biological effect from the knockdown. However, 
evaluation of YTHDF2 expression in a knockout cell line is necessary to fully eliminate 
HNRNPQ as a potential regulator of YTHDF2 expression. In addition, RIPs can be utilized to 
validate the RNA-protein interaction reported in our MS data.  
Finally, the knockdown efficiency of WTAP and METTL3 in HeLa cells appears to be on par 
with that of what we achieved in iPSCs in Chapter 3 (Fig. 3.9). Thus, we would predict a similar 
effect on m6A deposition. However, the experiments were performed in two different cell types, 
thus the impact on global m6A levels may differ. Assessment of global m6A levels via dot blot in 
control and siRNA-treated cells would be necessary to ensure that sufficient depletion was 
achieved. As mentioned above, there are differences in gene expression and regulatory 
mechanisms between cancer cell lines, like HeLa cells, and endogenous stem cells that also 
need to be taken into account when investigating factors that may enhance YTHDF2 translation 
(Cantz et al. 2008; Sánchez et al. 2016; Ye et al. 2015). Thus, the results of any future 
experiments performed in HeLa cells, positive or negative, need to be validated at some level in 
iPSCs. In sum, the results from our experiments indicate the IGF2BPs, HNRNPQ and m6A 
methylation are not high priority candidates as regulators of translation of YTHDF2. However, 
until the points above are addressed, we cannot rule these factors out completely. 
There are still other promising candidates from our list we have yet to follow up on including 
YXB1 (aka YB-1 or p50) and La (aka SSB). Both of these proteins have previously been 
implicated as regulators of mRNA translation (Evdokimova et al. 2009, 2006; Kim 2001; Brenet 
et al. 2009). Phosphorylation of YXB1 via AKT1 inhibits association of YXB1 with the 5’ cap, 
which represses translation (Nekrasov et al. 2003), and promotes interactions with mRNA UTRs 
where YXB1 promotes translation (Evdokimova et al. 2006, 2009). Intriguingly, YBX1 interacts 
with the major pluripotency factor NANOG mRNA to up-regulate mRNA and protein expression 
in mESCs (Guo et al. 2016). Moreover, YBX1 is highly expressed in certain areas of mouse 
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fetal brain tissue and is important for neural tube closure during the early stages of embryonic 
development (Fotovati et al. 2011; Uchiumi et al. 2006). Both of these observations are in line 
with the activity we predict a regulator of YTHDF2 might exhibit. Alternatively, La was initially 
found to regulate translation of viral RNAs (Svitkin et al. 1994). However, several studies have 
since described its impact on endogenous mRNA translation (Kim 2001; Trotta et al. 2003). Like 
YBX1, La-mediated translational regulation can be influenced by phosphorylation via AKT1 
(Brenet et al. 2009). Moreover, La is important for the establishment and maintenance of 
mESCs during early development (Park et al. 2006). Based on the evidence outlined above, 
both YBX1 and La appear to be promising candidates and future experiments may implicate 
one of these two proteins as the primary regulator of YTHDF2 translation in iPSCs. However, it 
will be important to take into account PTMs during these future experiments, as the regulatory 
activity of both proteins can be influenced by phosphorylation (Evdokimova et al. 2006; Brenet 
et al. 2009). 
It is also important to note that the regulation of YTHDF2 translation in iPSCs may be 
influenced by multiple factors. Indeed, two miRNAs have already been identified as regulators of 
YTHDF2 expression (Yang et al. 2017; Li et al. 2018a). Expression of miR-145, which regulates 
several of the major pluripotency factors, is increased upon stem cells exit from pluripotency (Xu 
et al. 2009) and its expression and regulatory activity continue to influence gene expression as 
NPC differentiate further down the neural lineage (Morgado et al. 2016). Perhaps then, an 
unidentified factor enhances the translation of YTHDF2 mRNA in a pluripotent state and, upon 
exiting pluripotency, miR-145 takes over as a repressor of translation. Alternatively, two or more 
RBPs may concomitantly regulate YTHDF2 translation. This is not an uncommon occurrence, 
both the IGF2BPs as well as YTHDF1 and YTHDF3 have redundant functions and targets (Bell 
et al. 2013; Li et al. 2017; Shi et al. 2017). However, the ability to tease this out in regards to 
regulation of YTHDF2 would require more rigorous experiments. 
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In conclusion, YTHDF2 protein expression decreases as pluripotent stem cells differentiate 
into other cell types. We believe elements in the 3’ UTR of YTHDF2 mRNA facilitate these 




Chapter 5: Mutual repression of the RNA-binding protein PCBP2 and long non-




Since reprogramming of human somatic cells to create iPSCs was first achieved in 2007 
(Takahashi et al. 2007), our understanding of how gene expression is regulated to maintain 
pluripotency and facilitate controlled differentiation has increased exponentially (Takahashi and 
Yamanaka 2016). It is clear that both transcriptional, and post-transcriptional events play vital 
roles and must be tightly coordinated. Nevertheless, the contributions of many, if not most, 
RBPs and lncRNAs to the establishment and maintenance of pluripotency remains largely 
uncharacterized. 
Tight control of mRNA abundance and processing is central to achieving cell-state 
transitions. Changes in alternative splicing (Fiszbein and Kornblihtt 2017) and polyadenylation 
(Mueller et al. 2013; Ji and Tian 2009) are clearly connected with pluripotency and 
differentiation, and in some cases the RBPs responsible have been identified. For example, 
MBNL proteins are repressed in stem cells and up-regulated during differentiation to block stem 
cell-specific splicing events, including a switch in splicing of the FOXP1 transcription factor 
which in turn regulates a number of pluripotency factors (Venables et al. 2013; Cieply et al. 
2016; Han et al. 2013a). Beyond mRNA processing, export (Ratnadiwakara et al. 2018), 
translation (Sampath et al. 2008; Sugiyama et al. 2017) and mRNA stability (Lloret-Llinares et 
al. 2018; Kami et al. 2018) also contribute  to the tight regulation of gene expression during cell-
state transitions and each of these steps are regulated by RBPs. 
Previously, we and others have noticed that mRNAs containing CREs are differentially 
regulated in stem cells (Huang et al. 2015b; Neff et al. 2012). Several RBPs recognize C-rich 
sequences including the PCBP family of KH domain proteins, hnRNP K and TIAR. Among 
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these, PCBP2 (also known as αCP2, and hnRNP E2) influences mRNA metabolism at multiple 
steps including splicing (Ji et al. 2018), polyadenylation (Ji et al. 2013), nuclear export (Xia et al. 
2015; Yanatori et al. 2016), translation (Smirnova et al. 2019) and decay (Han et al. 2013b; 
Zhang et al. 2015a), as well as regulating miRNA processing and acting as an iron chaperone 
(Li et al. 2012; Yanatori et al. 2016).  
Given the many shared properties of stem cells and cancer cells it is relevant that PCBP2 is 
aberrantly expressed in a variety of (Chang et al. 2007; Chen et al. 2018; Han et al. 2013b; 
Perron et al. 2018) Specifically, PCBP2 is up-regulated in gastric cancer and positively 
regulates translation of CDK2 mRNA via binding to the 3’ UTR (Chen et al. 2018). The increase 
in CDK2 expression enhances the viability of gastric cancer cells. Likewise, during progression 
of chronic myeloid leukemia (CML), PCBP2 is up-regulated and associates with the 5’UTR of 
C/EBPα mRNA where it represses translation (Chang et al. 2007), preventing myeloid 
differentiation and favoring a cancer stem cell phenotype. PCBP2 is also up-regulated in glioma 
where it binds to the 3’ UTR of FHL3 mRNA (Han et al. 2013b). However, rather than 
influencing translation, PCBP2 facilitates decay of FHL3 mRNA, which subsequently promotes 
proliferation and represses apoptosis. 
Strictly speaking from a developmental biology perspective, PCBP2 is essential during 
embryogenesis as PCBP2 knockout is lethal at day E13.5 (Ghanem et al. 2015). Finally, PCBP2 
regulates hematopoietic stem cells differentiation by modulating splicing of the master regulator 
RUNX1 (Ghanem et al. 2018). Based on the evidence outlined above, we hypothesized that 
pluripotent stem cells utilize PCBP2 to modulate differentiation and self-renewal. 
Here, we report that extended depletion of PCBP2 in self-renewing iPSCs disrupts the 
expression of multiple pluripotency markers and leads to precocious differentiation. At the level 
of the transcriptome, PCBP2 depletion results in down-regulation of several transcripts 
associated with pluripotency and development, including LIN28B, and the up-regulation of a 
class of lncRNAs that contain human endogenous retrovirus subfamily H (HERV-H) elements. 
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Intriguingly, HERV-H lncRNA abundance also influences PCBP2 protein expression, thus 
regulation is reciprocal. Moreover, differentiation of iPSCs into any of the three germ layers, 
which dramatically reduces HERV-H lncRNAs expression, leads to increased expression of 
PCBP2. Taken together, our findings reveal stem cells rely on PCBP2 to exert tight control of 
gene expression in a pluripotent state and during differentiation, and this regulation may be 
achieved in part through interactions between PCBP2 protein and HERV-H lncRNAs.  
 
5.2 Results 
5.2.1 PCBP2 plays a role in modulating pluripotency in human iPSCs 
To determine whether PCBP2 plays in modulating pluripotency and/or driving differentiation, 
we evaluated the impact of PCBP2 depletion in iPSCs. iPSCs were transfected daily for up to 6 
days with either a global negative control or PCBP2-targeting siRNA. Efficient knockdown was 
verified at the protein (Fig. 5.1A-C) and mRNA (Fig. 5.1D) levels. Over the course of siRNA 
treatment, we observed interesting changes in cell and colony morphology between control and 
PCBP2 depleted cells. As seen in Figure 5.1E, after four and, most notably, six days we 
observed a loss in the structural integrity of the colonies. Specifically, cells were no longer as 
tightly packed together, and individual cells and cell borders could be discerned. These 
characteristics are indicative of differentiation (Nagasaka et al. 2017; Wakao et al. 2012). 
Another characteristic of stem cell differentiation is enlargement of the nucleus (Rozwadowska 
et al. 2013; Khatau et al. 2012). We quantified the area of nuclei from control and PCBP2 KD 
cells via ImageJ, and observed a significant increase, >2-fold, upon PCBP2 depletion (Fig. 5.2A 
and B). Together, these morphological changes suggest depletion of PCBP2 pushes stem cells 








Figure 5.1: Depletion of PCBP2 effects the cell and colony morphology of iPSCs. A-B: 
Representative western blots using iPSC extracts to demonstrate effective depletion of PCBP2 
following two (A) and six (B) days of siRNA transfection. GAPDH was used as a loading control. C: 
Quantification of (A) and (B). Asterisks indicate significant difference in the relative mean protein 
expression between siRNA negative control and PCBP2 depleted samples (***p-value<0.0005). D: 
RT-dPCR analysis of PCBP2 mRNA abundance in siRNA negative control and PCBP2 depleted 
samples normalized to GAPDH mRNA. Asterisks indicate significant difference in mean abundance 
between control and PCBP2 KD samples (***p-value<0.0005). E: iPSCs were subjected to two, four 
and six days of treatment with control or PCBP2 siRNAs. Bright field images of siRNA negative control 








Figure 5.2: PCBP2 knockdown in iPSCs influences nucleus size and expression pluripotency 
markers. A-C: iPSCs were subjected to six days of treatment with negative control or PCBP2 siRNAs. 
The nucleus was stained with DAPI. (A) Representative image of nucleus size in control and PCBP2 
depleted samples. (B) Nucleus size of siRNA negative control or PCBP2 depleted cells (n=50) was 
quantified via ImageJ. *p-value <0.05. (C) The indicated protein was detected by immunofluorescence 




Consistent with this, we also saw reduced expression of pluripotency factors/markers, OCT4, 
TRA1-60 (Grigor’eva et al. 2019; Vilà-González et al. 2019) and SSEA4 (Zhang et al. 2018b) as 
assessed by IF staining (Fig. 5.2C). In sum, depletion of PCBP2 in iPSCs leads to loss of 
pluripotency and precocious differentiation. 
 
5.2.2 RNA-seq reveals that depletion of PCBP2 influences expression of many genes 
In order to gain insight into the changes in gene expression that occur following PCBP2 
depletion, we performed RNA-sequencing on control and PCBP2-depleted cells following two 
and six days of siRNA treatment. Filtered reads were aligned to the hg19 genome and 
differential expression was determined via DESeq2 (Love et al. 2014). To assess the overall 
structure of the RNA-seq data, samples were analyzed using a distance matrix approach and 
PCA (Fig. 5.3A,B and Appendix 4). As expected, both analyses grouped control and knockdown 
replicates together, indicating treatment was the primary differentiating factor. Moreover, PCBP2 
exhibited one of the most dramatic decreases in expression. All of these observations gave us 
confidence in the quality of our data. 
Differential expression analysis revealed depletion of PCBP2 for six days (Fig. 5.3C; 1,509 
DE transcripts) resulted in over three times more differentially expressed transcripts than seen 
after two days (Appendix 4; 414 DE transcripts). For this reason, and because no visible 
phenotype was observed after two days, we focus here on the results from six day depleted 
samples in our follow up. For more detailed information about the two day results and analysis 
see Appendices 4 and 5.  
 
5.2.3 Down-regulated mRNAs with functions connected to development are associated with 
PCBP2 
We performed a GO-term analysis on the 853 and 656 genes that were up- and down-





Figure 5.3: 1,509 transcripts were differentially expressed following six days of PCBP2 
depletion in iPSCs. A: Distance matrix showing the Euclidean distances between RNA-seq 
replicates. Replicates with a lower distance (darker blue) are more closely correlated in terms of gene 
expression. Distances were calculated from log-stabilized normalized read counts of all detected 
transcripts (>5 read counts per replicate). B: PCA plot of RNA-seq replicates following DESeq2 
analysis (Love et al., 2014). Control and PCBP2 depleted samples are labeled in red and blue, 
respectively. C: Volcano plot generated from sequencing data showing the adjusted p-value (y-axis) 
plotted against the fold change (x-axis) for individual genes. Differentially expressed genes are shown 
in green (differential expression: read counts>5, Benjamini-Hochberg adjusted p-value<0.05 and log2-




GO-term analysis of the up-regulated set of transcripts revealed an enrichment of biological 
functions associated with the immune response (Fig. 5.4A). This is in agreement with reports 
that PCBP2 regulates the mitochondrial antiviral signaling protein (MAVS)-mediated signaling 
pathway (You et al. 2009; Xia et al. 2015; Qin et al. 2017) and interacts with viral RNAs (Hadian 
et al. 2009; Palusa et al. 2012; Bedard et al. 2004). However, we also noticed biological 
functions associated with development, indicated by red asterisk, were over-represented. 
Likewise, we made the same observation in regards to the down-regulated set of transcripts 
(Fig. 5.4B). We identified several genes that exhibited the highest levels of differential 
expression and were associated with GO terms connected to development and independently 
validated the changes in mRNA abundance following PCBP2 depletion via RT-dPCR (Fig. 
5.4C,D). 
Next, we performed RIPs in iPSCs to assess whether these developmental-associated 
transcripts directly interacted with PCBP2. Briefly, PCBP2-specific and IgG control antibodies 
were incubated in iPSC extracts and retrieved using protein G-conjugated magnetic beads. 
RNA was isolated from input, PCBP2 IP and IgG IP samples. RNA-protein interactions were 
evaluated by assessing fold enrichment over IgG for each mRNA via RT-dPCR. Previous 
reports have shown that PCBP2 protein binds its own mRNA (Ghanem et al. 2015), therefore 
PCPB2 mRNA was used as a positive control. The efficiency of the RIP protocol was evaluated 
by measuring PCBP2 abundance in Input, PCBP2 IP and IgG IP samples via western blot (Fig. 
5.5A). Intriguingly, transcripts down-regulated following PCBP2 depletion were significantly 
enriched in PCBP2 IPs compared to IgG (Fig. 5.5B), indicating an interaction with PCBP2 
protein. However, preliminary data suggested none of the up-regulated transcripts are bound by 






Figure 5.4: GO-term analysis reveals transcripts associated with immune response and 
development are up- and down-regulated, respectively, following depletion of PCBP2 in iPSCs. 
A and C: Functional annotation clustering of biological process performed by DAVID on genes up- (A) 
and down- (C) regulated following six days of PCBP2 depletion. Annotation clusters with the highest 
enrichment according to FDR p-value are listed. The number of genes in each cluster is shown next to 
the respective bar and fold enrichment over background is given in parenthesis. B and D: RT-dPCR 
analysis of mRNA abundances in control and PCBP2 depleted samples for transcripts identified as 
up- (B) and down- (D) regulated in the sequence dataset. mRNA abundance normalized to GAPDH 
for transcripts. Data is reported as log2 fold change (PCBP2 KD/Control). Asterisks indicate significant 




















































































Figure 5.5: PCBP2 binds to developmental-associated transcripts and modulates their nuclear 
export. A: Representative western blot showing PCBP2 protein abundance in Input, IgG IP and 
PCBP2 IP samples from RIP experiment. B: RT-dPCR analysis of transcript abundance in IgG and 
PCBP2 IP samples. Data is represented as fold enrichment over IgG (PCBP2 IP/IgG IP). Asterisks 
indicate significant difference in mean enrichment between PCBP2 IP and IgG IP, which is set to one 
(*p-value<0.05, **p-value<0.005, ***p-value<0.0005). C: Half-lives of transcripts from siRNA negative 
control (black) and PCBP2 KD (gray) samples. No significant difference in mean half-life between 
control and PCBP2 KD samples was observed. D: Nuclear localization of transcripts from siRNA 
negative control (black) and PCBP2 KD (gray) samples. tRNA and 45S rRNA were used as 
cytoplasmic and nuclear controls, respectively. Asterisks indicate a significant difference in the mean 




5.2.4 PCBP2 modulates the nuclear export of down-regulated targets associated with 
development 
Once we established a group of transcripts directly targeted by PCBP2, we attempted to 
characterize the underlying mechanism responsible for the observed changes in gene 
expression. To do this, we assessed the impact that PCBP2 expression had on mRNA stability 
and subcellular localization of mRNA targets. Of the three transcripts we tested, none exhibited 
a notable change in mRNA half-life when PCBP2 was depleted (Fig. 5.5C). However, we did 
observe that all three exhibited a significant increase in nuclear localization following PCBP2 
depletion (Fig. 5.5D). In contrast localization of BRIX1 mRNA, which exhibited no change in 
abundance following PCBP2 depletion (see GEO, to be determined), was unaffected. 
 
5.2.5 Regulation of LIN28B is not solely responsible for the morphological changes in PCBP2 
depleted iPSCs 
Among the mRNA targets we identified, LIN28B, like its homolog the pluripotency factor 
LIN28A, also plays an important role in mediating self-renewal and differentiation (Copley et al. 
2013; Piskounova et al. 2011; Chien et al. 2015; Oh et al. 2018; Zhang et al. 2016b). Thus, we 
wondered if the loss of pluripotency and morphological changes we observed following 
depletion of PCBP2 were due to its regulation of LIN28B. To address this, we depleted LIN28B 
in iPSCs for six days via siRNA transfection and evaluated the effect on cell and colony 
morphology compared to transfection with a negative siRNA control. We measured LIN28B 
mRNA abundance via RT-dPCR in control and knockdown samples and observed a ~90% 
decrease (Fig. 5.6A), a more dramatic decrease than seen in our RNA-seq analysis (~60%). 
However, there were no discernable cell and colony morphological changes in iPSCs after six 








Figure 5.6: Depletion of LIN28B in iPSCs does not recapitulate the cell and colony morphology 
changes observed following PCBP2 depletion. iPSCs were subjected to six days of treatment with 
control or LIN28B siRNAs. A: RT-dPCR analysis of LIN28B mRNA abundance in siRNA negative 
control and LIN28B depleted samples normalized to GAPDH mRNA. Asterisks indicate significant 
difference in mean abundance between control and LIN28B KD samples (**p-value<0.005). B: Bright 




To summarize, these findings show the results from our RNA-seq data is reproducible. We 
observed that mRNAs encoding factors associated with pluripotency are both up- and down-
regulated following depletion of PCBP2, but only the down-regulated mRNAs are directly bound 
by PCBP2. However, we have yet to gain the full mechanistic insight into how PCBP2 regulates 
their expression. Furthermore, decreased LIN28B expression is not solely responsible for the 
loss of pluripotency during PCBP2 depletion.  
In addition to mRNAs, there are a number of ncRNAs in the genome that have been 
reported to be involved in pluripotency. However, GO-term annotation is not as well-defined for 
these transcripts, thus it is important to evaluate ncRNAs separately. 
 
5.2.6 lncRNAs with HERV-H elements are up-regulated following PCBP2 depletion and strongly 
interact with PCBP2 protein 
When we sorted differentially expressed transcripts based on their coding potential, we 
found 107 out of 853 (12.5%) up-regulated transcripts were classified as ncRNAs compared to 
only 30 out of 656 (4.5%) down-regulated transcripts (Fig. 5.7A). When we explored the list of 
up-regulated ncRNAs further, we discovered several lncRNAs that contain HERV-H elements 
were present (Fig. 5.7B). This finding piqued our interest because HERV-H lncRNAs are 
expressed almost exclusively in stem cells and their transcription is driven by major pluripotency 
factors like OCT4 (Xie et al. 2013; Ohnuki et al. 2014; Santoni et al. 2012; Lu et al. 2014). 
Moreover, dynamic regulation of HERV-H lncRNAs is crucial for efficient reprogramming of 
iPSCs (Ohnuki et al. 2014). As a result of these findings, HERV-H RNAs have been classified 
as stem cell markers (Mareschi et al. 2019; Lu et al. 2014; Santoni et al. 2012), although their 
functions in iPSCs are not fully understood. Four of the HERV-H lncRNAs present in our 
dataset, indicated by red asterisk in Fig. 5.7B, have previous associations with pluripotency 





Figure 5.7: lncRNAs with HERV-H elements are up-regulated following PCBP2 depletion and 
strongly interact with PCBP2 protein. A: Differentially expressed transcripts were sorted based on 
their protein coding potential. 107 out of 853 (12.5%) of up-regulated and 30 out of 656 (4.5%) of 
down-regulated transcripts were classified as non-coding. B: Log2 fold change of lncRNAs containing 
HERV-H elements according to DESeq2 analysis (see GSE139626). Red asterisks indicate lncRNAs 
with reported associations to pluripotency. C: RT-dPCR analysis of lncRNA abundances in control 
and PCBP2 depleted samples normalized to GAPDH for transcripts. Data is reported as log2 fold 
change (PCBP2 KD/Control). Asterisks indicate significant difference in mean abundance between 
control and PCBP2 KD samples (*p-value<0.05, **p-value<0.005,***p-value<0.0005). D: RT-dPCR 
analysis of transcript abundance in IgG and PCBP2 IP samples. Data is represented as fold 
enrichment over IgG (PCBP2 IP/IgG IP). Asterisks indicate significant difference or trend in mean 





We selected seven HERV-H lncRNAs and validated changes in expression following 
PCBP2 depletion on independent replicates via RT-dPCR. We also assessed global HERV-H 
expression using a primer set that recognizes a region that is generally conserved between 
HERV-H elements (Vargiu et al. 2016). All seven of the HERV-H lncRNAs we measured and 
global HERV-H abundance were significantly increased in PCBP2 depleted samples compared 
to controls (Fig. 5.7C).  
HERV-H elements are unusually C-rich (Jern et al. 2005), and PCBP2 binds to CREs. 
Therefore, we assessed interactions between PCBP2 protein and HERV-H lncRNAs via RIPs, 
as described above. We observed that four out of seven of the lncRNAs tested were 
significantly enriched in PCBP2 IPs compared to IgG control IPs (Fig. 5.7D). Our global HERV-
H primer set did not show significant enrichment (p=0.053), perhaps because only a subset of 
HERV-H elements are recognized by PCBP2. The observation coupled with the fact all the 
HERV-lncRNAs assessed here were significantly increased following depletion of PCBP2 in 
iPSCs was rather curious. Intriguingly, changes in the abundance of one HERV-H lncRNA can 
influence the expression of several others (Zhang et al. 2019a) (see 5.3 Discussion for more 
details). In summary, HERV-H lncRNAs are up-regulated following depletion of PCBP2 in iPSCs 
and a majority directly recruit PCBP2 protein. 
 
5.2.7 The sequence context of HERV-H elements influences PCBP2 interactions 
We analyzed the distribution of cytosine across the length of each lncRNA as well as the 
percent overlap with the HERV-H consensus sequence (Table 5.1) (Vargiu et al. 2016). This 
approach failed to identify any differentiating characteristics between lncRNAs that were bound 
by PCBP2 (indicated by underline) and those that were not.  
 Next, we evaluated if specific region(s) of the HERV-H genome are present in HERV-H 
RNAs that interact with PCBP2. To do this, we used BLASTN under default parameters 
(Altschul et al. 1997) to align the lncRNAs to the HERV-H consensus sequence 
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Table 5.1: Sequence analysis of HERV-H lncRNAs. Information gathered from sequence analysis of 
the HERV-H lncRNAs includes cytosine (C) percentage across the entire HERV-H lncRNA as well as only 
the HERV-H regions and percent overlap with the HERV-H consensus sequence. HERV-H lncRNAs 




Percent C in total 
transcript 
Percent C in 
HERV-H regions 
Percent overlap with HERV-
H consensus sequence 
LINC01356 32.8 32.4 66.1 
LINC00458 29.6 33 55.8 
ESRG 30.3 33.7 63.8 
LINC-ROR 24.2 32.5 51.5 
LINC00678 24.4 33.3 60.9 
LNCPRESS2 17 29.6 53.4 





(Vargiu et al. 2016). Portions of all the lncRNAs, except ERVH48-1, which was not bound by 
PCBP2 (Fig. 5.7D), aligned to various regions of the HERV-H consensus sequence (Fig. 5.8). A 
more in-depth alignment analysis of ERVH48-1 alignment via Geneious Prime revealed 
numerous short regions did in fact align to the HERV-H consensus sequence, however they 
were discarded based on the default parameters of BLASTN. Notably, all of the other lncRNAs 
exhibited high alignment scores to a portion of the 5’ long tandem repeat (LTR; ~500-800 
nucleotide region of the consensus sequence) and moderate alignment scores to sections of the 
3’ LTR (~10,600-11,300 nucleotide region). Thus, these HERV-H regions likely do not influence 
PCBP2 interactions as they are present in both sets of lncRNAs. Intriguingly, the four lncRNAs 
that were bound by PCBP2 aligned to a portion of the Gag-Pro-Pol domain (~3200-3400 region 
of the consensus sequence) that was absent for the other lncRNAs. Moreover, LINC01356, 
which exhibited the strongest interaction with PCBP2, had an additional unique alignment to an 
upstream portion of the 5’ LTR (~150-425 nucleotide region). Indeed, there are several highly C-
rich stretches within these two regions which may facilitate binding of PCBP2 protein. Together, 
these results suggest binding of PCBP2 to HERV-H containing lncRNAs is influenced by the 
HERV-H region present in the lncRNA. 
 
5.2.8 Reciprocal regulation occurs between PCBP2 protein and HERV-H lncRNAs 
There is evidence that association of RBPs with ncRNAs can sequester the RBP (Lee et al. 
2016; Hirose et al. 2014; Kim et al. 2016), or in some cases induce its decay (Wang et al. 
2015a; Yoon et al. 2013). Moreover, a form of this regulation exists for PCBP2, as miR-328 
regulates PCBP2 activity by serving as a decoy and soaking up PCBP2 protein (Eiring et al. 
2010). As mentioned above, HERV-H lncRNAs are almost exclusively expressed in pluripotent 






Figure 5.8: Individual HERV-H lncRNAs align to different regions of the HERV-H consensus 
sequence. HERV-H lncRNAs were aligned to the reported HERV-H consensus sequence (Vargiu et 
al., 2016) using BLASTN under default parameters (Altschul et al. 1997). A color key was used to 
represent the alignment scores for different regions across each HERV-H lncRNA. A higher alignment 
score indicates the HERV-H lncRNA and HERV-H consensus sequences are more analogous to one 
another. Approximate annotations for the HERV-H consensuses sequence are listed at the top. 
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Based on this information, we wondered if the group of HERV-H lnRNAs that interacted with 
PCBP2 somehow also regulated PCBP2 activity or expression.  
We chose to investigate the regulation of PCBP2 expression first. To do this, we selected 
the lncRNA with the strongest association with PCBP2, LINC01356 (which also exhibited the 
third highest expression level in iPSCs relative to the other HERV-H lncRNAs in this study (See 
GSE139626), and reduced its expression in iPSCs via transfection of siRNAs targeting a unique 
region of the transcript and measured PCBP2 expression. We predicted depletion of LINC01356 
in iPSCs would alter PCBP2 expression. We observed >60% knockdown of LINC01356 via RT-
dPCR (Fig. 5.9A). There was no dramatic effect on the cell or colony morphology of LINC01356 
depleted iPSCs and no change in OCT4 protein expression (Fig. 5.9B,C). As predicted, PCBP2 
protein expression was dramatically increased in LINC01356 depleted iPSCs compared to 
those transfected with a negative control as determined by western blot (Fig. 5.9B,C) and IF 
(Fig. 5.9D). Moreover, PCBP2 mRNA levels were unchanged (Fig. 5.9F). Thus, depletion of 
LINC01356 results in the up-regulation of PCBP2 protein, but not mRNA, abundance. The 
absence of any change in mRNA abundance indicates PCBP2 repression must occur either 
through reduced translation or destabilization of the protein. 
Given the high homology and overlap in targets between PCBP2 and PCBP1 (Ghanem et 
al. 2015), we evaluated whether other PCBPs were also influenced by LINC01356. Western 
blotting revealed that PCBP1, but not the more divergent PCBP3, was increased following 
depletion of LINC01356 (Fig. 5.9B,C). This indicates that binding to LINC01356, and the 
subsequent regulatory mechanism, is unique to PCBP1 and 2. 
To directly evaluate the effects individual HERV-H lncRNAs have PCBP2 expression, we 
artificially introduced them into HeLa cells, which normally have no detectable HERV-H 
expression (Schön et al. 2001). We transfected expression plasmids for individual HERV-H 





Figure 5.9: Depletion of LINC01356 in iPSCs results in a dramatic increase in PCBP2 
expression. A: RT-dPCR analysis of LINC01356 abundance in siRNA negative control and 
LINC01356 depleted samples normalized to GAPDH mRNA. Asterisks indicate significant difference 
in mean abundance between control and LINC01356 KD samples (***p-value<0.0005). B,C: 
Representative western blots to detect PCBP2 (B) and PCBP1, PCBP3 and OCT4 (C) in negative 
control and LINC01356 depleted iPSC extracts. GAPDH was used as a loading control. D: 
Quantification of (B) and (C). Asterisks indicate significant difference in the relative mean protein 
expression between negative control and LINC01356 depleted samples (*p-value<0.05, **p-
value<0.005). E: iPSCs were subjected to two days of treatment with negative control or LINC01356 
siRNAs. The nucleus was stained with DAPI. PCBP2 protein was detected by IF staining. Scale bars 
indicate 10 µm. F: RT-dPCR analysis of PCBP2 abundance in siRNA negative control and LINC01356 
depleted samples normalized to GAPDH mRNA. No significant difference was observed in mean 





Figure 5.10: Over expression of LINC01356 or LINC00458 down-regulates PCBP2 protein 
expression. A: RT-dPCR analysis of lncRNA abundance in empty vector control and LINC01356 or 
LINC00458 over expression samples normalized to GAPDH mRNA. Asterisks indicate significant 
difference in mean abundance between control and LINC01356 over expression samples (*p-
value<0.05).No statistical analysis was performed for LINC00458 over expression because this is 
preliminary data and n=1. B: Representative western blot to detect PCBP2 in empty vector control and 
LINC01356 or LINC00458 over expression HeLa extracts. GAPDH was used as a loading control. C: 
Quantification of (B). Asterisks indicate significant difference in the relative mean protein expression 




As expected, over-expression of LINC01356 or LINC00458 resulted in a significant decrease in 
PCBP2 protein expression (Fig. 5.10 B,C). However, expression of LINC01356 elicited a greater 
decrease in expression compared to LINC00458. These findings indicate two different HERV-H 
lncRNAs, LINC01356 and LINC00458, can influence PCBP2 protein expression. Taken 
together, our results suggest a subset of HERV-H lncRNAs, and LINC01356 in particular, may 
regulate PCBP2 protein expression in iPSCs. 
 
5.2.9 PCBP2 expression increases following differentiation of iPSCs into the three germ layers 
In the section above we discovered that certain HERV-H lncRNAs are able to regulate the 
expression PCBP2 protein. Moreover, HERV-H expression is dramatically reduced following 
differentiation of pluripotent stem cells into the three germ layers (Xie et al. 2013; Ohnuki et al. 
2014; Santoni et al. 2012; Lu et al. 2014). Based on this information, we hypothesized that 
differentiation of iPSCs would result in up-regulation of PCBP2. To assess this, we assessed 
PCBP2 expression in iPSCs that were induced to differentiate into each of the three germ layers 
and observed that PCBP2 protein expression increased upon differentiation down all three 
lineages (Fig. 5.11A,B). Differentiation into endoderm and ectoderm elicited a large (>60-fold) 
increase in PCBP2 protein abundance with no detectable effect on mRNA levels (Fig. 5.11C). In 
contrast, differentiation into mesoderm resulted in a more modest yet significant (~6-fold) 
change in protein abundance which was partially accounted for by a ~2-fold change in mRNA 
levels. Taken together, these results suggest PCBP2 expression is up-regulated upon 
differentiation down any lineage and that this is primarily achieved through enhanced translation 
or protein stability. This change in expression correlates with the expected reduction in HERV-H 






Figure 5.11: PCBP2 expression is increased following differentiation of iPSCs into all three 
germ layers. A: Representative western blot of PCBP2 expression in untreated or following 
differentiation down the three germ layers iPSC extracts. GAPDH was used as a loading control. B: 
Quantification of (A). Asterisks indicate significant difference in the relative mean protein expression 
between untreated and differentiated samples (*p-value<0.05). C: RT-dPCR analysis of PCBP2 
mRNA abundance in untreated or following differentiation down the three germ layers iPSC samples. 
Asterisks indicate significant difference in the relative mean mRNA abundance between untreated and 





In this study, we observed that extended depletion of PCBP2 leads to changes in cell and 
colony morphology and reduced expression of pluripotency markers, both of which are signs of 
precocious differentiation. At the level of the transcriptome, transcripts associated with 
pluripotency and development, like LIN28B and PTBP2, are down-regulated following depletion 
of PCBP2, and are retained in the nucleus. In addition, HERV-H-containing lncRNAs, which play 
an important role in stem cell biology and are C-rich (Santoni et al. 2012; Lu et al. 2014), 
experience increased expression after PCBP2 knockdown and interact with PCBP2 protein. 
Interestingly, depletion of LINC01356, one HERV-H-containing target of PCBP2, in iPSCs 
results in a marked increase in PCBP2 protein expression, but does not impact PCBP2 mRNA 
abundance. Moreover, PCBP1, which has high homology to PCBP2, protein expression was 
also increased but the more divergent PCBP3 was not. In reciprocal experiments where 
LINC01356 or LINC00458, another HERV-H target of PCBP2, were over-expressed in HeLa 
cells, PCBP2 protein expression was down-regulated. These findings indicate the HERV-H-
containing lncRNAs and PCBP2 protein mutually repress each other’s expression. In summary, 
the results of our study indicate PCBP2 influences whether a pluripotent stem cell favors a state 
of self-renewal or begins to differentiate. To this end, the interactions between PCBP2 protein 
and HERV-H lncRNAs may have larger implications for stem cell biology. 
As highlighted above, HERV-H lncRNAs have an important, but ill-defined, role in 
maintaining a pluripotent state (Xie et al. 2013; Ohnuki et al. 2014; Santoni et al. 2012; Lu et al. 
2014; Mareschi et al. 2019). Stem cell-specific transcription of HERVs is driven by the presence 
of long-terminal repeats (LTRs), specifically LTR7 in the case of HERV-H lncRNAs, which 
recruits pluripotent transcription factors (Santoni et al. 2012; Xie et al. 2013; Lu et al. 2014). 
LTR-derived transcripts play an important role in regulating the nuclear transcriptome in stem 
cells and associate with enhancer regions involved in the maintenance of pluripotency (Fort et 
al. 2014). To this end, HERV-H lncRNAs influence the creation and boundaries of topologically 
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associating domains (TADs) in pluripotent stem cells (Zhang et al. 2019a). TADs are 
compartments within the chromatin structure that are relatively ‘open’, thus exhibit high levels of 
transcription and are generally conserved between cell types (Dixon et al. 2012, 2015; Jin et al. 
2013). These reports indicate a key function for HERV-H lncRNAs in the nucleus. In this study, 
we observed that the nuclear export of several mRNAs is regulated by PCBP2 (Fig. 5.5D). 
Therefore, it would interesting to determine if nuclear localization of HERV-H lncRNAs is also 
influenced by PCBP2, as this may impact both the activity and expression of HERV-H lncRNAs. 
Alternatively, PCBP2 may be modulating the transcription or stability of HERV-H lncRNAs. 
Depletion of PCBP2 in iPSCs followed by 4sU labeling would allow us to assess both of these 
possibilities simultaneously. Furthermore, altered expression of an individual HERV-H 
abrogates formation of its associated TAD boundaries and impacts expression of genes located 
up to 500 kilobase pairs away (Zhang et al. 2019a). Some of the genes affected by this were 
other HERV-H lncRNAs, suggesting that regulating a subset of HERV-H lncRNA(s) can impact 
the abundance of several other HERVs. This observation may provide some clarity as to how 
changes in PCBP2 expression can influence global HERV-H expression, despite our findings 
that PCBP2 does not directly bind to every HERV-H lncRNA. 
As mentioned above, HERV-H lncRNAs contain elements of a retrovirus (Jern et al. 2004). 
Thus, it is important to note that PCBP2 can modulate immune response, according to our 
findings (Fig. 5.4) as well as many other reports (Xia et al. 2015; You et al. 2009), and can also 
bind to several viral RNAs (Palusa et al. 2012; Blyn et al. 1997), including human 
immunodeficiency virus (HIV) which is also a retrovirus (Lin et al. 2014; Hadian et al. 2009). It is 
therefore plausible that the roles PCBP2 plays in these models may shed light its interaction 
and regulation of HERV-H lncRNAs. However, the majority of these works describe how PCBP2 
is ‘hijacked’ by a specific virus and that binding of PCBP2 to these viral RNAs enhances 
translation and subsequently viral replication (Palusa et al. 2012; Lin et al. 2014; Blyn et al. 
1997). Thus, on the surface, these interactions do not appear to give any mechanistic clues in 
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regards to how PCBP2 may be regulating HERV-H lncRNAs. Nevertheless, findings from these 
fields should be monitored closely, as new developments or the discovery additional interactions 
between viral RNAs and PCBP2 may have a more direct correlation mechanistically to the 
regulation of HERV-H lncRNAs. 
We also observed several mRNAs associated with pluripotency that were impacted by 
PCBP2 depletion. As noted above, LIN28B plays a role in stem cell self-renewal and modulation 
of neuronal differentiation (Copley et al. 2013; Piskounova et al. 2011; Chien et al. 2015; Oh et 
al. 2018). Although the down-regulation of LIN28B following PCBP2 knockdown is not solely 
responsible for the phenotype we observed in PCBP2-depleted iPSCs (Fig. 5.6), it likely does 
have some impact on pluripotency. Of note, LIN28B helps to regulate Let-7 miRNA biogenesis 
(Piskounova et al. 2011; Copley et al. 2013) which has a plethora of downstream consequences 
in cancer progression and cell potency (Sun et al. 2016). Interestingly, there are two isoforms of 
LIN28B (long and short) that differentially regulate Let-7 biogenesis (Mizuno et al. 2018). The 
long-isoform binds and inhibits maturation of Let-7 miRNAs, whereas the short-isoform is able to 
bind but does not inhibit maturation. Thus, it would be interesting for future experiments to 
evaluate i). if PCBP2 differentially regulates the isoforms of LIN28B and ii). how changes in 
PCBP2 expression indirectly impact Let-7 expression. Based on our findings about PCBP2 
expression during differentiation and what is known about Let-7-mediated regulation, we would 
predict that PCBP2 promotes expression of the LIN28B short-isoform, thus increasing 
expression of mature Let-7 miRNAs and driving differentiation.  
Another target of PCBP2, PTBP2, regulates splicing patterns during embryonic development 
and also has ties to neural development (Li et al. 2014b; Licatalosi et al. 2012; Vuong et al. 
2016). Induction of PTBP2 initiates a splicing program that is critical for neuronal maturation and 
survival. Little is known about the post-transcriptional regulation of PTBP2. To date, only miR-
223 has been identified as a negative regulator of PTPB2 in CML (Agatheeswaran et al. 2013). 
Thus, our findings add to the currently limited knowledge regarding post-transcriptional 
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regulation of PTBP2 and present PCBP2 as a positive regulator. In future studies, it would be 
interesting to see if over expression of PCBP2 in iPSCs increases expression of PTBP2 and 
favors differentiation down the neural lineage. 
Above we hypothesized that a subset of HERV-H lncRNAs is responsible for regulating 
PCBP2 expression in iPSCs. In support of this, we identified two HERV-H lncRNAs, LINC01356 
and LINC00458, that are able to repress PCBP2 protein expression (Fig. 5.9 and 5.10). 
However, there are still additional questions to be addressed including: i). What differentiates 
HERV-Hs which are able to regulate PCBP2 vs. those that cannot? ii). By what mechanism do 
HERV-H lncRNAs promote degradation of PCBP2 protein? 
In response to the first of question, our sequence analysis of the different HERV-H lncRNAs 
revealed there is a region of homology, located in the Gag-Pro-Pol domain of the consensus 
HERV-H sequence, that is present in the HERVs bound by PCBP2 and absent in those that are 
not (Fig. 5.7 and 5.8). If this region is key to PCBP2 binding and its subsequent regulation, then 
we would predict that over expression of a HERV-H lncRNA that lacks this region will not impact 
PCBP2 protein levels. We also observed that LINC01356 has a more pronounced influence on 
PCBP2 protein expression compared to LINC00458 (Fig. 5.9 and 5.10), despite both containing 
the Gag-Pro-Pol domain region of interest and able to be bound by PCBP2. As these are 
unlikely to be identical, it may be the sequence present in LINC01356 has a higher binding 
affinity for PCBP2 than the LINC00458 sequence. Additionally, LINC01356 contains a unique 
region of the 5’ LTR in comparison to the other HERV-H lncRNAs we analyzed (Fig. 5.8). It is 
possible elements within this region may augment the repressive capacity of LINC01356 by 
enhancing interactions with PCBP2 and/or facilitating the recruitment of additional factors. We 
provide potential evidence for the former in this study (Fig. 5.7). However, additional research is 
necessary to fully support this notion. For example, we could create LINC01356 constructs with 
deletions of specific HERV-H regions (i.e. the Gag-Pro-Pol region and the unique portion of the 
5’ LTR) and measure their impact on PCBP2 binding affinity and protein expression in HeLa 
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cells. Based on our findings, we predict deletion of the Gag-Pro-Pol region would greatly reduce 
if not abrogate PCBP2 binding affinity towards LINC01356. Moreover, if a PCBP2-LINC01356 
interaction is required for regulation and deletion of the Gag-Pro-Pol region alters binding 
affinity, we would not expect to see a change in PCBP2 protein expression. Likewise, if the 
unique 5’ LTR region in LINC01356 enhances degradation of PCBP2 protein, then transfection 
of a construct with this region deleted should increase PCBP2 expression to a level on par with 
transfection of the LINC00458 construct, if not higher. 
In regards to the second question, future experiments will seek to identify the mechanism, 
and other factors, responsible for changes in PCBP2 protein expression. Due to the high 
binding affinity of PCBP2 for some HERV-H lncRNAs and our findings that PCBP2 protein, but 
not mRNA, is affected by changes in HERV-H expression, we hypothesize repression of PCBP2 
is being achieved through regulation of translation or stability of the protein. Although the former 
is possible, as PCBP2 protein is able to bind its own mRNA and HERV-H lncRNAs (Ghanem et 
al., 2015 and Fig. 5.7), regulation of protein stability seems more likely, as there is no evidence, 
to date, that PCBP2 can bind multiple mRNAs at once. Therefore, we favor initially following up 
on the regulation of protein stability. The first step to investigate this would be to determine if the 
stability of PCBP2 protein is affected following changes in LINC01356 expression (e.g. depletion 
in iPSCs or over expression in HeLas). This could be achieved via cyclohexamide treatment 
following altered LINC0136 expression and measuring PCBP2 protein levels over a time course. 
Additionally, it would be interesting to determine if an interaction between PCBP2 and HERV-H 
lncRNAs is required for regulation to occur. The experiments described above regarding 
LINC01356 deletion constructs may shed some light on this. However, an additional route would 
be to assess how deletion of the KH domains influences protein expression. We could achieve 
this by co-transfection of FLAG-tagged truncated versions of PCBP2 and LINC01356 or control 
constructs in HeLa cells. If binding of PCBP2 to HERV-H lncRNAs is required for regulation, we 
would predict truncated versions would be unaffected by the presence of LINC01356 compared 
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to the control. Some of the future experiments to characterize the regulation of PCBP2 
described above are currently in progress. 
In conclusion, PCBP2 helps to modulate differentiation in pluripotent stem cells by regulating 
the expression of specific mRNAs and ncRNAs. Specifically, the reciprocal regulation between 





Chapter 6: General Discussion 
 
 
The findings in this thesis build upon previous evidence that m6A modifications (Heck and 
Wilusz 2019; Geula et al. 2015) and CREs (Huang et al. 2015b; Neff et al. 2012) can influence 
mRNA decay rates and play important roles in modulating pluripotency in stem cells by 
beginning to characterize the roles of YTHDF2 and PCBP2, RBPs that recognize these RNA 
features, in the context of iPSCs. Below we provide two models that illustrate the proposed 
function of each RBP. 
 
6.1 Expression of YTHDF2 helps maintains a pluripotent state in stem cells by 
repressing a genetic program for neural development  
In Chapters 3 and 4, we provide evidence  that YTHDF2 influences differentiation of 
pluripotent stem cells down the neural lineage. Our findings indicate YTHDF2 protein is 
expressed at relatively high levels in iPSCs and decreases as cells become more differentiated. 
Evidence suggests enhanced translation of YTHDF2 mRNA mediated by an unknown factor 
that interacts with the first 300 nucleotides of the 3’ UTR is the primary mechanism for increased 
expression of YTHDF2. In iPSCs, YTHDF2 binds to and destabilizes neural-specific transcripts 
in an m6A-dependent manner. Moreover, depletion of YTHDF2 in iPSCs prior to induction 
disrupts gene expression, resulting in aberrant expression of neural and pluripotency factors as 
well as precocious differentiation. Based on these findings, we propose a model in which 
YTHDF2 is highly abundant in iPSCs and degrades m6A-modified neural-specific transcripts to 
maintain a pluripotent state (Fig. 6.1). Upon neural induction, down-regulation of an unknown 
factor (referred to as ‘factor X’) results in decreased expression of YTHDF2, which leads to 
stabilization and subsequent increased expression of neural-specific transcripts. This activation 





Figure 6.1: YTHDF2 modulates neural differentiation of iPSCs. Graphical representation of the 
role YTHDF2 plays in modulating pluripotency and neural differentiation. Stem cells utilize YTHDF2 to 
degrade methylated transcripts associated with neural development. Upon neural induction, YTHDF2 
expression is decreased and, in some cases, the methylation status of neural associated transcripts is 
decreased as well. This facilitates subsequent differentiation into a neural progenitor cell. 
 
 



















As described in Chapters 3 and 4, future directions of study might focus on: i). identifying the 
factor(s) involved in enhancing translation of YTHDF2, ii). characterizing how neural-specific 
transcripts, out of a broad spectrum of m6A-modified RNAs in stem cells, are selected by 
YTHDF2, iii)  investigating the impact of YTHDF2-mediated gene expression in downstream 
differentiation events of the neural lineage; i.e. why does YTHDF2 appear to repress iPSC to 
NPC differentiation, yet promote differentiation of NPCs into glial or neuronal cell types (Li et al. 
2018b)? 
 
6.2 PCBP2 regulates multiple aspects of gene expression involved in modulating self-
renewal and differentiation of pluripotent stem cells 
In Chapter 5, we observed that altered expression of PCBP2 in iPSCs results in an apparent 
loss in pluripotency. To this end, transcripts, both mRNAs and ncRNAs, associated with 
pluripotency and development are differentially expressed following depletion of PCBP2 in 
iPSCs. Of note, we discovered lncRNAs that contain HERV-H elements, known to be important 
for pluripotency, are up-regulated following PCBP2 depletion and a subset are bound by PCBP2 
protein. Intriguingly, this regulation is reciprocal, as changes in the expression of some HERV-H 
lncRNAs bound by PCBP2 can also impact PCBP2 protein expression. Overall, our data from 
Chapter 5 indicates that PCBP2 helps to modulate differentiation of iPSCs and the reciprocal 
regulation of HERV-H lncRNAs and PCBP2 protein may be an important aspect of stem cell 
biology. Based on this, we propose a model where PCBP2 participates in multiple regulatory 






Figure 6.2: PCBP2 participates in reciprocal regulation with HERV-H lncRNAs and also 
modulates other aspects of pluripotency in iPSCs. Graphical representation of the roles PCBP2 
plays in modulating self-renewal and differentiation in iPSCs. Notably, PCBP2 and HERV-H lncRNAs 
reciprocally regulate each other. HERV-H lncRNAs are expressed in stem cells and down-regulate 
PCBP2 at the level of translation or protein stability. PCBP2 is dramatically up-regulated in 
differentiated cells and may modulate localization, RNA stability or transcription to down-regulate 
HERV-H lncRNAs. Additionally, PCBP2 up-regulates LIN28B and PTBP2 mRNAs and appears to 




















The balancing act between HERV-H lncRNAs and PCBP2 protein expression is prominent 
in our model. In stem cells, high expression of HERV-H lncRNAs wins out to reduce PCBP2 
protein levels by decreasing protein stability or translation. Upon differentiation, an increase in 
PCBP2 expression may flip the scales, facilitating a decrease in HERV-H expression abrogated 
via mechanisms that are yet to be fully characterized. Alternatively, a down-regulation of HERV-
H lncRNAs, possibly at the transcriptional level, may promote an increase in PCBP2 expression. 
In addition to this reciprocal regulation, PCBP2 also directly interacts with and promotes the 
expression of several mRNAs encoding factors associated with pluripotency and development, 
like LIN28B and PTBP2. Given the frequency of CREs and previous evidence from our lab and 
others regarding CRE the differential expression in pluripotent stem cells and differentiated 
fibroblasts (Neff et al. 2012; Huang et al. 2015b), it is plausible there are additional PCBP2 
targets that may add to this model. Additionally, the indirect effects, some of which are 
presented as preliminary data here, may broaden the impact PCBP2 has on pluripotency. Thus, 
PCBP2 appears to have multiple roles in regards to regulating gene expression during 
pluripotency and differentiation.  
Future directions for research in this area, as described in Chapter 5, might include: i) 
characterizing the mechanism by which PCBP2 modulates expression of HERV-H lncRNAs, 
both directly and indirectly, ii) identifying the HERV-H sequence elements and PCBP2 protein 
domains responsible their interaction, iii) characterizing the regulatory mechanism by which 
HERV-H lncRNAs modulate PCBP2 protein level. 
 
6.3 Implications for clinical use of induced pluripotent stem cells 
As described in Chapter 1, the ability to create patient-specific iPSC lines as well as less 
accessible cell types via differentiation of iPSCs is of great interest for gene therapy, 
personalized medicine and basic research (Cubillo et al. 2018; Avior et al. 2016; Karagiannis 
2019). Moreover, some of these avenues are already being explored (Mandai et al. 2017; Loring 
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2018; Penney et al. 2019). However, additional insight into the mechanisms governing 
pluripotency are necessary to improve the efficiency and accuracy of reprogramming and 
subsequent differentiation of iPSCs to enable their full potential in the clinical setting to be 
reached. Based on the evidence presented in this thesis, modulation of YTHDF2 or PCBP2 may 
enhance the efficiency of certain reprogramming or differentiation protocols. For example, one 
of the more common methods of iPSC neural induction involves inhibition of the transforming 
growth factor-β/SMAD signaling pathway, which typically yields around 80% induction efficiency 
(Chambers et al. 2009; Shi et al. 2012). One of the pathways regulated by this signaling in 
pluripotent stem cells is m6A methylation (Bertero et al. 2018). Thus, including a mechanism to 
modulate YTHDF2 expression, which represses neural programming in iPSCs according to our 
findings (Chapter 3), may increase the efficiency of these protocols. On the other hand, our 
results indicate PCBP2 is more highly expressed in differentiated cell types compared to 
pluripotent stem cells and negatively regulates HERV-H lncRNAs (Chapter 5). Expression of 
HERV-H lncRNAs is critical for reprogramming (Ohnuki et al. 2014). Therefore, the efficiency of 
reprogramming protocols might be enhanced by including a mechanism to down-regulate 
PCBP2. It is important to note these ideas are by no means guaranteed to have any effect on 
reprogramming or differentiation efficiencies. However, given the results of this thesis, they are 
worthy of consideration. 
 
6.4 Concluding remarks 
In the experiments presented here, we established that YTHDF2 plays a key role in the 
ability of m6A methylation to influence self-renewal and neural differentiation of iPSCs by 
targeting neural-specific transcripts for degradation. Destabilization of neural-specific transcripts 
while iPSCs are in a pluripotent state not only prevents inappropriate activation of neural gene 
expression, but also enables rapid and coordinated differentiation to occur upon neural 
induction. Additionally, we demonstrated that YTHDF2 protein expression decreases as 
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pluripotent stem cells differentiate into lineage-specific cell types. Our findings indicate the 
change in YTHDF2 expression is primarily driven by elements in the 3’ UTR of YTHDF2 mRNA 
that help to enhance YTHDF2 translation. 
We also identified PCBP2 as a regulator of differentiation in iPSCs. We observed PCBP2 
protein expression is dramatically increased as iPSCs differentiate into the three germ layers, 
and this change in expression impacts mRNAs and HERV-H lncRNAs associated with 
pluripotency and development. Furthermore, a subset of HERV-H lncRNAs can also influence 
PCBP2 protein expression, indicating PCBP2 and HERV-H lncRNAs participate in reciprocal 
regulation. 
Although there are numerous regulatory factors and networks involved in pluripotency, the 
studies presented here further our understanding of the post-transcriptional mechanisms utilized 
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Appendix 1: miR-145 is highly expressed in HFFs compared to iPSCs 
RT-dPCR analysis of miR-145 abundance in HFFs and iPSCs normalized to 5S rRNA. Asterisks indicate 






Appendix 2: Depletion of DICER does not impact YTHDF2 expression in HeLa cells 
A: Western blot to detect YTHDF2 in control and DICER knockdown HeLa cell lines; three and two 
independent extracts were assessed, respectively. B: Quantification of (A). No significant decrease in the 




Appendix 3: Depletion of HNRNPQ has a biological effect in iPSCs 
RT-dPCR analysis of GAP43 and SYT1, two known HNRNPQ targets, mRNA abundance in siRNA 
negative control and HNRNPQ depleted iPSC samples normalized to GAPDH mRNA. No statistical 













Appendix 4: 414 transcripts were differentially expressed following two days of PCBP2 
depletion in iPSCs 
A: Distance matrix showing the Euclidean distances between RNA-seq replicates. Replicates with a lower 
distance (darker blue) are more closely correlated in terms of gene expression. Distances were calculated 
from log-stabilized normalized read counts of all detected transcripts (>5 read counts per replicate). B: 
PCA plot of RNA-seq replicates following DESeq2 analysis (Love et al., 2014). Control and PCBP2 
depleted samples are labeled in red and blue, respectively. C: Volcano plot generated from sequencing 
data showing the adjusted p-value (y-axis) plotted against the fold change (x-axis) for individual genes. 
Differentially expressed genes are shown in green (differential expression: read counts>5, Benjamini-




Appendix 5: GO-term analysis and independent validation of results from two day 
PCBP2 in iPSCs 
A and C: Functional annotation clustering of biological process performed by DAVID on genes up- (A) 
and down- (C) regulated following two days of PCBP2 depletion. Annotation clusters with the highest 
enrichment according to FDR p-value are listed. The number of genes in each cluster is shown next to 
the respective bar. Fold enrichment are not listed because these numbers were skewed due to the low 
number of differentially expressed genes. B and D: RT-dPCR analysis of mRNA abundances in control 
and PCBP2 depleted samples for transcripts identified as up- (B) and down- (D) regulated in the 
sequence dataset. mRNA abundance normalized to GAPDH for transcripts. Data is reported as log2 fold 
change (PCBP2 KD/Control). Asterisks indicate significant difference in mean abundance between 














































































Appendix 6: mRNAs up-regulated following PCBP2 depletion in iPSCs are not bound by 
PCBP2 protein 
RT-dPCR analysis of transcript abundance in IgG and PCBP2 IP samples. Data is represented as fold 
enrichment over IgG (PCBP2 IP/IgG IP). No statistical analysis was performed because this is preliminary 
data and n=1. 
 
 
 
 
 
 
